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Zusammenfassung
Diaphanous-related formins (DRFs) sind Multidomänen-Proteine, die an der Nukleation
und dem Zusammenbau von Aktinfilamenten beteiligt sind. Sie werden durch eine
autoinhibitorische Interaktion der C-terminalen Domäne (Diaphanous-autoregulatory do-
main, mDiaDAD) mit der N-terminalen Domäne (Diaphanous-inhibitory domain, mDiaDID)
reguliert. Durch die Bindung von aktivem RhoA wird dieser inhibitorische Zustand
aufgelöst und das Formin gleichzeitig zur Plasmamembran rekrutiert. Eine aktuelle
Studie indentifizierte Liprin-α3 als einen weiteren Interaktionspartner des Formins
mDia1. Es konnte gezeigt werden, dass die Überexpression von Liprin-α3 zu einer Ver-
ringerung in der Menge an zellulärem Aktin sowie zu der Aufhebung der Lokalisierung
von mDia1 an der Plasmamembran führte. Das Ziel dieser Arbeit war es, die Bindung
von Liprin-α3 an mDia1 strukturell und mechanistisch zu charakterisieren, und zu
analysieren welchen Einfluss dies auf die Aktivität von mDia1 hat.
Umfassende ITC Studien wurden durchgeführt, um ein minimales Liprin-α3 Fragment
zu definieren, das noch immer dazu in der Lage ist an mDia1 zu binden und die
Menge an zellulärem Aktin zu verringern. Dieses Fragment wurde dazu verwendet,
die Kristallstruktur des mDia1 •Liprin-α3 Komplexes zu lösen. Mit Hilfe von ther-
modynamischen und kinetischen Analysen konnte gezeigt werden, dass Liprin-α3
die Bindung von RhoA an mDiaN effizienter inhibiert als die Bindung von mDiaDAD
an mDiaN. Zusätzlich deuten die strukturellen Daten darauf hin, dass die Dissozi-
ation von Liprin-α3 von mDia1 durch RhoA allosterisch erfolgt, während mDiaDAD
und Liprin-α3 um eine überlagernde Bindestelle an mDia1 konkurrieren. Überex-
pressionsstudien mit Liprin-α3 in HeLa und N2a Zellen zeigten Unterschiede in der
Lokalisierung von Liprin-α3 und dem inhibitorischen Potential von Liprin-α3 auf die
Funktion von mDia1. Diese Ergebnisse lassen auf Zelltyp abhängige Mechanismen
schließen, welche die Funktion von Liprin-α3 regulieren.
Basierend auf den in der Studie gewonnenen Daten werden die folgenden Mechanis-
men bezüglich der Inhibierung von mDia1 durch Liprin-α3 postuliert. Erstens, die
Wiederherstellung des autoinhibitorischen Zustandes wird unterstützt durch die verän-
derten Bindungsaffinitäten von RhoA und mDiaDAD an mDiaN. Zweitens, RhoGAPs
sind in der Lage effektiver mit mDiaN um die Bindung von RhoA zu konkurrieren.
Dadurch wird die Hydrolyse von gebundenem GTP in RhoA verstärkt, was zu einer
Inaktivierung von RhoA und anschließend von mDia1 führt. Drittens, Liprin-α3
schwächt die Interaktion mit weiteren mDia1 aktivierenden Proteinen und ist in der
Lage zusätzliche mDia1 regulierende Proteine zu rekrutieren. Zusammengefasst
präsentiert diese Arbeit ein Modell für die Inhibierung der Aktivität von mDia1
durch Liprin-α3 und verdeutlicht die Bedeutung vom Gerüstprotein Liprin-α3 für die
Regulierung des Aktinzytoskeletts.
”Men love to wonder, and that is the seed of science“
Ralph Waldo Emerson, Philosopher
Abstract
Diaphanous-related formins (DRFs) are multi-domain proteins, that are involved in the
nucleation and assembly of actin filaments. They are regulated by an autoinhibitory
interaction of the C-terminal Diaphanous-autoregulatory domain (mDiaDAD) with the
N-terminal Diaphanous-inhibitory domain (mDiaDID). Binding of active Rho proteins
to the N-terminal domain leads to the release of the inhibitory state and plasma
membrane localization of DRFs. Most recently, Liprin-α3 has been identified as a novel
interaction partner of mDia1. It was shown, that overexpression of Liprin-α3 leads
to a reduction in the amount of cellular F-actin and the translocation of mDia1 from
the plasma membrane. The aim of this thesis was to structurally and mechanistically
characterize the binding of mDia1 and Liprin-α3 and to investigate how the presence
of Liprin-α3 influences the activity of mDia1.
Comprehensive in vitro studies were performed to define a minimal Liprin-α3 fragment
(Liprin-core region, LCR), that still binds to mDia1 and is able to induce a reduction
in the amount of cellular F-actin. Using this fragment the interaction of Liprin-α3
and mDia1 was also characterized structurally. Presence of Liprin-α3 reduced the
binding affinity of RhoA to mDiaN more efficiently than the binding of mDiaDAD
to mDiaN, as determined by thermodynamic and kinetic analysis. Furthermore, the
structural data revealed, that the dissociation of Liprin-α3 from mDia1 by RhoA is
mediated allosterically, while mDiaDAD dissociates Liprin-α3 by competing for the a
highly overlapping binding site on mDiaN. Additionally, overexpression of Liprin-α3
in HeLa and N2a cells displayed differences in Liprin-α3 localization and the reduction
of the cellular amount of F-actin. This indicated the importance of cell-type dependent
mechanisms that regulate the function of Liprin-α3.
Based on the data obtained in this study the following mechanisms explaining the
inhibition of mDia1 by Liprin-α3 were postulated. Firstly, the re-establishment of the
mDia1 autoinhibitory state is supported by the altered binding affinities of RhoA and
mDiaDAD for mDiaN. Secondly, RhoGAPs can compete more efficiently with mDiaN
for RhoA binding. This leads to the downregulation of RhoA activity due to enhanced
GTP hydrolysis and subsequently the inactivation of mDia1. Thirdly, Liprin-α3 inhibits
the interactions of mDia1 with additional activating proteins, besides RhoA, and is
able to recruit further regulatory proteins of mDia1 function. In conclusion, this thesis
presents a model for the inhibition of mDia1 function by Liprin-α3, emphasizing the
impact of the scaffold protein Liprin-α3 on the regulation of the actin cytoskeleton.
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1. Introduction
1.1. Actin cytoskeleton
The cytoskeleton is essential for many cellular processes such as cell migration, mitosis,
cell division, cell polarity and many more (Clarke & Spudich, 1977; Pollard, 1976).
In vertebrates it can be composed of microfilaments, microtubules and intermediate
filaments. All three work together to form highly organized networks and are thereby
able to respond to and to mediate internal and external signals (Zigmond, 1996).
Microtubules are polymeric structures that consist of α- and β-tubulin dimers. They
are important for the establishment of the spindle apparatus, intracellular transport
processes and macromolecular assemblies, such as flagella or cilia (Petry et al., 2013;
Vale, 2003). Important for the biological function is their polar organization. At
their plus-end only β-subunits are present, whereas the minus-end is composed
of α-subunits. The elongation rate is distinct faster at the plus-end, compared to
the minus-end (Walker et al., 1988). Intermediate filaments are assembled of two
parallel coiled-coil dimers, that align in an anti-parallel orientation. In difference to
microtubules and microfilaments this leads to a nonpolar organization, of so-called
A11-tetramers (Herrmann et al., 1996). The second notable difference is their distinct
specificity for tissues and organisms (Block et al., 2015). Based on their sequence
homology, they are classified in five subfamilies. They all have in common to provide
the cell with mechanical resilience and stability (Schopferer et al., 2009). Well described
members are Keratin, Desmin and Vimentin (Lin et al., 2010; Pawelzyk et al., 2014).
Microfilaments or filamentous actin (F-actin) are composed of polar, globular actin
(G-actin) monomers. G-actin has a molecular weight of approximately 42 kDa and
is the most abundant protein in eukaryotic cells (Figure 1.1) (Pollard, 1986). Similar
to microtubules the filaments exhibit a structural polarity, accomplished by a unidi-
rectional orientation of G-actin molecules. Based on this polarity the filament end
where increased elongation occurs, is termed ”plus-end“ and the opposite site where
the depolymerizaion happens is called ”minus-end“ (Small et al., 1978; Woodrum
et al., 1975). The ”plus-end“ is also termed ”barbed end“ and the ”minus-end“ is
also referred to as ”pointed end“. These annotations derive from their appearance in
electron microscopy experiments using myosin decoration of microfilaments (Huxley,
1969).
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Figure 1.1 Ribbon representation of a G-
actin monomer.
Crystal structure of a G-actin monomer of stri-
ated muscle tissue of a rabbit in complex with
ATP and Mg2+. The monomer is orientated
with the minus-end on top and the plus-end at
the bottom. The two domains I (subdomain 1
and 2, blue) and domain II (subdomain 3 and
4, purple) are depicted, as well as the bound
ATP molecule in the middle of these domains.
The linker α-helix is shown in green. Modified
from Graceffa & Dominguez (2003).
Despite the globular structure of G-actin it is composed of two domains consisting of
two subdomains each (Figure 1.1). The nucleotide binding pocket is at the interface
of these four domains. Upon binding of ATP, ADP or in the nucleotide free state
the monomer cycles between different structural conformations and can adapt open
and closed states. Another special feature is the flexible DNase I binding loop in
subdomain 2, that it most likely transitioned into an α-helix, upon ATP hydrolysis and
the release of the γ-phosphate (Otterbein et al., 2001).
1.1.1 F-actin polymerization
The polymerization of actin filaments is characterized by three different phases (Fig-
ure 1.2). Based on the instability of actin dimers and trimers spontaneous filament
polymerization is an unlikely event (lag-period or nucleation phase). However, once
a stable nucleus of three or more G-actin monomers has been formed the addition
of further actin monomers occurs (elongation phase). The third phase (steady-state
Figure 1.2 Three phases of in vitro actin polymerization.
Modified from Lodish et al. (2000).
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phase) is defined by the decreasing concentration of free G-actin during the elongation
process. At some point the concentration reaches a level at which the simultaneously
polymerization equals the dissociation and no net change in filament length takes
place. This indicates the importance of actin nucleation as a rate limiting step.
The ratio of the dissociation rate constant (kdiss) and the association rate constant
(kass) of ATP-G-actin monomers to the filaments ends describes the so-called critical
concentration Cc or equilibrium dissociation constant (KD). At concentrations higher
than Cc G-actin polymerizes. Polymerization assays have determined a Cc for the
plus-end of 0.12 µM and 0.6 µM for the minus-end (Figure 1.3) (Wegner, 1976; Wegner
& Engel, 1975). This shows that lower concentrations of free actin are needed for
the elongation at the plus-end, compared to the minus-end. In consequence, during
the steady-state actin elongation happens at the barbed-end while actin dissociation
occurs at the pointed-end, resulting in a movement of bound G-actin filaments to
the pointed-end. This effect is also called treadmilling effect (Kirschner, 1980; Wegner,
1976).
ATP ATP
 KD = 2.0  KD = 2.0
 KD = 0.6  KD = 0.12
barbed-end
(+)
pointed-end
(-)
Figure 1.3 Treadmilling model after Wegner.
Association and dissociation rates at actin filaments. Association rates are depicted as µM -1 s-1,
dissociation rates have the unit s-1 and the equilibrium dissociation constant is shown in µM.
Modified from Pollard & Borisy (2003).
Additional to the polarity of the filaments, the nucleotide state of the G-actin monomer
influences the actin assembly (Figure 1.3). While the incorporation of ATP-G-actin at
the barbed-end is highly driven by the increased association rate constant compared to
the pointed-end, the equilibrium constant for ADP-G-actin is the same at both filament
ends. Following the incorporation, the bound ATP is rapidly and irreversible hy-
drolyzed (half time 2 s) (Blanchoin & Pollard, 2002; Carlier et al., 1988). The subsequent
phosphate dissociation is distinctly slower (half time 350 s), determining the filament
lifetime. (Carlier & Pantaloni, 1986). ADP-Pi-actin intermediates in the filaments have
similar properties as ATP-G-actin. Although the ATP-hydrolysis is not needed for
the polymerization of actin filaments itself, it is a crucial step for the treadmilling
effect, due to the altered kinetics at both ends of the filament. In the steady-state
phase the elongation at the barbed-end depends on the amount of free G-actin, and is
thereby limited by the dissociation at the pointed-send. Under these conditions the
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filament growth is limited to approximately 0.04 µm min-1. However, cell movement
of 10 µm min-1 has been shown, indicating the requirement of additional regulatory
mechanisms (Pollard & Borisy, 2003). One example is the conformational change of
the G-actin monomers upon binding of cations, which increases the polymerization
(Maruyma & Tsukagoshi, 1984; Selden et al., 1983). Furthermore, more than 60 protein
classes exist, that modulate the F-actin formation (Vale & Kreis, 1999). Elongation
can be inhibited by F-actin capping proteins, that bind to the barbed end (Cooper &
Schafer, 2000), or by binding of Thymosin β4 to ATP-G-actin preventing binding to
the filaments (Carlier et al., 1993). Another actin binding protein named Profilin binds
to ADP-actin monomers and enhances the exchange of ADP to ATP (Lu & Pollard,
2001). Secondly, Profilin bound ATP-G-actin is recruited to prolin rich regions of pro-
teins, such as WASP family members and formins. This local increase of ATP-G-actin
enhances the nucleus formation (Watanabe et al., 1997). The protein class of formin
homology proteins, especially mDia1 is introduced in greater detail in 1.2. Furthermore
a range of microfilament regulatory processes involving Arp2/3-complexes and their
activating proteins are introduced in 1.1.2.
1.1.2 Actin filament regulation and remodeling
As mentioned before the nucleation is a crucial step in the actin filament formation.
Hitherto, three protein classes have been identified to aid in nucleation and promote
polymerization of new actin filaments. These proteins belong to the actin-related
protein 2/3 (Arp2/3) complex, formins and a protein class containing tandem repeats
of G-actin binding motifs, such as Spire, Cordon-bleu or Leiomodin (Ahuja et al., 2007;
Goley & Welch, 2006). The Arp2/3 complex consists of seven subunits, including the
Arp2 and Arp3 subfamilies (Machesky & Insall, 1998), and possesses a low nucleation
activity on its own (Mullins et al., 1998). So-called nucleation promotion factors (NPFs)
are of importance for the activity of Arp2/3. These NPFs can be divided into two
classes.
Class I NPFs mediate the actin nucleation via their C-terminally located Verprolin
homology (V), central (C) and acidic (A) regions (Machesky et al., 1999). The V-domain
(also called W or WH2 for WASp homology 2) binds to actin monomers and the C
and A motifs interact with multiple subunits of the Arp2/3 complex. Thereby, NPFs
recruit actin monomers to the Arp2/3 complex. The Arp2 and Arp3 subunits form
a trimeric structure with the actin monomer, inducing a different conformation of
Arp2/3. This leads to more potent state to promote the actin nucleation step for new
filaments (Chereau et al., 2005; Marchand et al., 2001).
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Class I NPFs can be further classified into five groups
1. Wiskott-Aldrich Syndrome protein (WASP) and neuronal-enriched homologue of
WASP (N-WASP)
2. WASP family Verprolin-homologous (WAVE) proteins (Suppressor of cAMP
receptor [Scar])
3. WASP and Scar homologue (WASH)
4. WASP homologue associated with actin, membranes and microtubules
(WHAMM)
5. Junction-mediating regulatory protein (JMY)
Class II NPFs contain proteins, such as Cortactin another activating protein of the
Arp2/3 complex. However, Cortactin displays a weaker effect on the nucleation,
compared to class I NPFs. Instead, it mainly aids in the stabilization of branch
junctions and inhibits debranching (Weaver et al., 2001).
In contrast to the class of Diaphanous-related formins (see 1.2) the activated Arp2/3
complex initiates 70◦ branching of existing actin filaments. In this process the new
daughter filament is anchored by Arp2/3 with its pointed end to the mother filament
(Rouiller et al., 2008). As a result, Arp2/3 mediates the formation of a so-called
dendritic network of branched actin filaments (Blanchoin et al., 2000), and is thereby
regulating the cell morphology. The branching of actin filaments has been shown to
be crucial for many cellular processes, including cell migration and adhesion (DeMali
et al., 2002; Machesky et al., 1997), phagocytosis (May et al., 2000) and trafficking events
(Stamnes, 2002).
1.2. Diaphanous-related formins
Formin homology (FH) proteins, or short formins, are multidomain proteins consisting
of more than 1000 amino acids. The first formin genes (FMN1/2) were identified
by mutations of the limb deformity gene locus in mouse, that induced severe defects
cell polarity and morphogenesis (Maas et al., 1990). Although, more recent studies
ascribed the phenotype to gremlin, a gene located on the same chromosomal locus
(Zuniga et al., 2004). Subsequent studies showed, that mutations of the Drosophila
gene dia lead to impaired cytokinesis, with a gene product (Diaphanous) homologous
to formin (Castrillon & Wasserman, 1994). Additionally, studies in budding yeast
(Saccharomyces cerevisiae) displayed the importance of the formin Bni1 for the assembly
of microfilaments (Evangelista et al., 2002). A comparison of the FMN1/2 proteins of
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mice, Diaphanous of flies and Bni1 of yeast showed a high sequence homology of two
regions termed formin-homology FH1 and FH2. These domains are present, albeit
in different sizes, in all known formins with the exception of ForC in Dictyostelium
discoideum, which consists only of the FH2 domain (Castrillon & Wasserman, 1994).
The conservation of these domains indicates their functional importance in formins.
Indeed, both domains are involved in the regulation and formation of microfilaments
and microtubules during a variety of cellular processes (Palazzo et al., 2001; Wallar &
Alberts, 2003).
Hitherto, in mammals 15 different formins are described, that can be classified into
eight groups: (Breitsprecher & Goode, 2013; Schönichen & Geyer, 2010)
1. Dia (Diaphanous homolog formin)
2. DAAM (dishevelled-associated activator of morphogenesis)
3. FMNL (formin-like protein)
4. WHIF (WH2 domain-containing formin)
5. INF (inverted formin)
6. FHOD (formin homology domain-containing)
7. Delphilin
8. FMN (formin)
Besides the conserved FH1 and FH2 domains a third domain FH3 was identified at the
N-terminus of Fus1 in Schizosaccharomyces pombe (Petersen et al., 1998). The FH3 has
been further divided into the diaphanous-inhibitory domain (DID) and the subsequent
dimerization-domain (DD), and is a special feature of a formin class that is regulated
by autoinhibition. These Diaphanous-related formins (DRFs) are autoregulated by an
intramolecular interaction between the C-terminal Diaphanous-autoregulatory domain
(DAD) and the N-terminal DID domain (Alberts, 2001; Li & Higgs, 2003; Nezami et al.,
2006; Otomo et al., 2010). Another characteristic domain of DRFs is the N-terminally
located GTPase-binding domain (GBD), which is located C-terminally of the DID (Rose
et al., 2005). Upon binding of active Rho GTPases to the GBD the DID-DAD interaction
and thereby autoinhibition is relieved (Lammers et al., 2005; Rose et al., 2005; Seth et al.,
2006; Westendorf, 2001).
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An overview of the domain organization of one formin of each class is shown in
Figure 1.4.
Figure 1.4 Modular domain organization of human formins.
Overview of the domain organization of one example for each formin class. Show-
ing the GTPase binding domain (GBD), Diaphanous-inhibitory domain (DID), dimeriza-
tion domain, coiled-coil domain (CC), formin homology domains 1,2,3 (FH1, FH2, FH3),
Diaphanous- autoregulatory domain (DAD), Wiskott-Aldrich syndrome homology region 2
(WH2), microtubule-binding domain (MTBD) and PDZ homology domain. Modified from
Schönichen & Geyer (2010).
The DRFs Dia1, Daam1, FMNL1 and FHOD1 display a typical GTPase binding domain
and a Diaphanous-inhibitory domain (DID) at their N-terminus, followed by the FH1
and FH2 domains and the C-terminal Diaphanous-autoregulatory domain (DAD). It
has been shown, that GBD/DAD deletion mutants of DRFs are constitutively active
and induce the formation of actin stress fibers, in presence of ROCK (Rho associated
coiled-coil kinase) (Copeland & Treisman, 2002; Watanabe et al., 1999). Delphilin is the
only formin containing PDZ domains, that are required for binding of the glutamate
receptor delta 2 subunit (GluRδ2) (Miyagi et al., 2002), thus shown to be important
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for the localization at dendritic spines of Purkinje cells (Matsuda et al., 2006). INF1
is able to interact directly with microtubules via a C-terminal microtubule-binding
domain (MTBD), which leads to co-alignment of microtubules with actin filaments
(Young et al., 2008). Instead of DAD the formin WHIF1 (INF2) has an C-terminally
located WH2 (WASP homology 2) domain. Similar to the DAD the WH2 domain binds
to the DID, but additionally binds to actin monomers, accelerating F-actin nucleation
(Chhabra & Higgs, 2006). Interestingly, the binding of WH2 to the DID solely impacts
actin polymerization and not nucleation processes (Chhabra et al., 2009).
Since formins are able to interact with small GTPases of the Rho-family and simultane-
ously with proteins regulating the actin cytoskeleton (e.g. F-BAR proteins, Profilin)
they display important effector proteins that mediate signal transduction. The reg-
ulation of DRFs and their impact on F-actin nucleation and polymerization will be
discussed in the subsequent sections.
1.2.1 Autoinhibition and activation of DRFs by Rho GTPases
Although the autoinhibitory interaction of the Diaphanous-inhibitory domain (DID)
and the Diaphanous-autoregulatory domain (DAD) is a common feature of all
Diaphanous-related formins (DRFs) (Alberts, 2001; Liu et al., 2008; Vaillant et al.,
2008), so far only the structure of the mDia1 inhibition has been solved by X-ray crys-
tallography (Lammers et al., 2005; Nezami et al., 2006; Otomo et al., 2010). A simplified
model of the autoinhibitory state of mDia1 is depicted in Figure 1.5. The DAD binds
to the DID adjacent to the GTPase binding domain (GBDN), leading to the formation
of a closed state and the inactivation of the formin.
N
C
open conformation
GBDN DID DD FH1 FH2 DAD
autoinhibited conformation
N
Figure 1.5 Model of the au-
toregulatory mechanism of
mDia1.
Presented are the open and
closed (autoinhibited) confor-
mation of mDia1. Shown are
the GTPase-binding domain
(GBDN), the Diaphanous-
inhibitory domain (DID),
dimerization domain (DD),
Formin-homology domain
(FH1,2) and the Diaphanous-
autoinhibitory domain (DAD).
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Figure 1.6 Crystal structure of the mDiaDID •mDiaDAD complex.
Left: The ribbon presentation shows the mDiaDID domain in complex with the mDiaDAD core
region exhibiting the amino acids 1180-1195 (PBD: 2BAP). Right: Zoom in on the binding
interface, depicting some of the major amino acids involved in the binding. Modified from
Lammers et al. (2005).
The DAD of mDia1 can be divided into the DAD core region (DCR; aa 1175-1195) and
a subsequent basic region, which varies in length and sequence (Lammers et al., 2005;
Wallar et al., 2006). In the first solved crystal structure of the DID •DAD complex,
only the DCR is visible forming an amphipathic helix that binds to the hydrophobic
concave side of the armadillo repeat region (ARR) of the DID (Figure 1.6) (Lammers
et al., 2005). Although the subsequent amino acids of the DAD are not visible in the
structure they are important for the binding affinity (Wallar et al., 2006). It has been
postulated that the C-terminal part of the DAD contacts the negatively charged patches
on mDiaN along the α-helix (interdomain helix, α17), connecting the DID domain with
the dimerization domain (DD) (Nezami et al., 2010; Otomo et al., 2010). This binding
mechanism seems to be similar in all DRFs sharing the following consensus sequence
for DAD (G/A)(V/A)MDXLLEXL(K/R/Q)X(G/A)(S/G/A)(A/P) (Alberts, 2001).
Binding of active Rho GTPases to the regulatory N-terminus (mDiaN, GBDN-DID-CC)
leads to the release of the DID-DAD interaction and resolves the autoinhibited state.
The formin p140mDia was the first to be identified as effector protein of small GTPases
(Watanabe et al., 1997). In recent years the binding specificity and the interaction has
been studied intensively with biochemical, structural and cell dependent methods.
Especially, the activation of mDia1 isoforms and their interaction with various GTPases
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has been characterized in great detail (Lammers et al., 2008). Described interactions of
formins with specific Rho GTPases are summarized in Table 1.1.
Table 1.1 DRFs and their GTPases. Modified from Kühn & Geyer (2014).
Formin binding domain Rho GTPases Reference
mDia1, mDia2 GBD-FH3 RhoA (Alberts et al., 1998; Watanabe
et al., 1999, 1997)
mDia1, mDia2 GBD-FH3 RhoB (Wallar et al., 2007; Watanabe
et al., 1999)
mDia1 GBD-FH3 RhoC (Rose et al., 2005; Watanabe
et al., 1999)
mDia2, mDia3 GBD-FH3 Cdc42 (Alberts et al., 1998; Peng et al.,
2003; Yasuda et al., 2004)
mDia1, mDia2 GBD-FH3 Rac1,2 (Ji et al., 2008; Lammers et al.,
2008; Rose et al., 2005)
hDia2 n.d. RhoD (Gasman et al., 2003)
mDia2 n.d. Rif (Pellegrin & Mellor, 2005)
Daam1 N-terminus (aa 41-477) RhoA, -B, -C (Habas et al., 2001; Higashi
et al., 2008)
Daam1 N-terminus (aa 1-698) Rac1 (Matusek et al., 2008)
Daam1 n.d. Cdc42 (Aspenström et al., 2006)
FMNL1 n.d. Rac1 (Favaro et al., 2013; Gomez et al.,
2007; Yayoshi-Yamamoto et al.,
2000)
FMNL1 N-terminus (aa 1-450) Cdc42 (Seth et al., 2006)
FMNL2 N-terminus (aa 27-276) RhoC (Kitzing et al., 2010)
FMNL2 GBD-FH3 (aa 1-379) Cdc42 (Block et al., 2012)
FMNL3 n.d. RhoC (Vega et al., 2011)
FHOD1 FH1 (aa 422-717) Rac1 (Gasteier et al., 2003; Westen-
dorf, 2001)
INF2 FH3 (aa 1-340) Cdc42 (Madrid et al., 2010)
The first crystal structure of a GTPase in complex with a formin was solved by the
group of Wittinghofer (Figure 1.7) (Rose et al., 2005). In accordance with other effector
proteins, these data revealed that active, GppNHp loaded RhoC binds mainly via switch
I and II. While switch I binds interacts with mDia1 via the GBDN, switch II contacts
residues in the ARR of the DID. Moreover, the Rho-insert helix also locates in close
approximation to the fifth armadillo repeat of the DID. Notably, the residues located
in the switch I and II regions involved in formin binding, are conserved throughout
the Rho GTPases (Kühn & Geyer, 2014). A major contribution to the specificity of
the mDia1-GTPase interaction seems to be created by the triple asparagine motif in
the loop connecting the third helix of ARM1 and the first helix of ARM2 in mDiaDID.
Mutating the motif to the residues TSH (Thr, Ser, His) of mDia2 and mDia3, increases
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the affinity of mDia1 for Cdc42. Further specificity of the DRF-GTPase interaction is
created by the Rho-insert helix (Lammers et al., 2008). The specific interactions of the
switch I and II region of RhoC with the ARR and GBDN are shown in Figure 1.7.
switch II
switch I
GppNHp
insert helix
GBDN
dimerization domain
(DD)
interdomain helix
(ID)
Diaphanous-inhibitory
domain (DID)
RhoC
A B
Figure 1.7 Interaction between mDia1 and RhoC. A: Ribbon presentation of the
mDia1 •RhoC •GppNHp complex of PDB: 1Z2C. B: Interactions created between Rho and
the armadillo repeat region (ARR, DID) and the GTPase binding domain (GBDN) of mDia.
Modified from Rose et al. (2005).
As depicted in Figure 1.8 the binding interfaces of mDiaDAD and RhoC on mDiaN
only partially overlap. However, the formation of a putative ternary complex of
mDiaDID •mDiaDAD •Rho has been experimentally ruled out in several studies (Lam-
mers et al., 2008, 2005; Nezami et al., 2006; Otomo et al., 2005a). A two step mechanism
for the dissociation of mDiaDAD from mDiaDID by RhoA has been suggested, that
includes an initial weak binding of RhoA to mDia1, followed by a tighter association.
This would subsequently lead to the dissociation of mDiaDAD from mDiaDID by
steric interference and additional charge-charge repulsion (Lammers et al., 2005).
Whether the initial loose binding is initiated by the Rho-insert helix and is thereby
also important the specificity, or if the RhoA first binds loosely to the GBDN and then
forms stronger contacts to the mDiaDID remains unclear.
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Figure 1.8 mDia1 binding interface of DAD and RhoC .
A: mDiaDAD (mDia Diaphanous-autoinhibitory domain) binding interface on mDia1. Shown
are the residues of the mDiaDID (mDia Diaphanous-inhibitory domain) involved in the binding
of mDiaDAD (PDB: 2F31) (Nezami et al., 2006). Depicted in light blue are the residues N217,
N310 and Q352 that mediate hydrogen bonds with mDiaDAD. K213 of mDiaDID, which forms a
salt bridge with D1183 of mDiaDAD is shown in blue. Hydrophobic interactions of I222, K252,
L253, A256, I259, L260, Q307, A311, T314, V351, and V355 are colored yellow. B: RhoC binding
interface on mDia1. Shown are the residues of the GBDN-DID involved in the binding of RhoC
(PDB: 1Z2C). Hydrophobic interactions of M90, M94, N95, L96, P103, L104, and M115 are
depicted in yellow, polar interactions of K100 and Q118 (GBD) and N164, N165, N166 and
N217 (mDiaDID) in light blue. The created salt bridge of K107 is marked in blue color. Modified
from Kühn & Geyer (2014).
1.2.2 Formin induced actin nucleation and elongation
Mandatory for the activity of Diaphanous-related formins (DRFs) are the release of the
autoinhibitory state by Rho GTPase binding and the distinct features of the dimeric
formin structure. DRFs accelerate F-actin formation by enhancing the nucleation
process and by supporting the elongation at the barbed end. These effects are mainly
driven by their FH1 and FH2 domain.
Actin nucleation
It has been shown, that the isolated FH2 domain is able to nucleate actin filaments in
vitro (Pring et al., 2003; Pruyne et al., 2002). Based on structural data it was postulated
that the nucleation is accelerated by the recruitment and stabilization of actin dimers
and trimers (Figure 1.9). The crystal structure of the FH2 domain of the formin Bni1p of
S. cerevisiae displays the complete α-helical composition. The monomers are arranged
head-to-tail in the dimer, forming a donut-shaped ring (Xu et al., 2004). Important
for the dimerization of the FH2 is the N-terminally located region, also referred
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to as lasso, which contacts the post domain of the other monomer (Xu et al., 2004)
(Figure 1.9). Furthermore, this region displays minor differences between the structure
of Bni1p and mDia1. Additionally, Otomo et al. could show by crystallization with
tetramethylrhodamine-actin (TMR-actin), that the dimeric FH2 domain contacts three
actin molecules, while each FH2 monomer exhibits two actin binding sites. (Otomo
et al., 2005b). Crucial for the actin binding are a conserved isoleucine (in Bni1p I1431)
and lysine (in Bni1p K1601) (Lu et al., 2007; Otomo et al., 2005b) and mutations of these
residues results in reduced activity of the formin (Bartolini et al., 2008; Ramabhadran
et al., 2012).
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Figure 1.9 Dimeric FH2 structure in complex with actin. A: Crystal structure of the FH2
domain of the S. cerevisiae formin Bni1p showing the residues 1350-1760 (PDB: 1UX5, Xu et al.
(2004)). The FH2 monomers are presented in green and purple. Labeled are the lasso, linker,
knob, coiled-coil, and post regions of the green FH2 subunit. B: Ribbon representation of the
FH2 domain of Bni1p (residues 1350-1760) in complex with muscle actin (PDB: 1Y64, Otomo
et al. (2005b). The three actin subunits of the polymer are depicted as surface representation
in blue and gray, labeled 1 to 3 from the barbed- to the pointed-end. Modified from Paul &
Pollard (2009b).
The knob region of FH2 domains contact the actin molecules in the hydrophobic
groove between the subdomains 1 and 3. Additionally, the post site of the FH2 forms
electrostatic contacts along subdomain 1 of actin subunits (Figure 1.9 B). However,
the reported binding affinities of the FH2 domain for single G-actin monomers are
rather low (>5 µM) (Evangelista et al., 2003; Zigmond, 2004) or not present at all
(Chesarone et al., 2010). On the other hand the affinity for the barbed end is very high
(low nanomolar KD, Moseley et al. (2004)). Together with the slow in vitro nucleation
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rate of the FH2 domain it is therefore hypothesized that the FH2 is needed for the
stabilization of spontaneously formed actin dimers or trimers in vitro and additional
regions of formins are involved in actin nucleation in vivo. An alternative nucleation
mechanism has been postulated involving the FH1 domain. The FH1 domain, which
is predicted to be mostly unstructured contains several proline-rich motifs (Kovar et al.,
2003; Michelot et al., 2005). These motifs are known to be recognition areas for Profilin
and SH3 (Src-homology 3) and WW domains (WWP repeating motif) (Bedford et al.,
1997; Imamura et al., 1997; Macias et al., 2002). Especially the binding and recruitment
of Profilin bound ATP-G-actin at the FH1 was believed to initiate nucleation (Sagot
et al., 2002). More recent studies indicate that the interaction of the FH1 domain and
Profilin •G-actin might only play minor role in the nucleation (Paul & Pollard, 2008).
Latest data reveal the emerging importance of the formins tail regions. Sequences
located C-terminally of the FH2 domain bind actin monomers and thereby effectively
enhance nucleation (Gould et al., 2011; Heimsath & Higgs, 2012). In addition, an
increasing number of regulatory proteins, that bind to the tail regions have been
identified (Graziano et al., 2011; Okada et al., 2010). These proteins include so-called
nucleation promoting factors (NPFs) ( 1.2.3).
Actin elongation
Formins fulfill several functions, that lead to a regulated elongation at the barbed end
of actin filaments. They prevent the binding of capping proteins, which would block
further elongation (Harris et al., 2004; Kovar et al., 2005; Zigmond et al., 2003), they
prevent the annealing of barbed filament ends to pointed ends (Kovar et al., 2003) and
finally they recruit actin monomers to the growing barbed end. It has been emphasized,
that the FH1 domain is needed for Profilin •G-actin recruitment to the FH2 domain,
resulting in accelerated elongation at the barbed-end (Paul & Pollard, 2009a). Early
electron micrographs and additional kinetic assays indicated that formins stay bound
to the barbed end during the processive elongation (Pruyne et al., 2002; Zigmond et al.,
2003). This would require an intensively debated translocation of the FH2 domain for
each actin monomer that is added to the barbed end. The initial theory explaining
this mechanism is known as ”stair stepping“ model. (Otomo et al., 2005b; Xu et al.,
2004). These models were based on structural information of the FH2 domain and
indicated that formins act as leaky capping proteins. Due to conformational changes
of the FH2 dimer, formins can switch between an ”open state“ and a ”closed state“.
During the closed state both parts of the dimer bind tightly to the actin subunits
at the barbed end, which are orientated in a planar structure with a 180◦ rotation
between consecutive subunits. This unfavorable conformation presents no contacts for
further actin subunits. Partial dissociation of the FH2 (step off) would lead to a more
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relaxed rotation of 167◦ of actin subunits and enable one free G-actin in the solution to
bind to the exposed FH2, as well as the barbed end. Assembly of the actin monomer
subsequently leads to the re-establishment of the closed state (Kozlov & Bershadsky,
2004; Paul & Pollard, 2009a; Vavylonis et al., 2006; Zigmond et al., 2003). The time span
between the alternating open and close states is defined as the ”gating factor“ (Paul &
Pollard, 2009b). This value varies from almost 1 (uninhibited) for mDia1 to nearly 0
(capping) for Cdc12 in S. pombe (Kovar et al., 2006) and could explain differences in the
elongation rates of different formins (Block et al., 2012; Kovar et al., 2003; Neidt et al.,
2008).
1 2 3
45
Figure 1.10 ”Stepping second“ mechanism of actin elongation. This model shows the hy-
pothesized FH2 induced 5 step elongation of actin at the barbed end in regard of the FH2
dimer translocation. In green depicted is the leading half of the FH2 dimer and the trailing
part is shown in magenta. K, P refer to the knob and post site of the FH2 domain. Actin
monomers are blue and silver and interactions with the knob or post site are indicated as (+) or
(-). The 5 steps are illustrated as the side view of the filament with the barbed end orientated
downwards (upper image) and the top view of the barbed end (lower image). The closed and
open state of the FH2 dimer is indicated by the green and red angle symbols. Images 1,2 and
4,5 are equivalent images of the cycle. Modified from Paul & Pollard (2009b).
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However, the initial ”stair stepping“ model did not take the helical twist of F-actin
into account. Induced by the helical structure the FH2 needs to rotate relatively to the
filament in an angle of 14◦ per elongation cycle. Therefore, the stair stepping model was
expanded by the ”screw mode“ (Shemesh et al., 2005) and also the ”stepping second”
hypothesis has been emphasized (Paul & Pollard, 2009b). The latter is displayed in
Figure 1.10.
The ”stepping second“ model is based on the new structure data of incorporated actin
subunits provided by Oda et al. (2009). Upon incorporation into the microfilament the
actin monomers become flattened. This lead to the conclusion that the bound FH2
dimer might influence the orientation as well as the conformation of the actin subunits
and vice versa (Paul & Pollard, 2009b). Paul and Pollard propose, that following each
open state and actin subunit insertion, the formin subunit is transiently bound to the
interior actin in the microfilament. Subsequently, the tense FH2 domain translocates to
the newly build end and shifts into the closed state, lowering its free energy (Paul &
Pollard, 2008). Similar to the ”stair stepping“ model the ”stepping second“ mechanism
includes several steps of partially dissociation of the FH2 domain. In comparison to
the ”stair stepping“ model, during the ”stepping second“ model the dissociation and
translocation occurs after the incorporation of actin monomers. Notably, recent studies
using single-molecule fluorescence polarization could confirm the rotational movement
of mDia1 during the elongation of actin filaments (Mizuno et al., 2011).
1.2.3 mDia1 localization and interacting proteins
Besides the activation, the localization of DRFs is also influenced by Rho GTPases.
This has been shown for many different formins and GTPases (Evangelista et al., 1997;
Martin et al., 2007; Tolliday et al., 2002). The prenylated GTPases bind to the GBD
domain and recruit the activated DRFs to the membrane. Notably, recent studies
identified several new mechanisms mediating the plasma membrane localization of
formins, that are independent of Rho GTPases. Another protein, that binds to the
mDiaN region upon the release of the autoinhibitory state is the scaffolding protein
IQGAP1. The interaction with IQGAP1 is mandatory for the proper localization of
mDia1 in phagocytic cup formation and phagocytosis (Brandt et al., 2007). Furthermore,
scaffolding proteins containing membrane associated BAR domains could have an
impact on formin localization (Frost et al., 2009). These interactions have been found
for mDia1, which binds with the FH1 domain to the SH3 domain of IRSp53 (BAR-
domain protein) (Fujiwara et al., 2000; Goh et al., 2012) and Daam1, which interacts
with SH3 domain of Cip4 (Aspenström et al., 2006). Other sequences, important for the
localization of formins, have been postulated for Bnr1 in S. cerevisiae and Cdc12 in S.
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pombe (Gao et al., 2010). These regions are also located at the N-terminus of the formin
and interact with septin-associated kinases, regulating the function of Bnr1 (Buttery
et al., 2012).
Alongside the phosphorylation by septin-associated kinases a variety of post transla-
tional modification (PTM) has been described for formins. Phosphorylation by Prk1p
of both tails is involved in the release of the autoinhibitory state of Bni1 in S. cerevisiae
(Wang et al., 2009). The formins mDia2 (Diaphanous homolog 3) and FHOD1 are
activated upon interaction with the Rho-associated protein kinase (ROCK) (Dean et al.,
2011; Hannemann et al., 2008; Takeya et al., 2008). Additionally, the formin mDia3
is phosphorylated and regulated by the kinase Aurora B (Cheng et al., 2011) and
the formins FHOD1 and FHOD3 are targets of CK2 (casein kinase 2 subunit α) and
PRKG1 (cGMP-dependent protein kinase 1) (Iskratsch et al., 2010, 2013). The described
farnesylation and myristoylation of INF2 (inverted formin-2) and FMNL2 (formin-like
protein 2), have a more direct impact on the membrane localization (Block et al., 2012;
Chhabra et al., 2009)
Notably, in mDia1 and mDia2 polybasic clusters at the N- and C-terminus have been
identified, that might directly associate with phospholipids through electrostatic in-
teractions (Gorelik et al., 2011; Ramalingam et al., 2010). The direct interaction with
phospholipids has also been confirmed for the plant formins AFH1, formin1 and
class II formins (Cheung et al., 2010; Martiniere et al., 2011; van Gisbergen et al., 2012),
indicating a general mechanism of several species.
Another protein, that binds to the N-terminal region of mDia1 and is involved in
F-actin regulation is is the scaffolding protein Liprin-α3 (Sakamoto et al., 2012a). This
new class of mDia1 interaction proteins will be further introduced in 1.4.
1.3. Guanine nucleotide binding proteins
The signal transduction of extracellular stimuli to the intracellular compartments is
an important step for many cellular functions. These processes are often controlled
and mediated by guanine nucleotide binding proteins (GNBP), also named G-Proteins.
Based on their structural and sequential similarities they can be divided into TRAFAC
(translation factor) and SIMIBI (signal recognition GTPases, MinD and BioD) (Leipe
et al., 2002). Well known examples of the TRAFAC GNBPs are the translation factor
IF-2, the Ras-superfamily (e.g. Rho, Ras, CDC42) and the myosin-kinesin superfamily.
Proteins associated with the SIMBI-GNBPs are often involved in protein localization
and targeting. Besides their structural categorization GNBPs can also be classified
regarding their function, which results in five distinct groups.
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1. α-subunits of heterodimeric G-proteins (Gαs)
2. Translation factors (e. g. IF-2, elongation factor Tu)
3. Ras superfamily (e. g. Rho, Ras, Cdc42)
4. Signal recognition particle (SRP) and SRP-receptor
5. Large GNBPs (e. g. Dynamin)
Hitherto, in humans more than 150 members of the Ras superfamily are known.
Most of them are structurally and functionally described in great detail. They have
a molecular weight of approx. 20-25 kDa and can be further divided into five major
subfamilies based on structural and functional similarities (Table 1.2). The first member
and eponym of the superfamily, Ras (rat sarcoma) , was identified by Chien et al. (1979)
as the product of a proto-oncogene.
Table 1.2 The five major subfamilies of the Ras superfamily. Classification based on Wenner-
berg et al. (2005) and Rojas et al. (2012).
Ras Rho Rab Arf Ran
quantity 39 22 65 30 1
function morphology, cytoskeleton, vesicle- vesicle- nuclear transport,
differentiation, gene expression, trafficking trafficking mitotic spindle-
apoptosis, polarity, formation
proliferation growth
examples (H/K/N)-Ras Rho (A/B/C) Rab1A Arf1 Ran
Rap Rac1 Rab2 Arf6
Rheb Cdc42 Rab3A Sar1
Ral Rif
Proteins of the Ras-subfamily mediate cell-proliferation, -apoptosis, -morphology and
-differentiation (Vojtek & Der, 1998). Concerning their diverse functions it is not
surprising, that mutations of Ras can be found in diverse tumors and in fact 20-30 % of
all human tumors carry a Ras-activating mutation (Prior et al., 2012). Rho-proteins (Ras-
homologous) play important roles in the regulation of the cytoskeleton, cell growth
and also gene expression (Kitayama et al., 1989; Sander & Collard, 1999). Regulation of
vesicular transport is controlled by ADP-ribosylation factor (Arf) family proteins and
Ras-like proteins in brain (Rab) (Moss & Vaughan, 1998; Schimmöller et al., 1998). The
ran-related nuclear (Ran) proteins are involved in the nucleocytoplasmic transport of
proteins and RNA (Weis, 2003).
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Their common feature is the ability to cycle between an active GTP-bound state and an
inactive GDP-bound state (1.3.3), which is determined by conformational changes of
the G-domain (1.3.2). Only in the GTP-bound form effector proteins can bind, which
leads to their activation (e.g. DRFs) and signal transduction events occur. The state of
GPTases is highly regulated by the hydrolysis (1.3.4) and the exchange (1.3.5) of the
guanine nucleotide.
1.3.1 Small GTPases of the Rho-family
Based on their sequence homology and functional similarities proteins of the Rho-
family can be subdivided into six major groups (Table 1.3) (Wennerberg & Der, 2004). In
mammals the first described Rho proteins of the Rho-family were the isoforms RhoA, B
and C (Madaule & Axel, 1985). Today, the most noted and well characterized members
are RhoA (ras homologous A), Rac1 (ras-related C3 botulinum toxin substrate) and
Cdc42 (cell division cycle 42) (Hall, 1998).
Table 1.3 The Rho subfamily of Ras proteins. Classification based on Wennerberg & Der
(2004).
Rho Rac Cdc42 Rnd Miro RhoBTB
RhoA Rac1 Cdc42 Rnd1 Miro1 RhoBTB1
RhoB Rac1b TCL Rnd2 Miro2 RhoBTB2
RhoC Rac2 Wrch1 Rnd3 RhoBTB3
Rac3 Chp
RhoG TC10
The small GTPases of the Rho-family are involved in a wide range of cellular processes,
such as cell-cell adhesion, cell polarity, cell migration and gene transcription. Many
of these processes are mediated by the activation of effector proteins, involved in the
regulation of the actin cytoskeleton (Chimini & Chavrier, 2000; Kaibuchi et al., 1999;
Van Aelst & DSouza-Schorey, 1997). RhoA, Cdc42 and Rac1 display distinct effects on
the actin cytoskeleton if activated in cells (Figure 1.11).
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Figure 1.11 Impact of RhoA, Rac and Cdc42 on the actin cytoskeleton.
Quiescent, serum-starved Swiss 3T3 fibroblasts cells with activated RhoA by lysophosphatidic
acid addition (C,D), microinjection of constitutively active Rac (E,F) and microinjection of the
Cdc42 exchange factor FGD1 (G,H). Staining of actin in (A), (C), (E) and (G) vinculin staining
in (B), (D), (F) and (H). Modified from Hall (1998).
Activation of RhoA leads to an increase in the amount of F-actin (Figure 1.11 C) and to
the formation of focal adhesions (Figure 1.11 D). The effector protein mDia1, involved
in acceleration of actin nucleation and elongation, is activated upon RhoA binding (Hill
et al., 1995). In comparison, Cdc42 mediates filopodia formation (Figure 1.11 G) and
Rac induces the formation of lamellipodia, by the activation of the Arp2/3 complex
through binding to NPFs (e.g. WASP, WAVE)(Figure 1.11 E) (Bishop & Hall, 2000;
Ridley et al., 1992). Moreover, the small GTPases are regulated by a cross-talk between
the Rho proteins. It has been shown that Cdc42 can also activate Rac, while Rac in
turn is able to activate Rho (Nobes & Hall, 1995; Ridley et al., 1992)
1.3.2 The G-domain of the Ras-superfamily
The G-domain is the central structural motif of Ras-superfamily proteins and de-
termines nucleotide and effector protein binding (Figure 1.12 A). It consists of six
β-sheets and five adjacent α-helices, which are linked by ten loop regions. A distinct
feature of Rho proteins is the insert helix (α3), that has been shown to be important
for the activation of ROCK (Rho-associated protein kinase) (Zong et al., 2001). Five of
the loop regions (G1-G5) hold the key elements for specific nucleotide and effector
binding (Bourne et al., 1991; John et al., 1990; Schmidt et al., 1996; Via et al., 2000). The
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Figure 1.12 Superposition of several GNBP G-domains in their GTP- and GDP-bound state.
The ribbon presentation displays the difference of the switch I and II region, dependent on
the guanine nucleotide bound state. A: In the GTP-bound active state the switch I and II
adopt a rigid conformation. B: In the Inactive GDP-bound state the switches are more flexible.
Additional, structural features of Ran (red), Arf (blue) and Rho (purple) are highlighted.
Modified from Vetter & Wittinghofer (2001).
P-loop (G1) with the consensus sequence GxxxxGK(S/T) mediates the high affinity
binding of the nucleotide by interactions with the β- and γ-phosphates (Saraste et al.,
1990). Interaction with effector and regulatory proteins depend on the switch I and
switch II regions (G2, G3). They bind to the γ-phosphate of GTP and Mg2+. Upon
hydrolysis the binding is disrupted and conformational changes occur explaining the
molecular switch mechanism (Figure 1.12 B) (Spoerner et al., 2001; Wittinghofer & Pal,
1991). Guanine-binding specificity is created by the G4 and G5 loop motifs due to the
formation of specific hydrogen bonds with the guanine base (Zhong et al., 1995).
1.3.3 Regulatory cycle
Small GNBPs are binary molecular switches with nucleotide dependent conformations.
They are able to cycle between a GTP- and GDP-bound form (Figure 1.13). In the GTP-
bound active state the conformation of the switch I and switch II regions are stabilized
by the interaction with the γ-phosphate. The intrinsic hydrolysis rate and nucleotide
dissociation of small GTPases are extremely low. Without additional proteins that
support and regulate these processes, GTPases would not be a molecular switch of
biological significance.
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Figure 1.13 Regulatory cycle of Rho GTPases.
Small GNBPs are regulated by three distinct protein classes. The guanine nucleotide exchange
is mediated by GEFs (guanine nucleotide exchange factors), the hydrolysis of GTP to GDP is
accelerated by GAPs (GTPase activating proteins) and GDIs (guanine nucleotide dissociation
inhibitors) extract the inactive prenylated GTPases from the membrane. Modified from Etienne-
Manneville & Hall (2002).
Active GTP-bound Rho GTPases are inhibited by RhoGAPs (1.3.4). These proteins
accelerate the hydrolysis rate of GTP to GDP. The activation of Rho GTPases is mediated
by so-called GEFs (guanine-nucleotide exchange factors), that accelerate the nucleotide
dissociation (1.3.5). In addition the localization of GTPases is regulated by GDIs
(guanine nucleotide dissociation inhibitors), which are able to extract prenylated Rho
proteins from lipid bilayers (Figure 1.13).
1.3.4 RhoGAPs
RhoGAPs play a crucial role to switch off signaling transduction pathways. Without
RhoGAPs the slow intrinsic GTP-hydrolysis rate of GNBPs would lead to an ongoing
downstream signaling, which would result in drastic consequences for cell functions.
Since the discovery of the first RhoGAP more then 25 years ago (Trahey & McCormick,
1987), over 70 members of yeast to human RhoGAPs have been identified today and
some of them are structurally and functionally characterized (Bernards, 2003; Peck et al.,
2002). The RhoGAPs of specific GTPases are conserved, however among the different
Rho subfamilies they display different mechanisms to accelerate to the GTP-hydrolysis
(Scheffzek et al., 1997; Seewald et al., 2002). Three of these mechanisms are depicted in
Figure 1.14.
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Figure 1.14 Differences in the GAP-accelerated GTP-hydrolysis of Rho proteins.
Essential for the effectiveness of the different GAPs is the positioning of a H2O molecule for the
nucleophilic attack on the γ-phosphate. a: The catalytic glutamine of Ras/Rho is positioned by
the arginine of RasGAP (Scheffzek et al., 1997). b: RanGAPs use an asparagine to stabilize the
glutamine (Seewald et al., 2002). c: Rap1 specific GAPs use an asparagine to position the water
molecule directly (Daumke et al., 2004). Illustration from Rehmann & Bos (2004).
The successful crystallizations of several small GTPases in complex with GAPs made
it possible to gain further insights into the catalytic mechanisms. Ras- and RhoGAPs
insert a positively charged arginine (”arginine finger“) into the active site. One effect is
the neutralization of the negative charge of the phosphates. As a second important
function the arginine positions the glutamine (position 61 in Ras and 63 in RhoA) in
trans. This glutamine on the other hand, orients the water molecule that attacks the
γ-phosphate (Figure 1.14 a). RhoA exhibits an intrinsic hydrolysis rate of 0.022 min-1,
which is increased to nearly 100 min-1 by p190RhoGap (Zhang & Zheng, 1998). Despite
their structural differences, a similar mechanism seems to be the basis for all RhoGAP
catalyzed hydrolysis reactions in GTPases. In RanGAPs the arginine is replaced by
a asparagine, that stabilizes the glutamine of Ran, while the catalytic effect remains
basically the same (Figure 1.14 b). Furthermore, the asparagine releases the inhibitory
effect of the tyrosine 39 in Ran, that contacts the β-phosphate and orients the catalytic
glutamine in cis (Brucker et al., 2010). A distinct mechanisms is used for Rap1, which
does not possess a catalytic glutamine. In Rap proteins the H2O molecule is positioned
directly by the asparagine of the GAP (”asparagine thumb“), as postulated by Daumke
et al. (2004) and Scrima et al. (2008).
1.3.5 Activation by guanine nucleotide exchange factors
The intrinsically slow dissociation of bound nucleotides is the rate determining step
in the transition of GNBPs into the active GTP-bound conformation. Hence, the
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dissociation rate is increased by guanine nucleotide exchange factors (GEFs). Although,
the different GEFs display structural differences the general reaction mechanism is
functionally similar. Induced by GEFs the guanine nucleotide dissociation rate is
accelerated by several orders of magnitude (Hutchinson & Eccleston, 2000; Klebe
et al., 1995). The concentration of GTP in the cell is approximately tenfold increased
compared to GDP. Thus, upon dissociation of GDP, the GTPase is preferentially
binding GTP instead of GDP. The GEFs p190RhoGEF and PDZ-RhoGEF increase the
nucleotide exchange from 4.8 x 10-4 min-1 to 1930 x 10-4 min-1 (van Horck et al., 2001),
and from 5.5 x 10-4 min-1 to 1179 x 10-4 min-1, respectively (Gasmi-Seabrook et al., 2010).
Figure 1.15 Schematic presentation
of the “push and pull” mechanism
of GEFs.
GEFs reduce the binding affinity of
nucleotides to GNBPs. The inser-
tion of several side chains into the
active site impair the positioning of
the P-loop and Mg2+. Furthermore
the switch I region is pulled out and
the switch II region is pushed in the
catalytic site. Modified from Vetter &
Wittinghofer (2001).
During the course of the so-called “push and pull” mechanism the switch I region is
pulled out and the switch II region is pushed in the nucleotide binding site (Vetter et al.,
1999). The insertion of additional amino acids into the nucleotide binding site by GEFs
alters the conformation of the P-loop and displaces the Mg2+-Ion, which is needed
for the high nucleotide binding affinity (Gasper et al., 2008; Lenzen et al., 1998). This
ultimately lowers the nucleotide affinity. Upon GEF-binding the P-loop lysine (K16 in
Ras; K18 in Rho) is not able to interact with the negative charges of the phosphates but
instead is orientated to the switch II (Figure 1.15). Notably, GEFs have no influence on
the binding selectivity of GTPases regarding GTP or GDP. The insertion of guanine
nucleotides is only driven by their intracellular concentration.
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1.4. Scaffold protein Liprin-α3
Liprin-α has been firstly described as binding partner of leukocyte common antigen-
related (LAR) family of receptor protein tyrosine phosphatases (LAR-RPTPs) (Pulido
et al., 1995; Serra-Pages et al., 1995). Based on their primary structure the liprin protein
family can be subdivided into Liprin-α, Liprin-β, Kazrin, and Liprin-γ. In mammals
four different Liprin-α have been found, namely Liprin-α1, -α2, -α3 and -α4 together
with Liprin-β1 and -β2 and KazrinE (Groot et al., 2004; Serra-Pages et al., 1998). For
Drosophila melangolaster only one Liprin-β and Dliprin-α as the only Liprin-α have
been described (Kaufmann et al., 2002). Additionally, Liprin-γ (ortholog of KazrinE)
has been found in D. melangolaster (Astigarraga et al., 2010). The only Liprin-α in C.
elegans is Syd-2 (synapse-defective 2) (Zhen & Jin, 1999). Especially, Liprin-α displays a
high degree of conservation with approximately 50 % amino acid similarity between
the human Liprin-α1 and Syd-2 (Spangler & Hoogenraad, 2007).
Liprin-α2 and -α3 are mainly expressed in the brain, whereas Liprin-α1 is ubiquitously
expressed and Liprin-α4 is predominantly present in muscle tissues (Zürner et al.,
2011; Zürner & Schoch, 2009). The expression of the different Liprin-α isoforms in
brain lysates has been further characterized. It has been shown, that Liprin-α1 is
most abundant in the olfactory gland and in cultured glia cells, Liprin-α2 and -α3 are
predominant in the hippocampus and Liprin-α4 is abundantly expressed at parallel
fiber-Purkinje cell synapses (Spangler et al., 2011).
1.4.1 Domain organization and interaction partner of Liprin-α
The subfamily of Liprin-α is composed of a predicted N-terminal coiled-coil domain
and three C-terminal SAM (steril-α-motif) domains, also referred to as liprin homology
(LH) domain (Pulido et al., 1995; Serra-Pages et al., 1995). Homodimerization of Liprin-α
occurs via the N-terminal domain (Taru & Jin, 2011), whereas heterodimerization with
Liprin-β is mediated by the SAM domains (Serra-Pages et al., 1995). The N-terminal
region of Liprin-α binds additionally to the ELKS protein family (ERC/CAST, ELKS-
Rab6-interacting protein-CAST) (Dai et al., 2006; Ko et al., 2003b), RIM (Rab3-interacting
molecul)(Schoch et al., 2002), GIT1 (G-protein coupled receptor kinase interactor) (Ko
et al., 2003a), KIF1A (kinesin family member 1A) (Shin et al., 2003) and most recently
discovered also to mDia1 (Diaphanous) (Sakamoto et al., 2012a). The SAM domains
are involved in the binding of LAR-RPTPs (Pulido et al., 1995; Serra-Pages et al., 1995),
CASK (calmoduin-dependent serine protein kinase) (Olsen et al., 2005; Samuels et al.,
2007), ATP (Serra-Pagès et al., 2005), CaMKII (Ca2+/calmodulin-dependent protein
26 1. Introduction
kinase II) (Hoogenraad et al., 2007) and GRIP (glutamate receptor interacting protein)
(Wyszynski et al., 2002). The interactions are also summarized in Table 1.4.
Table 1.4 Overview of Liprin-α binding proteins. Modified and completed from Spangler &
Hoogenraad (2007)
Binding partner Liprin- Function Reference
Liprin-β α1-3 Unknown (Serra-Pages et al., 1998)
LAR-RPTP α1-3 presynaptic active zone
formation
(Dunah et al., 2005; Serra-
Pages et al., 1995, 1998)
GIT1 α1-4 AMPAR trafficking (Ko et al., 2003a,b)
GRIP1 α1-4 AMPAR trafficking (Wyszynski et al., 2002)
CASK α2 neurotransmitter release (Olsen et al., 2005)
CaMKII α1 dendrite and spine develop-
ment
(Hoogenraad et al., 2007)
CAST/ERC α1-4 presynaptic scaffolding (Dai et al., 2006; Ko et al.,
2003b)
RIM α3,4 neurotransmitter release (Schoch et al., 2002)
KIF1A α1,2,4 microtublar transport (Shin et al., 2003)
mDia1 α3 microfilament formation (Sakamoto et al., 2012a)
1.4.2 Liprin-α functions
The proteins of the Liprin-α family have been shown to be involved in many processes,
that regulate cellular and synaptic functions. Thereby, they mainly act as scaffolding
proteins, linking specific components into larger protein complexes. Their versatile
functions for the development and morphology at synapses is described briefly in the
following. Additionally, the new emerged role of Liprin-α3 for the regulation of the
F-actin formation is elucidated.
Pre- and postsynaptic development and the release of neurotransmitter
The subfamily of Liprin-α has been shown to be involved in the assembly of presynap-
tic components of many organisms. Loss-of-function mutation studies of the liprin-α
homologue gene, syd-2 in C. elegans caused severe defects in presynaptic structures
(Zhen & Jin, 1999). The mutation led to translocalization of several synaptic vesicle
proteins and increased the length of the active zones. Further studies showed, that
SYD-2 additionally recruits GIT (G-protein-coupled interactor), SAD-1 (synapses of
amphids defective-1), ELKS-1 (CAST/ERC) and SNN-1 (synapsin-1) to the presynaptic
site (Patel et al., 2006). A similar effect was observed in Drosophila using the liprin-α
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homologue Dliprin-α. Mutations of Dliprin-α led to an impaired morphology of the
active zone and the reduction of synaptic boutons (Kaufmann et al., 2002).
The syd-2 and Dliprin-α mutants did also influence the synaptic transmission, indicat-
ing an impact on the neurotransmitter release and vesicle cycling (Kaufmann et al.,
2002; Zhen & Jin, 1999). Two proteins involved in these processes, CAST and RIM
(Rab3-interacting molecule), are linked by Liprin-α and co-localized at the synapses.
Another complex that assembles in the presence of Liprin-α is composed of CASK
(Ca2+/calmodulin-dependent serine protein kinase), MALS (mammalian LIN-seven
protein) and Mint1. The disruption of this complex decreased the excitatory postsy-
naptic currents (Olsen et al., 2005).
At the postsynaptic site Liprin-α interacts with GRIP1 (glutamate receptor-interacting
protein 1) (Wyszynski et al., 2002), an AMPAR (AMPA (α-amino-3-hydroxy-5-
methylisoxazole-4-propionic acid) receptor) binding protein (Dong et al., 1997). The
interaction of Liprin-α with this receptor is required for a proper localization and
expression of AMPAR. Additionally, the binding of Liprin-α to leukocyte common
antigen-related (LAR) receptors regulates AMPAR and the morphology of dendritic
spines (Dunah et al., 2005).
Intracellular transport mechanism
Liprin-α has an additional role in the trafficking of synaptic proteins. It has been
reported that Liprin-α binds to the Kinesin-like protein KIF1A, an axonal transporter
of synaptic vesicles (Miller et al., 2005; Shin et al., 2003). Mutations of liprin-α in
Drosophila, resulted in impaired movement of synaptic vesicles (Miller et al., 2005). In
complex with GRIP1, Liprin-α is also connected to cadherins and β-catenin, proteins
involved in the maintenance of focal adhesions. Therefore, postulated models indicate,
that Liprin-α is able to recruit structure-bearing protein complexes, such as cadherin-β-
catenin and also functional complexes (AMPAR) to the synapse (Dunah et al., 2005;
Spangler & Hoogenraad, 2007).
Inhibition of stress fiber formation
The interaction of Liprin-α3 and the Diaphanous formin mDia1 has most recently been
described by Sakamoto et al. (2012a). They showed via pulldown assays, that Liprin-α3
binds with its N-terminal coiled-coil domain to mDiaDID-DD (Diaphanous-inhibitory
domain, Dimerization-domain) of mDia1. Furthermore, they postulated a competition
of Liprin-α3 with the mDiaDAD (Diaphanous autoregulatory domain) for mDiaDID
binding. Overexpression of Liprin-α3 resulted in reduced RhoA activated stress fiber
formation and delocalization of mDia1 from the plasma membrane. In accordance with
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these results knowndown of Liprin-α3 by RNAi resulted in enhanced microfilament
formation. However, the exact binding mechanism of Liprin-α3 and mDia1, and the
influence on the mDia1 activity remained unclear.
2. Aim of this thesis
Liprin-α3 has recently been identified as a novel interaction partner of the formin
mDia1. It has been shown that Liprin-α3 inhibits the mDia1 induced formation of
F-actin and that it translocates mDia1 from the plasma membrane. However, the
underlying mechanisms remained unclear. In order to gain further insights into the
inhibitory potency of Liprin-α3 on the mDia1 function, the following questions were
addressed in this thesis.
1. How and where binds Liprin-α3 to mDia1?
The first aim of this study was to functionally and structurally characterize the inter-
action sites of Liprin-α3 and mDia1. Based on these data determinants of specificity
underlying the interaction were further investigated.
2. Is the autoregulation of mDia1 affected by Liprin-α3?
In order to study how Liprin-α3 downregulates the mDia1 function, the influence of
Liprin-α3 on mDia1 activation by RhoA, as well as its impact on the mDia1 autoinhibi-
tion were analyzed thermodynamically and kinetically. This included the question of
potential ternary complexes and the possible dissociation of Liprin-α3 from mDiaN by
RhoA and mDiaDID.
3. Is the minimal mDia1-binding Liprin-α3 fragment able to mediate the F-actin
reducing effect?
The last part of this thesis addressed the question, whether the overexpression of the
shortest mDia1-binding Liprin-α3 fragment is sufficient to obtain the same reducing
effect on the amount of cellular F-actin as full-length Liprin-α3. Additionally, the
question arose, if cell type specific mechanisms exist, that regulate the activity and the
inhibitory potential of Liprin-α3.

3. Materials and Methods
3.1. Materials
3.1.1 Cell strains
Name Supplier
E.coli BL21 (DE3) T1 New England Biolabs®
E.coli DH5a New England Biolabs®
3.1.2 Antibiotics
Antibiotic Final concentration
Ampicillin 100 µg mL−1
Kanamycin 25 µg mL−1
3.1.3 Vectors
Vector Supplier
pGEX4T5-TEV* GE Healthcare
pEGFP-N3 BD bioscience
mCherry-C1 Clontech Laboratories
* This vector was designed on basis of the commercially available pGEX4T1 vector. An additional TEV
(tabacco etch virus) restriction site was inserted between Thrombin cleavage site and the multiple
cloning site (MCS). Neither the Thrombin cleavage site, nor the reading frame were affected.
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3.1.4 Buffers and solutions
Name Components
phosphate buffered saline (PBS) 10 mM Na2HPO4, 2 mM KH2PO4, 137 mM
NaCl, 2.7 mM KCl, pH 7.4
phosphate buffered saline - Tween (PBST) 10 mM Na2HPO4, 2 mM KH2PO4, 137 mM
NaCl, 2.7 mM KCl, 0.1 % Tween-20, pH 7.4
protein buffer 25 mM Tris/HCl, 150 mM NaCl, 5 mM
MgCl2, 2 mM β-ME, pH 7.4
protein wash buffer 25 mM Tris/HCl, 500 mM NaCl, 5 mM
MgCl2, 2 mM β-ME, pH 7.4
exchange buffer 50 mM Tris/HCl, 100 mM NaCl, 5 mM
EDTA, pH 7.4
GSH elution buffer 25 mM Tris/HCl, 150 mM NaCl, 5 mM
MgCl2, 2 mM β-ME, 30mM GSH, pH 7.4
Laemmli sample buffer 50 mM Tris/HCl, pH 6.8, 50 % (v/v) Glyc-
erol, 500 mM DTT, 10 % (w/v) SDS, 0.5 %
(w/v) Bromphenolblue
coomassie staining solution 40 % (v/v) methanol, 10 % (v/v) acetic acid,
0.4 % (w/v) Coomassie-R250. 0.4 % (w/v)
Coomassie-G250
coomassie destaining solution 40% (v/v) ethanol, 10% (v/v) acetic acid
anode buffer 200 mM Tris/HCl, pH 8.9
cathode buffer 100 mM Tris/HCl, 100 mM tricine, 0.1 %
(w/v) SDS , pH 8.2
RIPA buffer 50 mM Tris/HCl, 150 mM sodium chloride,
1.0 % Triton X-100, 0.5 % sodium deoxy-
cholate, 0.1 % (w/v) SDS, pH 8.0
mild stripping buffer 1.5 % (w/v) glycine, 0.1 % (w/v) SDS, 1 %
(v/v) Tween20, pH 2.2
transfer buffer 25 mM Tris, base, 150 mM glycine, 10%
(v/v) methanol
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3.1.5 Media
Media Components (1L)
LB 10 g peptone, 5 g yeast extract, 10 g NaCl,
pH 7.4
LB agar 10 g peptone, 5 g yeast extract, 10 g NaCl,
16 g agar, pH 7.4
3.1.6 Crystallization Screens
Name Manufacturer
Additive Screen HT™ Hampton Research
Crystal Screen™ Hampton Research
Crystal Screen 2™ Hampton Research
PEG/Ion Screen™ Hampton Research
PEG/Ion 2 Screen™ Hampton Research
Index™ Hampton Research
JCSG-plus Molecular Dimensions
PACT Premier™ Molecular Dimensions
Morpheus® HT-96 Molecular Dimensions
Crystal Strategy Screen™ I HT-96 Molecular Dimensions
Crystal Strategy Screen™ II HT-96 Molecular Dimensions
PGA-LM HT-96 Screen™ Molecular Dimensions
Structure Screen I Molecular Dimensions
Structure Screen II Molecular Dimensions
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3.1.7 Antibodies and actin filament staining
Antigen Origin Manufacturer Catalog no. Dilution
mCherry rabbit abcam® ab167453 1:1250
eGFP mouse Acris Antibodies AM20710PU-N 1:1250
α-tubulin rat abcam® ab6160 1:1000
rabbit-IgG (HRP) goat abcam® ab6721 1:10000
mouse-IgG (HRP) rabbit abcam® ab6728 1:10000
rat-IgG (HRP) rabbit abcam® ab6734 1:10000
Phalloidin Biotium 00041 1:60
3.1.8 Enzymes
Name Supplier
Digest
EcoRI-HF New England BioLabs
BamHI-HF New England BioLabs
XhoI New England BioLabs
HindIII-HF New England BioLabs
BglII-Hf New England BioLabs
PCR
Phusion® High-Fidelity DNA Polymerase New England BioLabs
Ligation
T4 DNA ligase New England BioLabs
3.1.9 Chromatography columns
Name Supplier
Superdex 75 10/300 GL GE Healthcare
Superdex 200 10/300 GL GE Healthcare
Superdex 75 16/60 GL GE Healthcare
Superdex 75 26/60 GL GE Healthcare
Superdex 200 16/60 GL GE Healthcare
Superdex 200 26/60 GL GE Healthcare
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3.1.10 Cloning primer
All primers were purchased from MW-Biotech and are listed in the table below.
Primer for cloning into expression vectors
Table 3.1 Primers used for cloning into the pGEX4T5-TEV vector.
protein size vector sense / antisense enzyme
mDia1 mouse 79-369 pGEX4T5-TEV
5’−GGAATTCTCAGACGAGCAAGTTCTTGTC−3’ EcoRI
5’−CCGCTCGAGCGGTTATCCCTTCAGATCAAAG−3’ XhoI
mDia1 mouse 74-369 pGEX4T5-TEV
5’−GGAATTCTCATTGCAGGACATCTCAGAC−3’ EcoRI
5’−CCGCTCGAGCGGTTATCCCTTCAGATCAAAG−3’ XhoI
mDia1 mouse 69-369 pGEX4T5-TEV
5’−GGAATTCGACCCCACTGCTCAGTCATTGCAGG−3’ EcoRI
5’−CCGCTCGAGCGGTTATCCCTTCAGATCAAAG−3’ XhoI
mDia1 mouse 79-435 pGEX4T5-TEV
5’−GGAATTCTCAGACGAGCAAGTTCTTGTC−3’ EcoRI
5’−CCGCTCGAGCGGTTAGTGTAGAACTATCTGAGAAAC−3’ XhoI
mDia1 mouse 79-443 pGEX4T5-TEV
5’−GGAATTCTCAGACGAGCAAGTTCTTGTC−3’ EcoRI
5’−CCGCTCGAGCGGTTAGAAGTCAGGATCAGTTCCATTTTTG−3’ XhoI
mDia1 mouse 74-443 pGEX4T5-TEV
5’−GGAATTCTCATTGCAGGACATCTCAGAC−3’ EcoRI
5’−CCGCTCGAGCGGTTAGAAGTCAGGATCAGTTCCATTTTTG−3’ XhoI
mDia1 mouse 69-443 pGEX4T5-TEV
5’−GGAATTCGACCCCACTGCTCAGTCATTGCAGG−3’ EcoRI
5’−CCGCTCGAGCGGTTAGAAGTCAGGATCAGTTCCATTTTTG−3’ XhoI
mDia1 mouse 69-435 pGEX4T5-TEV
5’−GGAATTCGACCCCACTGCTCAGTCATTGCAGG−3’ EcoRI
5’−CCGCTCGAGCGGTTAGTGTAGAACTATCTGAGAAAC−3’ XhoI
mDia1 mouse 69-451 pGEX4T5-TEV
5’−GGAATTCGACCCCACTGCTCAGTCATTGCAGG−3’ EcoRI
5’−CCGCTCGAGCGGTTAATCAATCTGCAGGTGTCGG−3’ XhoI
mDia1 mouse 69-570 pGEX4T5-TEV
5’−GGAATTCGACCCCACTGCTCAGTCATTGCAGG−3’ EcoRI
5’−CCGCTCGAGCGGTTAAGCAGCACTGCTAGAAAC−3’ XhoI
mDia1 mouse 135-369 pGEX4T5-TEV
5’−GGAATTCTCTGCCATGATGTACATCC−3’ EcoRI
5’−CCGCTCGAGCGGTTATCCCTTCAGATCAAAG−3’ XhoI
mDia1 mouse 135-525 pGEX4T5-TEV
5’−GGAATTCTCTGCCATGATGTACATCC−3’ EcoRI
5’−CCGCTCGAGCGGTTATTTCTGTGCAGTGATCTGCTGC−3’ XhoI
mDia1 mouse 135-570 pGEX4T5-TEV
5’−GGAATTCTCTGCCATGATGTACATCC−3’ EcoRI
5’−CCGCTCGAGCGGTTAAGCAGCACTGCTAGAAAC−3’ XhoI
mDia1 mouse 135-500 pGEX4T5-TEV
5’−GGAATTCTCTGCCATGATGTACATCC−3’ EcoRI
5’−CCGCTCGAGCGGTTAAAAGTCATTTTCCATCTTTTTC−3’ XhoI
mDia1 mouse 135-550 pGEX4T5-TEV
5’−GGAATTCTCTGCCATGATGTACATCC−3’ EcoRI
5’−CCGCTCGAGCGGTTACTTGGCATCTTCTAGTTCTTTTG −3’ XhoI
mDia1 mouse 135-475 pGEX4T5-TEV
5’−GGAATTCTCTGCCATGATGTACATCC−3’ EcoRI
5’−CCGCTCGAGCGGTTACAGCTCTGTAGCTTTGGCCTC −3’ XhoI
mDia1 mouse 135-451 pGEX4T5-TEV
5’−GGAATTCTCTGCCATGATGTACATCC−3’ EcoRI
5’−CCGCTCGAGCGGTTAATCAATCTGCAGGTGTCGG−3’ XhoI
mDia1 mouse WW-1145-1200 pGEX4T5-TEV
5’−CGGGATCCTGGTGGATGCGGAGAGCAAAATTAGC−3’ EcoRI
5’−CCGCTCGAGCGGTTACCCTCTCTTCCGTCGGAATG −3’ XhoI
mDia1 mouse WW-1145-1209 pGEX4T5-TEV
5’−CGGGATCCTGGTGGATGCGGAGAGCAAAATTAGC−3’ EcoRI
5’−CCGCTCGAGCGGTTACCCAGCCTTCCTGTTG−3’ XhoI
Liprin-α3 mouse 20-587 pGEX4T5-TEV
5’−CGGAATTCGGCCCGGACGAGGCC−3’ EcoRI
5’−CCGCTCGAGCGGTTACGGTGACCCTGCTTGC −3’ XhoI
Liprin-α3 mouse 25-587 pGEX4T5-TEV
5’−GGAATTCGGCGAGCTGGAGCGCCTCATG−3’ EcoRI
5’−CCGCTCGAGCGGTTACGGTGACCCTGCTTGC−3’ XhoI
Liprin-α3 mouse 77-587 pGEX4T5-TEV
5’−CGGAATTCGCTCTGCCTCAGGAG−3’ EcoRI
5’−CCGCTCGAGCGGTTACGGTGACCCTGCTTGC−3’ XhoI
Liprin-α3 mouse 90-587 pGEX4T5-TEV
5’−CGGAATTCAACTTATGTCGGGAAC−3’ EcoRI
Continued
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protein size vector sense / antisense enzyme
5’−CCGCTCGAGCGGTTACGGTGACCCTGCTTGC−3’ XhoI
Liprin-α3 mouse 110-587 pGEX4T5-TEV
5’−CGGAATTCCGAAACAACACCCGG−3’ EcoRI
5’−CCGCTCGAGCGGTTACGGTGACCCTGCTTGC−3’ XhoI
Liprin-α3 mouse 217-587 pGEX4T5-TEV
5’−CGGAATTCGCCGAGACCTTACCA−3’ EcoRI
5’−CCGCTCGAGCGGTTACGGTGACCCTGCTTGC−3’ XhoI
Liprin-α3 mouse 271-587 pGEX4T5-TEV
5’−CGGAATTCATGAACGATGACCAC−3’ EcoRI
5’−CCGCTCGAGCGGTTACGGTGACCCTGCTTGC−3’ XhoI
Liprin-α3 mouse 306-587 pGEX4T5-TEV
5’−GGAATTCGAGGAGAAGAACTC−3’ EcoRI
5’−CCGCTCGAGCGGTTACGGTGACCCTGCTTGC−3’ XhoI
Liprin-α3 mouse 457-587 pGEX4T5-TEV
5’−GGAATTCGAGGAGAAGAACTCCCTGAGCGAGGA−3’ EcoRI
5’−CCGCTCGAGCGGTTACGGTGACCCTGCTTGC−3’ XhoI
Liprin-α3 mouse W-532-587 pGEX4T5-TEV
5’−CGGGATCCTGGGGAGGAAGTCCTGCCCGGGAG−3’ EcoRI
5’−CCGCTCGAGCGGTTACGGTGACCCTGCTTGC−3’ XhoI
Liprin-α3 mouse W-541-587 pGEX4T5-TEV
5’−CGGGATCCTGGGGAACCAACCATGTCTCTAAG−3’ BamHI
5’−CCGCTCGAGCGGTTACGGTGACCCTGCTTGC−3’ XhoI
Liprin-α3 mouse W-561-587 pGEX4T5-TEV
5’−CGGGATCCTGGGGAGGAGACACCCCACCACCCAC−3’ EcoRI
5’−CCGCTCGAGCGGTTACGGTGACCCTGCTTGC−3’ XhoI
Liprin-α3 mouse W-443-498 pGEX4T5-TEV
5’−CGGGATCCTGGGGAGGAAGTGGGCAAGCTGATGTGC−3’ BamHI
5’−CCGCTCGAGCGGTTAGTACCGGCCCAGCGAG−3’ XhoI
Liprin-α3 mouse W-443-491 pGEX4T5-TEV
5’−CGGGATCCTGGGGAGGAAGTGGGCAAGCTGATGTGC−3’ BamHI
5’−CCGCTCGAGCGGTTAGCCAGAACTGGACAC−3’ XhoI
Liprin-α3 mouse W-491-560 pGEX4T5-TEV
5’−CGGGATCCTGGGGAGGAGGCCTTGACTCGCTGG−3’ EcoRI
5’−CCGCTCGAGCGGTTATGGAACGGCTGGACCCTC−3’ XhoI
Liprin-α3 mouse W-541-571 pGEX4T5-TEV
5’−CGGGATCCTGGGGAACCAACCATGTCTCTAAG−3’ BamHI
5’−CCGCTCGAGCGGTTAGGCAGAGCGGGGCGTG−3’ XhoI
Liprin-α3 mouse 25-217 pGEX4T5-TEV
5’−GGAATTCGGCGAGCTGGAGCGCCTCATG−3’ EcoRI
5’−CCGCTCGAGCGGTTAGGCCTTCTGCAGGGTCTGTTGC−3’ XhoI
Liprin-α3 mouse 25-817 pGEX4T5-TEV
5’−GGAATTCGGCGAGCTGGAGCGCCTCATG−3’ EcoRI
5’−CCGCTCGAGCGGTTAGGGCAGCCCAAGGCTG−3’ XhoI
Liprin-α3 mouse 25-737 pGEX4T5-TEV
5’−GGAATTCGGCGAGCTGGAGCGCCTCATG−3’ EcoRI
5’−CCGCTCGAGCGGTTAGGACCCCGCCTGCAGTGCC−3’ XhoI
Liprin-α3 mouse W-561-581 pGEX4T5-TEV
5’−CGGGATCCTGGGGAGGAGACACCCCACCACCCAC−3’ EcoRI
5’−CCGCTCGAGCGGTTACGCCAAAGCCTGGGCCATCCTCTCAAGAC−3’ XhoI
Liprin-α3 mouse W-561-582 pGEX4T5-TEV
5’−CGGGATCCTGGGGAGGAGACACCCCACCACCCAC−3’ EcoRI
5’−CCGCTCGAGCGGTTACAGCGCCAAAGCCTGGGCCATCCTCTCAAG−3’ XhoI
Liprin-α3 mouse 1-737 pGEX4T5-TEV
5’−GGAATTCATGATGTGCGAGGTG−3’ EcoRI
5’−CCGCTCGAGCGGTTAGGACCCCGCCTGCAGTGCC−3’ XhoI
Liprin-α3 mouse 1-817 pGEX4T5-TEV
5’−GGAATTCATGATGTGCGAGGTG−3’ EcoRI
5’−CCGCTCGAGCGGTTAGGGCAGCCCAAGGCTG−3’ XhoI
RhoA human 1-193 pGEX4T5-TEV
5’−CGGGATCCATGGCTGCCATCCGG−3’ BamHI
5’−CGGAATTCCGTTACAAGACAAGGCAACCAG−3’ EcoRI
Primer for cloning into cell culture expression vectors
Table 3.2 Primers used for cloning into the pEGFP-N3 and mCherry-C1 vectors.
protein size vector sense / antisense enzyme
Liprin-α3 mouse 1-1043 mCherry-C1
5’−CCCAAGCTTGGGTTAGCAGGAGTAAGTCCGGACCGAAAC−3’ BglII
5’−GAAGATCTATGATGTGCGAGGTGATGCCTAC−3’ HindIII
Liprin-α3 mouse 1-817 mCherry-C1
5’−CCCAAGCTTGGGTTAGCAGGAGTAAGTCCGGACCGAAAC−3’ HindIII
5’−GGAATTCCTTAGGGCAGCCCAAGGCTG−3’ EcoRI
Liprin-α3 mouse 561-587 mCherry-C1
5’−GAAGATCTGGAGACACCCCACCACCCAC−3’ BglII
5’−AAGCTTGGGTTACGGTGACCCTGCTTGCAGCGC−3’ HindIII
Continued
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protein size vector sense / antisense enzyme
Liprin-α3 mouse 567-587 mCherry-C1
5’−GAAGATCTACGCCCCGCTCTGCCCGTCTTG−3’ BglII
5’−AAGCTTGGGTTACGGTGACCCTGCTTGCAGCGC−3’ HindIII
Liprin-α3 mouse (3GS)567-587 mCherry-C1
5’−GAGGATCCGGAACGCCCCGCTCTGCCCGTC−3’ BglII
5’−AAGCTTGGGTTACGGTGACCCTGCTTGCAGCGC−3’ HindIII
Liprin-α3 mouse 561-582 mCherry-C1
5’−GAAGATCTGGAGACACCCCACCACCCAC−3’ BglII
5’−AAGCTTGGGTTACAGCGCCAAAGCCTG−3’ HindIII
RhoA human 1-193 pEGFP-N3
5’−GAAGATCTATGGCTGCCATCCGGAA −3’ BglII
5’−GGATCCCAAGACAAGGCAAC−3’ BamHI
QuikChange® Site-Directed-Mutagenesis Primer
Table 3.3 Primers used for site-directed mutagenesis.
protein mutation sense / antisense
Liprin-α3 mouse R569E
5’−CACCACCCACGCCCGAATCTGCCCGTCTTGAG−3’
5’−CTCAAGACGGGCAGATTCGGGCGTGGGTGGTG−3’
Liprin-α3 mouse R572E
5’−GCCCCGCTCTGCCGAACTTGAGAGGATG−3’
5’−CATCCTCTCAAGTTCGGCAGAGCGGGGC−3’
Liprin-α3 mouse L573E
5’−CGCTCTGCCCGTGAGGAGAGGATGGCCCAG−3’
5’−CTGGGCCATCCTCTCCTCACGGGCAGAGCG−3’
Liprin-α3 mouse L575E
5’−CTGCCCGTCTTGAGGAAATGGCCCAGGCTTTG−3’
5’−CAAAGCCTGGGCCATTTCCTCAAGACGGGC−3’
Liprin-α3 mouse M576E
5’−GCCCGTCTTGAGAGGGAGGCCCAGGCTTTGG−3’
5’−CCAAAGCCTGGGCCTCCCTCTCAAGACGGGC−3’
Liprin-α3 mouse L580E
5’−GAGGATGGCCCAGGCTGAGGCGCTGCAAGCAGGGTC−3’
5’−GACCCTGCTTGCAGCGCCTCAGCCTGGGCCATCCTC−3’
Liprin-α3 mouse T563E
5’−GATCCTGGGGAGGAGACGAACCACCACCCACGC−3’
5’−GCGTGGGTGGTGGTTCGTCTCCTCCCCAGGATC−3’
Liprin-α3 mouse T567E
5’−GACACCCCACCACCCGAGCCCCGCTCTGCCCGTC−3’
5’−GACGGGCAGAGCGGGGCTCGGGTGGTGGGGTGTC−3’
Liprin-α3 mouse T563/567E
5’−GACGAACCACCACCCGAGCCCCGCTCTGCCCGTC−3’
5’−GACGGGCAGAGCGGGGCTCGGGTGGTGGTTCGTC−3’
mDia1 mouse N165D
5’−GAGTCTCTCTCAACGACAACCCTGTCAGTTG−3’
5’−CAACTGACAGGGTTGTCGTTGAGAGAGACTC −3’
mDia1 mouse A256D
5’−CAAAGCTGCTGTCTGACCTCTGTATCCTGC−3’
5’−GCAGGATACAGAGGTCAGACAGCAGCTTTG−3’
mDia1 mouse I259D
5’−GTCTGCCCTCTGTGACCTGCCGCAGCCGGAG−3’
5’−CTCCGGCTGCGGCAGGTCACAGAGGGCAGAC−3’
mDia1 mouse E317R
5’−CTCATCACTCCAGCTAGGGAACTGGACTTCCGAG−3’
5’−CTCGGAAGTCCAGTTCCCTAGCTGGAGTGATGAG−3’
mDia1 mouse E358R
5’−CTGTGCGTGTTTGATAGACAAGGGGATGAAGATTTC−3’
5’−GAAATCTTCATCCCCTTGTCTATCAAACACGCACAG−3’
mDia1 mouse E362R
5’−GATGAACAAGGGGATAGGGATTTCTTTGATCCTG−3’
5’−CAGGATCAAAGAAATCCCTATCCCCTTGTTCATC−3’
mDia2 mouse K369C
5’−CTGGATATACAACTTTGTGTCTTTGATGAGCAC−3’
5’−GTGCTCATCAAAGACACAAAGTTGTATATCCAG−3’
RhoA human Q63L
5’−GGGACACAGCTGGGCTGGAAGATTATGATCGC−3’
5’−GCGATCATAATCTTCCAGCCCAGCTGTGTCCC−3’
RhoA human G14V
5’−GGTGATTGTTGGTGATGGAGCCTGTGG−3’
5’−CCACAGGCTCCATCACCAACAATCACC−3’
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3.2. Molecular Biological Methods
3.2.1 Cloning
The cloning of specific protein fragments into the desired vectors required several
steps. The DNA was amplified, purified, restricted, again purified, ligated into the
vector and finally transformed into E. coli. Each step is described in the following.
Polymerase chain reaction
In the first step the inserts were amplified by polymerase chain reaction (PCR) using
the indicated primer (Table 3.1, 3.2) with the specific restriction sites. The primer were
pipetted together with the template DNA in a 50 µL reaction mixture as indicated.
PCR reaction mixture
Phusion buffer (5x) 10 µL
DMSO 1.5 µL
10 x dNTP (2 mM) 1 µL
5’-primer (10 pmol/µL) 1 µL
3’-primer (10 pmol/µL) 1 µL
Phusion® High-Fidelity DNA Polymerase 0.5 µL
template DNA (20-200 ng) 1 µL
H2O ad 50 µL
DNA amplification was performed using a thermal cycler with the following setup.
Subsequently, the DNA samples were purified.
Table 3.4 PCR Settings.
step duration temperature number of cycles
denaturation 30 sec 94 ◦C 1
denaturation 30 sec 94 ◦C
annealing 30 sec 55-75 ◦C 30
elongation 20 sec/ kb 72 ◦C
elongation 10 min 72 ◦C 1
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DNA purification
During the cloning procedure the DNA was purified at two steps. After the initial
PCR to ensure proper restriction the DNA was purified using the QIAquick PCR
Purification Kit (Quiagen). The digested DNA fragments and vectors were purified
using the QIAquick Gel Extraction Kit (Quiagen). Both protocols were done according
to the manufactures manual.
Restriction
The amplified and purified DNA strands were restricted with the corresponding
enzymes (Table 3.1, 3.2). Therefore, the samples were incubated at 37 ◦C for 1 h in
CutSmart® buffer. Simultaneously, 1 µg of the target vector was digested with the same
enzymes prior to the ligation.
Ligation
Ligation was performed according to the manufacturers protocol using the T4 DNA
ligase (NEB). Therefore, 50 ng of the vector DNA and a fivefold molar excess of insert
DNA were incubated with the ligase for 10 min at RT. The following heat inactivation
of the enzyme was performed at 65 ◦C for another 10 min. Afterwards, the sample was
transformed into E. coli cells as described in section 3.3.
Colony PCR
Correct and complete ligation of the desired DNA fragments into the vector was
controlled by Colony PCR. Following the transformation and cultivation the grown
E. coli colonies were picked and used as the template for a PCR using the 5 Prime Mas-
termix (5Prime) and vector specific primers. The amplified fragments were analyzed
by agarose gelelectrophoresis and stained with SYBR® Safe (Life technologies).
3.2.2 Site-directed mutagenesis
The exchange, deletion and insertion of specific nucleotides was performed using the
QuikChange® Site-Directed-Mutagenesis Protocol (Stratagene, Amsterdam, Belgium).
Therefore two reverse-complementary primer with the desired mutation flanked by
approximately 15 bases at each site were designed. To optimize the annealing, the
primer ended with an 5’ and 3’ guanosin or cytosin and had a melting temperature of
approximately 70 ◦C. The primer were pipetted together with the template DNA in a
50 µL reaction mixture as indicated.
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QuikChange reaction mixture
Phusion buffer (5x) 10 µL
DMSO 1.5 µL
10 x dNTP (2 mM) 1 µL
5’-primer (10 pmol/µL) 2.5 µL
3’-primer (10 pmol/µL) 2.5 µL
Phusion® High-Fidelity DNA Polymerase 0.5 µL
template DNA (2 ng) 1 µL
H2O ad 50 µL
The site directed mutagenesis was performed using a thermal cycler with the following
setup (Table 3.5). Subsequently, the sample was incubated with Dpn1 (NEB) for 2 h
at 37 ◦C. This enzyme cleaves only at methylated sites (template), keeping the PCR
product intact. Afterwards the sample was transformed into E. coli cells as described
in section 3.3.
Table 3.5 QuikChange PCR cycler settings.
step duration temperature number of cycles
denaturation 60 sec 94 ◦C 1
denaturation 60 sec 94 ◦C
annealing 60 sec 55 ◦C 30
elongation 30 sec/ kb 72 ◦C
elongation 10 min 72 ◦C 1
3.2.3 Purification of plasmid DNA
The used constructs were amplified using DH5α E. coli strains. These transformed cells
were cultivated in 4 mL LB-medium at 37 ◦C O/N and the plasmid DNA was purified
with the QIAprep Spin Miniprep Kit (Quiagen). For vectors used in cell culture assays
100 mL of LB-medium and the QIAGEN Plasmid Midi kit (Quiagen) were used. This
resulted in higher amounts of plasmid DNA with a high degree of purity suitably for
adequate transfection efficiencies.
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3.2.4 Denaturing SDS-polyacrylamid gelelectrophoresis
Discontinuous denaturing SDS-polyacrylamid gelelectrophoresis (SDS-PAGE) was
used to separate protein mixtures and to examine the different steps of the protein
purification process. Composition of the gels is shown in Table 3.6.
Table 3.6 SDS-PAGE gel composition.
stacking gel separation gel
acrylamide (%) 3.1 12
acrylamide solution 30 % / mL 2.48 12.4
tricine-buffer / mL 6 13.4
glycerol 86 % / mL 6.2
TEMED / µL 30 30
APS 10 % / µL 300 300
Before the samples were loaded on the SDS gels they were incubated with Laemmli
sample buffer and boiled at 96 ◦C for 5 min. The electrophoresis was performed in
the anode/cathode buffers for 45-60 min at 160 V. Subsequently, the gels were stained
with coomassie staining solution for approximately 30 min and then destained with
coomassie destaining solution.
3.2.5 Analysis of protein expression by immunoblotting
In order to control the expression of the mCherry-Lipfl and pEGFP-RhoA Q63L con-
structs in N2a and HeLa cells, the cells were seeded in 6-well plates and transfected
the next day (3.7.2). After 18 h the cells were lyzed in 50 µL RIPA buffer per well and
incubated with Laemmli sample buffer. Of these, 15 µg were used for the SDS-PAGE.
Proteins were transferred onto a methanol-activated PVDF membrane (GE Healthcare)
by semidry electrotransfer for 45 min at 150 mA in transfer buffer. The membrane
was blocked in 5 % (w/v) milk powder in PBS-T for 60 min at RT. Primary antibodies
were diluted in 3 % (w/v) milk powder in PBS-T according to Table 3.1.7 and used
for incubation at 4 ◦C O/N. The next day, the membrane was washed three times
with PBS-T for 10 min and subsequently incubated with the corresponding secondary
HRP-coupled antibody, which was also diluted in 3 % (w/v) milk powder in PBS-T. The
secondary antibodies were incubated for 60 min at RT and thereafter the membrane
was washed three times with PBS-T for 10 min. Signal development was induced with
Roti®-Lumin (Roth) in the darkroom.
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Stripping of the membrane for detection with additional antibodies was accomplished
by incubation and careful heating with the mild stripping buffer for 2 x 10 min. After
three following washing steps with PBS-T for 10 min the membrane was again blocked
with 5 % (w/v) milk powder in PBS-T for 60 min and incubated with another primary
antibody. Successful stripping of the membrane was controlled by incubation with
Roti®-Lumin (Roth) after the first washing step.
3.2.6 Peptide synthesis
All synthesized peptides used in this study were kindly provided by the group of Ines
Neundorf according to the protocol described in Brenig et al. (2015). The following
peptides were synthesized and finally used.
label amino acid sequence molecular weight
Lip567–587 TPRSARLERMAQALALQAGSP 2223.6 Da
Lip567–587 T567E EPRSARLERMAQALALQAGSP 2251.61 Da
F-Lip567–587 CF-GSGTPRSARLERMAQALALQAGSP 2784.11 Da
F-Lip567–582 CF-GSGTPRSARLERMAQALAL 2343.65 Da
3.3. E.coli transformation and cryopreservation
3.3.1 Preparation of competent E.coli cells
Preparation of chemically competent E. coli strains was accomplished with the CaCl2-
method (Mandel & Higa, 1970). As the first step 400 mL LB medium, inoculated with
5 mL of a preculture, was grown to OD600 = 0.3. The cells were pelleted for 10 min at
500 x g and resuspended in 25 mL of an ice-cold and sterile 0.1 M CaCl2 solution. After
incubation for 20 min on ice the cells were again centrifuged for 10 min at 500 x g . This
time the cells were resuspended in 2 ml ice-cold 0.1 M CaCl2 solution supplemented
with 15 % glycerol. Samples were divided in 200 µL aliquots, flash frozen in liquid N2
and stored at -80 ◦C.
3.3.2 Transformation
For cloning strategies E. coli DH5α cells were transformed, for protein expression BL21
(DE3) were used. Of these cells 100 µL were incubated with 50 ng Plasmid-DNA,
or 10 µL ligation sample, respectively. The samples were chilled on ice for 30 min
and subsequently heatshocked at 42 ◦C for 2 min. Afterwards the cells recovered for
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45 min at 37 ◦C. Eventually, they were pelleted and plated on agar plates with the
corresponding selection antibiotic.
3.3.3 E. coli cryopreservation
The agar plates with the grown E. coli cells were used for short-term storage of 1–2
weeks at 4 ◦C. For long-term storage 700 µL of the E. coli strains were supplemented
with 300 µL glycerine (86 %) and stored in CryoTubes™ (Sigma-Aldrich) at -80 ◦C.
3.4. Protein Purification
3.4.1 Expression of recombinant proteins
Up to five colonies from the agar plate were picked and used to inoculate 200 mL
pre-culture LB-medium. These cultures were grown at 37 ◦C, 140 rpm O/N. The final
10 L expression culture with LB-medium was inoculated 1:100 with the pre-culture
and cultivated at 37 ◦C, 160 rpm until an optical density at 600 nm (OD600) of 0.6–0.8
was reached. At this point the protein expression was induced by addition of 200 µM
isopropyl-β-D-thiogalactopyranoside (IPTG). The induced cultures were grown O/N
at 18 ◦C. The next day the E. coli cells were pelleted at 4000 x g for 20 min, resuspended
in 100-150 mL protein buffer and stored at -80 ◦C.
3.4.2 Cell lysis
The E. coli cells were lyzed by sonication using a Branson Sonifier 250. Therefore, the
thawed pellets were sonicated 3 x 2 min with 60 % duty cycle and a micro tip limit of 8.
Afterwards, the lysate was centrifuged at 50 000 x g for 45 min at 4 ◦C to separate the
cell debris from soluble protein.
3.4.3 Affinity purification
For all proteins used in this study GST-affinity purification was performed as initial
step. At first the column packed with approximately 40 mL of PureCube Glutathion
Agarose (Cube Biotech) was equilibrated with protein buffer. The equilibrated beads
were then loaded with the cleared protein lysate and the flowthrough was collected.
In order to get rid of non-specifically bound protein the column was washed with
5–10 column volumes (CV) protein wash buffer. Prior to the TEV-cleavage the buffer
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was again exchanged to protein buffer. Once the TEV-protease was added, the buffer
circulation was started and continued at 4 ◦C O/N. The protein was eluted the next
day. Since the TEV-protease was obtained by Ni-affinity purification the unwanted
protein could be removed with Ni-Sepharose 6 Fast Flow columns (GE healthcare). The
euluted protein was concentrated using ultrafiltration with AmiconUltra centrifugal
devices with the adequate pore size (molecular weight cut-off of 3, 10 or 30 kDa). If
the following size exclusion chromatography was not performed the same day, the
proteins were flash frozen and stored at -80 ◦C.
Column material regeneration
The GSH-column was rinsed with 2 CV GSH elution buffer, to remove the still bound
GST from the beads. A sample of this elution was taken to control the GST expression
by SDS-PAGE. Afterwards the column was washed with 2-3 CV water, before 2 CV of
6 M guanidinium hydrochloride was added. At the end the column was washed again
with 5 CV water.
3.4.4 Size exclusion chromatography
Following the affinity purification the proteins were further purified by size exclusion
chromatography (SEC). Thereby, possible existing impurities could be removed and a
proper folding of the protein was guaranteed. The size exclusion chromatographies
were performed with the ÄKTApurifier system (GE healthcare) and a set of Superdex
S75 and S200 columns. This system allows the protein elution at a constant flow and
pressure, as well as the monitoring of absorption at 220 nm and 280 nm. For each
run 2 mL of the protein sample were loaded and eluted with protein buffer in 2–4 mL
fractions. The eluted fractions were tested via SDS-PAGE and the fractions showing
high purity were pooled, concentrated, flash frozen and finally stored at -80 ◦C.
Analytical size exclusion chromatography
Besides the purification of proteins size exclusion chromatography can be used to get a
hint of the molecular size and oligomeric state of proteins. For this purpose 100 µL of
each sample was loaded onto either a Superdex S75 10/300 or Superdex S200 10/300
column and eluted with protein buffer at a flowrate of 0.5 mL/min. The Superdex S75
column was calibrated with Aprotinin (6.5 kDa), Ribonuclease A (13.7 kDa), Carbonic
Anhydrase (29 kDa), Ovalbumin (43 kDa) and Conalbumin (75 kDa). Additionally,
Aldolase (158 kDa), Ferritin (440 kDa) and Tyhroglobulin (669 kDa) were used for the
S200 column.
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3.4.5 Determination of protein concentration
The protein concentration was determined by measuring the absorption at 280 nm.
Using the Lambert-Beer law the concentration can be calculated as indicated.
A = e ∗ c ∗ l (3.1)
with the absorbance A, absorption coefficient e (M-1 cm-1), the concentration c (M)
and the cell path length l (cm). The applied extinction coefficients for the mDia1 and
Liprin-α3 fragments are summarized in Table 4.1.
In case of the protein RhoA another method was used due to the additional absorption
of the bound nucleotide at 280 nm. The concentration of RhoA was determined with
the BradfordUltra assay (Expedeon) measuring the reaction of the amino acid side
chains with Coomassie brilliant blue G-250 at 595 nm. Bovine serum albumin (BSA)
was used for the calculation of a standard curve.
3.4.6 Nucleotide exchange on RhoA
The bound nucleotide of RhoA was exchanged to 2‘/3‘-O-(N-Methylanthraniloyl)-
GppNHp (mant-GppNHp, Jena Bioscience) (Figure 3.1). Fluorescence of this non-
hydrolyzable nuleotide can be excited at 355 nm and detected at 448 nm.
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Figure 3.1 Structure of 2‘/3‘-O-(N-Methylanthraniloyl)-GppNHp.
For the nucleotide exchange 500 µL with 2 mg/mL of purified RhoA were incubated
with a fourfold molar excess of mant-GppNHp and 1 µL of calf intestinal phosphatase
(CIP, New England Biolabs®) at 4 ◦C O/N. The EDTA in the exchange buffer binds the
Mg2+ Ions, that are needed for the high affinity binding of small GTPases to GTP and
GDP. Furthermore, GTP and GDP are removed from the exchange equilibrium due to
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CIP induced hydrolysis. Analytical size exclusion chromatography with protein buffer
was used to remove the excess of unbound mant-GppNHp, and CIP. Additionally,
the nucleotide bound state was stabilized by the MgCl2 in the buffer. The obtained
RhoA •mant-GppNHp was aliquoted, flash frozen and stored at -80 ◦C for stopped-flow
fluorescence spectroscopy assays.
3.5. Biophysical Methods
3.5.1 Isothermal Titration Calorimetry
The protein-protein interactions were characterized by isothermal titration calorimetry
(ITC). A simple binding reaction of two components A and B can be described as:
A + B ⇀↽ AB (3.2)
The association constant (KA) is defined as:
KA =
[AB]
[A][B]
(3.3)
Additionally, KA is connected to the Gibbs free energy ∆G.
∆G = −RTlnKA = ∆H − T∆S (3.4)
with the Gibbs free energy ∆G, the ideal gas constant R, the absolute temperature T,
the equilibrium association constant KA, the reaction enthalpy ∆H and the reaction
entropy ∆S.
Every reaction is associated with a change in the reaction enthalpy and this change
can be measured indirectly. The binding ligand A is titrated step-wise to the reaction
partner B inside the measurement cell. Thereby, heat is either released (negative ∆H,
exothermic) or absorbed (positive ∆H, endothermic). The instrument determines the
energy that is needed to keep the temperature difference between the measurement
cell and the reference cell, filled with water at the exact same level (isothermal).
This supplied heat is integrated and plotted against the increasing concentration
of A against B. Fitting with a one-side model of these data results directly in the
equilibrium association constant (KA), stoichiometry (N) and reaction enthalpy (∆H)
of the investigated binding. The Gibbs free energy (∆G) and the reaction entropy (∆S)
can be derived from the equation 3.4.
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For this study an ITC200 (GE healthcare) was used. All measurements were performed
at 20 ◦C. Since, this method is highly sensitive, even small differences in the protein
buffers can lead to dilution heat signals. Therefore, all proteins used were purified in
the same buffer. In each experiment 2–3 µL of protein in the syringe was step-wise
titrated to the protein inside the measurement cell. Typically, the concentration in
the syringe was between 200–500 µL and ten fold increased compared to the protein
inside the cell (20–50 µL). A spacing of 120 sec between the injections was set with an
initial delay of another 120 sec. The differential power (DP) of six was initialized at
the beginning. Standard EDTA-CaCl2 sample tests were used to assess the statistical
significance of our observations, as described by MicroCal. The obtained values were
within the manufactures tolerance with ±20 % for the KA and ±10 % for ∆H.
The data analysis was performed with the software provided by the manufacturer
(MicroCAL Origin version 7.0).
ITC competition assays
In the case of the ITC competition assays an initial complex was preformed in an ITC
experiment. Therefore a tenfold molar excess of the ligand A was titrated to the protein
B in the sample cell. This resulted in saturated complexes with a twofold molar excess
of the ligand inside the sample cell. Abundant solution was removed from the cell and
the third binding partner C was added to the complex with a tenfold molar excess.
3.5.2 Fluorescence polarization assay
Fluorescence polarization assays were used to determine whether mDia1, RhoA and
Liprin-α3 can form ternary complexes. The method is based on the observation that
a fluorophore, which is exited with polarized light, will emit polarized light (Perrin,
1926). However, this is only the case for stationary molecules. A rotating and moving
molecule in solution will emit light that is largely depolarized and in a different
plane from the excitation light. The actual polarization of a fluorophore is thereby
proportional to the rotation, which in turn depends on the absolute temperature,
viscosity and for this purpose most important the molecular volume. A small molecule
in solution has a higher degree of movement and rotation and thus a high amount of
depolarized emitted light. Accordingly, in case of larger molecules the emitted light
remains polarized to a higher degree.
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Using a Paradigm Detection Platform (Beckman Coulter) with a detection cartridge for
fluorescein, the fluorophore was excited with polarized light and the emitted light was
monitored in the vertical and horizontal plane. The polarization signal is defined as:
P =
I‖ − I⊥
I‖ + I⊥
(3.5)
with:
I‖: Intensities with parallel polarizers
I⊥: Intensities with perpendicular polarizers
The small Liprin-α3 fragments Lip567–582 and Lip567–587 were N-terminally labeled
with 5,6-carboxyfluorescein (CF). The fluorophore was excited at 485 nm and the
emission was detected at 535 nm. Blank measurements were performed with Liprin-α3
fragments without the fluorophore. Each experiment was performed at 37 ◦C in protein
buffer with an integration time of 500 ms. The first measurement was performed with
100 nM of each single Liprin-α3 fragments. In the second step 10 µM of mDia1 and
in the third step additional 15 µM of RhoA Q63L were added. The solutions were
incubated until a stable polarization signal was reached. Data analysis was done with
GraphPad Prism 6.0 and each condition was measured independently three times.
3.5.3 Stopped-flow fluorescence spectroscopy
Stopped-flow fluorescence spectroscopy allows the analysis of fast interaction kinetics.
Thereby, the change of fluorescence signals is measured in a microsecond time-scale,
with a dead time of approximately 2-3 ms. The reaction partner are loaded into two
drive syringes. They are forced by a drive ram through a mixing chamber into the
observation cell. Simultaneously, this flow leads to a filling of the stop syringe, adjacent
to the observation cell. The flow is interrupted once the pistol of the stop syringe hits
the trigger switch, which is also the trigger of the data acquisition. Using this method
the association and dissociation rate constants (kon, ko f f ) of two reaction partners can
be determined. They are defined as:
A + B
kon−−⇀↽−
ko f f
AB (3.6)
Thus resulting in the rate of the complex formation of A and B:
d[AB]
dt
= kon[A][B]− ko f f [AB] (3.7)
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In a typical conducted stopped-flow experiment one reaction partner is used in a much
higher molar concentration than the other one. As a result, the concentration can
be assumed to be constant, leading to pseudo-first order reaction. The second-order
reaction kinetic v = k[A][B] can, hence, be simplified to v = kobs[B], resulting in
d[AB]
dt
= kobs[B]− ko f f [AB] (3.8)
with kobs = kon[A]. The solution of the differential equation is given by
[AB] =
kobs[B]0
kobs + ko f f
− kobs[B]0
kobs + ko f f
∗ e−t(kobs+ko f f ) (3.9)
with [B]0 : the concentration of B at time point zero
The changes in the fluorescence signal were plotted against the time and exponentially
fitted, which resulted in kobs. Due to the assumption of a pseudo-first order reaction it
can be further simplified to:
kobs = kon[A] + ko f f (3.10)
The values of kobs were plotted against the concentration of A and a linear fit was
applied, leading to kon. Furthermore, ko f f can be obtained from the y-intercept.
However, the ko f f determined this way are often not precise and were therefore
calculated from separate experiments. A complex of A and the fluorescently labeled
binding partner B was preformed and titrated with a high molar excess of non-
labeled protein B. The dissociation of the labeled protein was measured and single-
exponentially fitted.
In this study the experiments were performed at 20 ◦C using a SX20 Applied Photo-
physics spectrometer (Leatherhead). The mantGppNHp nucleotide, which was bound
to RhoA (3.4.6), was excited at 350 nm and the emission was recorded using a 420 nm
cut-off filter. In order to determine the association rate constant 250 nM of RhoA •mant-
GppNHp were titrated with increasing mDiaN concentration (0.6–40.7 µM). The effect
of Liprin-α3 on the binding kinetics was analyzed by adding a twofold molar excess
of different fragments to the mDiaN. For the dissociation rate constant a 100 nM com-
plex of mDiaN •RhoA •mant-GppNHp was mixed with 10 µM constitutively active
unlabeled RhoA Q63L in presence or absence of 10 µM Liprin-α3. Data analysis was
done with GraphPad Prism 6.0.
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3.6. Protein structure determination
3.6.1 Crystallization
The crystallization of proteins is a crucial step in the protein structure determination
by X-rays. This is most commonly achieved by a gradually decrease of the protein
solubility. As depicted in Figure 3.2 a higher saturated state can be reached by either
increasing the protein concentration or the precipitant concentration. However, protein
precipitation can occur if this transition happens too fast. Only in a certain cases it will
lead to nucleation of crystalline structures, that may be followed by further growth
up to three-dimensional crystals suitable for X-ray crystallography. Consequently, the
formation of proper crystals depends on the protein concentration, as well as the pH
value, ionic strength, composition of the precipitant and the temperature.
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precipitation
Figure 3.2 Crystallization phase diagram.
Simplified two-dimensional phase diagram depicting the importance of the protein concentra-
tion and precipitant.
Frequently used methods to obtain protein crystals are vapor diffusion crystallization
(sitting drop, hanging drop) and crystallization by dialysis. In this study sitting drop
vapor diffusion crystallization was used. Complexes with 5–10 mg/mL mDia1 with a
fivefold molar excess of Liprin-α3 were preformed and 150 nL of this protein solution
were mixed with 150 nL reservoir solution (Mosquito, TTPLabtech). The different
complexes used for the crystallization attempts are collected in Table 3.7 and the tested
crystallization screens are shown in Table 3.1.6.
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Table 3.7 mDia1 •Liprin-α3 complexes used for crystallization screens.
mDia1 Liprin-α3 concentration of mDia1
mDia135-570 Lip532-587 10 mg/mL
mDia135-570 Lip491-587 10 mg/mL
mDia79-369 Lip561-587 10 mg/mL
mDia79-369 Lip567-587 10 mg/mL
mDia79-435 Lip567-587 10 mg/mL
mDia79-443 Lip567-587 10 mg/mL
mDia135-443 Lip567-587 10 mg/mL
mDia135-435 Lip567-587 10 mg/mL
mDia135-369 Lip532-587 10 mg/mL
mDia135-369 Lip567-587 10 mg/mL
mDia135-369 Lip567-587 15 mg/mL
mDia135-369 Lip561-587 10 mg/mL
mDia135-369 (brown color) Lip567-587 10 mg/mL
Some of these tested conditions resulted in crystal formation of needle like structures,
that were not suitable for X-ray analysis. In these cases the commercial screening
solution was further varied, regarding pH or precipitant, in up-scaled hanging-drop
vapor diffusion crystallization screens using 1 µL of the protein complex and 1 µL
of the reservoir solution. However, no optimization in crystal formation could be
observed. Finally, the crystals obtained from the mDia135-369 (brown color) •Lip567-587
were fished with a 0.05-0.1 mm loop and prepared for cryoprotection.
Cryoprotection
To ensure long-term storage and a higher degree of stability during the measurement,
the protein crystals are flash frozen. Therefore, the crystals need to be in a cryogenic
solution. This was achieved by transferring the crystals into the same solution with
additional 30 % (w/v) of D-glucose as cryoprotectant. Afterwards they were flash
frozen and stored in liquid N2.
3.6.2 Data collection and processing
Data collection was performed at the Swiss Light Source (SLS), Paul Scherrer Institute
in Villigen, Switzerland. The crystal was mounted on the goniometer head and
orientated in the beamline X06DA. Finally, a dataset was collected at a wavelength
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of 1.0 Å at 100 K. A Dectris Pilatus 2M detector was in a distance of 165 mm and the
crystal rotated 0.1 ◦ for 1800 frames.
Further data processing was done with the program suite Ccp4 (Bailey, 1994). Mosflm
7.0.9 was used for the data indexing and integration. Scaling was performed with
SCALA 3.3.20 (Evans, 2006; Leslie & Powell, 2007; Steller et al., 1997). The quality of
the data was judged by the completeness of the collected reflexes, redundancy, the
signal to noise ratio of I/σI and data resolution. Additionally, the data were evaluated
by Rsym:
Rsym =
∑
hkl
N
∑
i=1
|Ii,hkl − 〈Ii,hkl〉|
∑
hkl
N
∑
i=1
Ii,hkl
(3.11)
with the reflex intensities I and miller indices hkl.
Phase determination
The electron density as function of position x,y,z can be expressed as the Fourier
transformation of the structure factors Fhkl:
p(xyz) =
1
V ∑hkl
Fhkl e−2pii(hx+ky+lz) (3.12)
Separating the structure factor Fhkl into its amplitude |Fhkl| and the phase of the
diffracted beams αhkl results in:
p(xyz) =
1
V ∑hkl
|Fhkl| e−2pii(hx+ky+lz)+iαhkl (3.13)
This elucidates the importance of the structure factor amplitudes, as well as the
corresponding phases. Each reflex of the diffraction pattern corresponds to a wave
with a specific amplitude and phase. However, while the amplitude can be calculated
from the collected intensity, no information about the phase can be obtained. The
loss of information is also termed as the phase problem. In this study molecular
replacement was used as one possible solution to overcome this problem. It can be
assumed that in a complex the mDiaDID has a much higher impact on the diffraction
pattern than the Liprin-α3 fragment Lip567-587. Therefore, the residues 135–369 of chain
B of the mDiaN •RhoC structure (PDB: 1Z2C) were suitable for the program Phaser,
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performing a search for two molecules per asymmetric unit (McCoy et al., 2007). Using
translation and rotation events an approximation of the unknown phases was possible.
3.6.3 Model building and refinement
The program Coot 0.7.1 was used to build the model into the 2Fo − Fc (countered
at 1.0 σ) and Fo − Fc (countered at 3.0 σ) electron density maps in iterative rounds of
refinement (Emsley & Cowtan, 2004). After the initial phasing and model building, re-
finements are mandatory to improve the geometry of the model and the approximation
of the phases. Through statistical adjustment of the atomic coordinates, the refinement
leads to a higher accordance with the diffraction data. Based on the refinement, new
amplitudes and phases are calculated for the structure factor Fhkl. Quality of the
refinement can be estimated by Rwork. This value describes the difference between the
calculated amplitudes from the structure Fcalc and the observed amplitudes Fobs.
Rwork =
∑
∣∣|Fobs| − |Fcalc|∣∣
|∑ Fobs| (3.14)
Notably, possible model bias can occur, since incorrect build areas of the atomic model
are also used to calculate the new structure factors. For this reason 5–10 % of the
reflections are excluded from the refinement and used for the calculation of R f ree, in
analog to Rwork (Brunger, 1992).
In this study the refinement was conducted with REFMAC5 (Murshudov et al., 1997)
and evaluated using MolProbity (Davis et al., 2007). All structure figures presented
here were made with PyMOL 1.6.9.0 (DeLano, 2002).
3.7. Immunocytochemistry
3.7.1 Cell cultivation
HeLa cells were grown in DMEM (Gibco) and N2a cells 1:1 DMEM/OptiMEM (Gibco).
Both media were supplemented with 10 % (v/v) fetal calf serum (FCS, PAN Biotech),
100 U/mL penicillin (Gibco) and 100 U/mL streptomycin (Gibco) and 1 % non-essential
amino acids (Gibco) at 37 ◦C with 5 % CO2. At a confluency of more than 70 % the cells
were trypsinated (0.25 % trypsin-EDTA, Sigma) and splitted. Long term storage was
performed at -80 ◦C in cell culture medium supplemented with 10 % (v/v) DMSO.
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3.7.2 Cell transfection and staining
Prior to the transfection 0.4 x 105 HeLa cells/mL and 0.5 x 105 N2a cells/mL were
seeded on cover glasses in 24-well plates and cultured in 1 mL medium for 24 h. For
the overexpression experiments 0.5 µg of each plasmid DNA was mixed together with
1 µL Plus Reagent™ in 100 µL Opti-MEM and incubated for 25 min. Finally, 1.5 µL
Lipofectamine® LTX (Invitrogen) was added for another 5 min incubation time, before
the mixture was pipetted to the cells. After 18 h the cells were washed with ice cold PBS
and fixed with 3 % paraformaldehyde for 20 min. Before the cells were permeabilized
with 0.5 % Triton X-100 for 15 min, they were washed again three times. Blocking of
unspecific binding was accomplished with 3 % BSA in PBS for 60 min. Subsequently, the
cell nuclei were stained with DAPI (1:20000, Santa Cruz Biotechnology) and staining of
filamentous actin was done with CF647-phalloidin (1:60, Biotium). Three washing steps
later, the cover slips were embedded in ProLong® Gold Antifade Reagent (Invitrogen)
for 24 h. At the end, the cover slips were sealed with nail polish and stored in the dark.
3.7.3 Microscopy and quantification
The immunofluorescence images were taken with an UltraView VoX, PerkinElmer Life
Sciences spinning disc confocal microscope. For data processing and quantification
the software ImageJ (National Institutes of Health) was used. In the first step, the
maximum Z-stack projection of the images was calculated before the CF647 intensity
of each cell was quantified. Normalization was done to non-transfected cells under
the same conditions. The mock transfected cells served as a reference to analyze the
effect of RhoA G14V and Liprin-α3 overexpression. At least 20 cells for each construct
were used for the analysis and each construct was tested at least two times. GraphPad
Prism 6.0 was used for statistical analysis.
4. Results
The binding of Liprin-α3 to mDia1 has been firstly described by Sakamoto et al. (2012a).
They narrowed down the binding sites to the amino acids 457–737 of Liprin-α3 and
the amino acids 135–570 of mDia1. In their work it was further concluded that the
binding of Liprin-α3 to mDia1 interferes with the binding of RhoA to mDia1. Yet, the
mechanisms how Liprin-α3 exerts its effect leading to a reduction in cellular F-actin
remains elusive. As a first step of this work the binding sites were narrowed down.
Using these minimal mDia1 and Liprin-α3 fragments their binding was thermodynam-
ically, kinetically and structurally characterized, as well as the interplay of Liprin-α3
with RhoA and the autoinhibitory state of mDia1.
4.1. Definition of the interaction sites of mDia1 and
Liprin-α3
4.1.1 Design and examination of soluble mDia1 and Liprin-α3 frag-
ments
In order to find the regions, that are necessary and sufficient for the interaction of
Liprin-α3 and mDia1, several constructs were cloned and purified. The different frag-
ments are shown in Table 4.1 with the according remark if expression and purification
was successful in regard of the quality and quantity of material, to perform biophysical
studies including X-ray crystallography.
56 4. Results
Table 4.1 Cloned and purified fragments of mDia1 and Liprin-α3.
protein fragment size extinction coefficient (e) purification
aa kDa M-1 cm-1
mDia1
79–369 34 9970 +
74–369 34 9970
69–369 35 9970
79–437 41 14440
79–435 41 14440 +
79–443 42 14440 +
74–443 43 14440
69–443 43 14440
69–435 42 14440
69–451 44 14440 +
69–570 58 14440 +
135–369 27 8480 +
135–525 45 12950
135–570 50 12950 +
135–500 42 14400
135–550 48 12950
135–475 39 12950
135–451 37 12950 +
WW-1145–1200 7 11000 +
WW-1145–1209 8 11000 +
Liprin-α3
20–587 64 23950
25–587 63 23950
77–587 57 23950
90–587 56 23950
110–587 53 23950
217–587 41 16960 +
271–587 34 16960 +
306–587 30 16960 +
457–587 14 1490 +
457–737 22 23490 +
W-532–587 6 5500 +
W-541–587 5 5500 +
W-561–587 3 5500 +
W-443–498 6 6990
W-443–491 6 5500 +
W-491–560 7 6990 +
W-541–571 5 5500
25–217 20 6990
25–817 88 70930
25–737 80 47440
W-561–581 3 5500 +
W-561–582 3 5500 +
1–737 82 47440
1–817 90 70930
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4.1.2 Purification of mDia1 and Liprin-α3 peptides
For each fragment the purification process was performed according to the work-flow
shown in Figure 4.1 A. The genes on the cloned pGEX4T5-TEV plasmids encoding for
the proteins were expressed in E. coli BL21 (DE3) cells after induction with IPTG. After
sonication the lysates were loaded onto a GSH-affinity chromatography column and
washed prior to TEV-cleavage over night (O/N). Finally, the samples were concentrated
and further purified using size exclusion chromatography (SEC), frozen in liquid N2
and stored at -80 ◦C. As an example the affinity purification of the mDiaN∆GCC
fragment (aa 135–570) is shown (Figure 4.1 B). The protein expression, as well as
the TEV-cleavage have been controlled by SDS-PAGE. The overexpressed GST-fusion-
protein is visible as a dominant band at 76 kDa in the lysate after induction with IPTG
(lane 2). This band is still present in the soluble fraction after sonication (lane 4). After
the TEV-cleavage the fusion-protein is cleaved to yield the desired mDia1 protein with
50 kDa (lane 6) and the cleaved GST-tag with 26 kDa (lane 7). In the next purification
step the protein was further separated from potential impurities by SEC. The first peak
(void volume) contains impurities, that are either by themselves or due to aggregation,
too large to enter the column pores. Purified and correctly folded proteins could be
collected from the second elution peak (Figure 4.1 C).
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Figure 4.1 Example of the two-step purification protocol using affinity columns and size
exclusion chromatography.
A: Work-flow of the different protein purification steps. B: GSH-column purification of
mDiaN∆GCC. The figure shows the SDS-PAGE with the overexpression of the gene plasmid in
E. coli BL21 (DE3) cells, the protein solubility after sonication and the successful TEV-cleavage.
C: Size exclusion chromatography (S200, 26/60) of the concentrated protein following the GSH-
purification. Elution of the protein was monitored using the absorption at 280 nm. Impurities
and correct size of the protein fragment are controlled by SDS-PAGE.
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The fragments that were finally used in this study to characterize the mDia1-Liprin-α3
binding are depicted in Figure 4.2. These fragments were expressed and purified to
sufficient yields and to a high level of purity (Figure 4.3) and were thereby suitable for
subsequent analyses.
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Figure 4.2 Overview of the mDia1 and Liprin-α3 domains and the used constructs.
Illustrated are the different domains of mDia1 and mouse Liprin-α3 and the constructs that
were used for the characterization of the protein interactions.
Quality control of the purified samples was performed by SDS-PAGE (Figure 4.3).
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Figure 4.3 SDS-PAGE of the mDia1 and Liprin-α3 fragments used for further studies.
Approximately 5 µg of each indicated protein was loaded per lane.
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All fragments used for the definition of the binding site exhibit a high degree of purity.
The samples show clear defined protein bands and a migration behavior according to
their molecular weight.
4.1.3 Definition of the mDia1-lip binding site by isothermal titration
calorimetry
Isothermal titration calorimetry (ITC) was used to define the minimal Liprin-α3 and
mDia1 interaction sites. All measured combinations of Liprin-α3 and mDia1 fragments
are collected in Table 4.2 and Figures A.3 to A.5. Sakamoto et al. restricted the bind-
ing site in pull-down assays to the N-terminal coiled-coil of Liprin-α3 (aa 457–737,
Lip457–737) and the N-terminal region of mDia1 lacking the guanine-nucleotide binding
domain (GBDN) mDiaN∆GCC (aa 135–570). These fragments bind in ITC measure-
ments in an exothermic reaction with an affinity of 3.0 µM and a molar ratio of 1.0,
indicating a 1:1 binding stoichiometry (N). A fragment containing GBDN (mDiaNCC)
showed no further increase of the binding affinity (5.9 µM, Figure 4.4 A), suggesting
that this region is indeed not needed for the binding of Liprin-α3. The N-terminal
elongated and C-terminal shortened Liprin-α3 fragment (aa 217–587, Lip217–587) binds
towards mDiaN∆GCC and mDiaNCC with a slightly decreased affinity of 13.5 µM
and 13.6 µM, respectively and an N-value of 0.5. Binding stoichiometry and binding
affinity could be restored by N-terminal deletion of the Lip217–587 fragment, resulting
in fragment Lip306–587 with binding affinities towards different mDia1 fragments of
2.9–11.0 µM and N-values of 0.7–0.9. As a result, the overlapping region of Lip306–587
and Lip457–737, namely Lip457–587 was purified and tested regarding its binding ca-
pacity towards mDia1. This fragment binds mDiaN∆GCC with an affinity of 5.7 µM.
Further C-terminally truncated fragments of Liprin-α3 spanning the residues 443–491
(Lip443–491) and 491–560 (Lip491–560) showed no binding in ITC measurements. Whereas
the fragment Lip561–587 (aa 561–587) still binds to mDiaNCC with an affinity of 6.2 µM.
Finally, the essential amino acids of Liprin-α3, needed for the mDia1 binding, could
be narrowed down to the region 567–587 (Lip567–587). This peptide was synthesized
and exhibits a 4.4 µM binding affinity towards mDiaN, suggesting that this fragment
contains all residues needed for mDia1 binding (Figure 4.4 B).
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Figure 4.4 Determination of the Liprin-α3-mDia1 binding site by ITC.
ITC measurements of the depicted mDia1 and Liprin-α3 fragments at 20 ◦C in protein buffer.
Shown are the interactions of A: mDiaNCC (aa 69–570) with Lip457–737, B: mDiaN (aa 69–451)
with Lip567–587 and C: mDiaDID (aa 135–369) with Lip567–587. Lip567–587 binds with a similar
affinity to mDiaDID as Lip457–737 to mDiaNCC. (KD: equilibrium dissociation constant; ∆H:
change in reaction enthalpy; ∆S: change in reaction entropy; N: stoichiometry of binding; T:
temperature in Kelvin)
The next aim was to further specify the binding area on the N-terminal mDia1 region.
As indicated by Sakamoto et al. and confirmed by ITC analysis the GBDN plays no
direct role in Liprin-α3 binding and can therefore be excluded. Performing ITC
measurements with the two shortest Liprin-α3 fragments (Lip561–587 and Lip567–587)
showed that the mDia1 Diaphanous-inhibitory domain (mDiaDID, aa 135–369) contains
all essential Liprin-α3 interaction residues. The determined binding affinities of
mDiaDID to Lip561–587 and Lip567–587 were 8.3 µM and 6.9 µM, respectively (Figure 4.4 C,
Table 4.2).
In summary using ITC analyses the binding site of mDia1 and Liprin-α3 could be
narrowed down to mDiaDID and Lip567–587 with a binding affinity of approx. 7 µM,
showing an exothermic heat profile. Furthermore, all reactions were driven by favorable
enthalpic interactions, while most of the reactions were also entropically favorable
(Table 4.2).
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Table 4.2 ITC measurements for the identification of the mDia1–Liprin binding-site. All
ITC measurements were performed in protein buffer at 20 ◦C. The protein concentration in
the cell (superscript: C) was between 30–50 µM, the concentration in the syringe (superscript:
S) was between 300–500 µM. (KD: equilibrium dissociation constant; ∆H: change in reaction
enthalpy; ∆S: change in reaction entropy; N: stoichiometry of binding; T: temperature in Kelvin)
Interaction KD ∆H T∆S N
µM kcal mol-1 kcal mol-1
Liprin 217–587 CLip217–587-SmDiaDID 12.0 ±0.8 −8.3 ±0.6 −1.8 0.5
CLip217–587-SmDiaN∆GCC 13.6 ±1.1 −9.3 ±0.5 −2.8 0.5
CLip217–587-SmDiaNCC 13.5 ±0.9 −6.6 ±0.3 −0.04 0.5
Liprin 306–587 CLip306–587-SmDiaN∆GCC 2.9 ±0.2 −4.9 ±0.1 2.4 0.7
CLip306–587-SmDiaN 8.0 ±0.8 −5.2 ±0.1 1.6 0.9
CLip306–587-SmDiaN∆G 11.0 ±0.9 −5.9 ±0.1 1.6 0.9
Liprin 457–587/737 CLip457–737-SmDiaNCC 5.9 ±1.0 −7.0 ±0.4 −0.02 0.9
CLip457–737-SmDiaN∆GCC 3.0 ±0.4 −5.1 ±0.2 2.3 1.0
CLip457–587-SmDiaNCC 9.1 ±1.1 −4.6 ±0.1 2.2 0.6
CLip457–587-SmDiaN∆GCC 5.7 ±0.4 −4.3 ±0.2 0.8 0.8
CLip457–587-SmDiaN 7.7 ±0.8 −3.8 ±0.2 3.1 0.8
CLip457–587-SmDiaDID 9.9 ±0.3 −8.9 ±0.2 −2.2 0.6
Liprin 491–587 CLip491–587-SmDiaN∆GCC 6.4 ±0.8 −5.6 ±0.3 1.4 0.8
Liprin 443–491 CLip443–491-SmDiaN no binding
Liprin 491–560 CLip491–560-SmDiaN no binding
Liprin 561/567–587 CLip561–587-SmDiaNCC 6.2 ±1.1 −4.2 ±0.3 2.7 1.1
SLip561–587-CmDiaDID 8.3 ±0.5 −10.4 ±0.2 −3.6 0.9
SLip561–587-CmDiaN 2.6 ±0.2 −7.1 ±0.1 0.4 0.9
SLip567–587-CmDiaN 4.4 ±0.2 −7.1 ±0.2 0.1 0.9
SLip567–587-CmDiaDID 6.9 ±0.2 −10.2 ±0.1 −3.3 0.8
4.1.4 Oligomeric states of Liprin-α3 and mDia1
The oligomeric state of a protein can have an impact on its biological function. There-
fore, the purified mDia1 and Liprin-α3 fragments were analyzed by coiled-coil predic-
tions and size exclusion chromatography (Figure 4.5).
As expected and supported by available structural data the coiled-coil predictions
of mDia1 show the presence of putative coiled-coil regions spanning the residues
452–570, that are adjacent to the dimerization domain (Figure 4.5 A). Moreover, fur-
ther coiled-coil regions are predicted to be localized near the C-terminus. Liprin-α3
has a high probability of N-terminal coiled-coil domains that are known to mediate
homooligomerization (Serra-Pages et al., 1998). The peptide Lip457–737 defined by
Sakamoto et al. is overlapping with these regions. However, in this study the essential
binding region of Liprin-α3 could be narrowed down to the peptide Lip567–587, which
is not contributing to the formation of the predicted coiled-coils.
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Figure 4.5 Coiled-coil predictions and oligomeric states of mDia1 and Liprin-α3 fragments.
A: Coiled-coil predictions of mDia1 and Liprin-α3 calculated with COILS version 2.1 B. Different
oligomeric states of the mDia1 and Liprin-α3 fragments as determined by size exclusion
chromatography with 5 mg/mL protein in protein buffer using different columns (S75 10/300,
S200 10/300). Elution was monitored by the absorption at 280 nm, except for the peptide
Lip567–587 which was monitored at 220 nm. The molecular weight (MW) of the fragments is
shown as the calculated value from the calibrated column (calc.) and the predicted size for the
respective monomers (mon.).
Additionally, the oligomeric states of the different mDia1 and Liprin-α3 fragments
were determined and compared (Figure 4.5 B). To that end, the constructs that were
used for the binding studies were analyzed by analytical size exclusion chromatog-
raphy (SEC). Depending on the expected molecular weight of a monomer fragment
(MW mon.) either a S75 10/300 or S200 10/300 column was used. The shortest mDia1
fragment, mDiaDID (aa 135–369), lacking the dimerization domain elutes as an elon-
gated monomer in solution. In comparison mDiaN (aa 69–451) and mDiaNCC (aa
69–570) seem to form higher oligomers, although structural data suggest the formation
of elongated dimers. For the fragments Lip561–587, Lip567–587 and Lip457–587 possible
trimeric elution profiles could be observed. Whether these peptides form trimers or this
running behavior is caused by a low content of secondary structure remains unclear
from these data. Strikingly, however, is the tenfold increase of the calculated MW in
the case of Lip217–587. This fragment is overlapping with the predicted N-terminal
coiled-coil region and seems to form a higher oligomer in solution, which would also
be consistent with the reduced binding stoichiometry as shown by ITC.
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4.2. Crystal structure of the mDia1 •Liprin-α3 complex
4.2.1 Crystallization attempts of different mDia1 •Liprin-α3 com-
plexes
The first crystallization setups were performed using Lip457–587 in complex with a
variety of mDia1 fragments (mDiaN∆GCC, mDiaN, mDiaDID and mDia79–443). Since the
extensive screenings did not lead to any successful protein crystal formation, smaller
Liprin-α3 fragments were used, namely Lip561–587 and the synthesized Lip567–587. Al-
though this did result in protein crystal formation (Figure 4.6 A,B), none of these
needle shaped crystals could be further optimized to result in evaluable X-ray diffrac-
tion. Finally, using the fragments Lip567–587 and mDiaDID in complex with Ni2+-Ions,
led to suitable crystal formation (Figure 4.6 C). These crystals had a final size of
approximately 50 ∗ 50 ∗ 20 µM. They were shock frozen in liquid nitrogen using 0.2 M
sodium chloride, 0.1 M Tris pH 8.0, 20 % w/v PEG 6k containing 30 % (w/v) dextrose
as cryoprotectant.
A B C
Figure 4.6 Protein crystals of Liprin-α3 •mDia1 complexes.
Shown are examples of the crystals that grew after 1–2 days under the listed condition of the
respective screens. A: Protein crystals of Lip567–587 •mDiaDID grown in Pact A5 (0.2 M, lithium
chloride 20 % w/v, PEG 6000, 0.1 M HEPES pH 7.0). B: Protein crystals of Lip567–587 •mDia79–443
grown in clear strategy I G6 (0.8 M sodium formate, 0.1 M Tris pH 8.5, 25 % w/v PEG 2k,
monomethyl ether). C: Protein crystals of Lip567–587 •mDiaDID grown in pact premier C6 (0.2 M
sodium chloride, 0.1 M Tris pH 8.0, 20 % w/v PEG 6k).
4.2.2 Data Collection and refinement
The atomic structure of the mDiaDID •Lip567–587 was solved up to a final resolution of
1.65 Å. The crystal contained two copies of mDiaDID •Lip567–587 per asymmetric unit
and belonged to the space group C121. An overview of the obtained refinement and
geometry validation is given in Table 4.3. Additional data concerning the geometry
validation are shown in the appendix (Table A.1, Figure A.7).
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Table 4.3 Data collection, refinement and structure validation of the mDiaDID •Lip567–587
structure.
The data collection and refinement statistics for the highest resolution shell are listed within
the parenthesis. One single crystal was used for data collection.
mDiaDID •Lip567–587
Data Collection
Space group C121
Cell dimensions
α,β,γ (Å) 121.09, 49.38, 106.37
a,b,y 90.0, 97.86, 90.0
Resolution (Å) 32.30−1.65 (1.74−1.65)
Rsym or Rmerge 0.066 (0.730)
I/σI 9.4 (1.6)
Completeness (%) 99.7 (99.9)
Redundancy 3.1 (3.2)
Refinement
Resolution (Å) 32.32 (1.65)
No. of reflections 71,251
Rwork / Rfree 17.55/ 21.01
No. of atoms
Protein 3926
Ligand/ion 16
Water 394
B factors
Protein 26.56
Ligand/ion
Ni2+ 22.98
Tris 31.94
Water 35.62
Root mean square deviations
Bond lengths (Å) 0.022
Bond angles (degrees) 2.007
Geometry
Poor rotamers 0
Ramachandran
Outliers (%) 0
Favored (%) 99.38 (480/483 aa)
Allowed (%) 100 (483/283 aa)
Cβ deviations > 0.25 Å 0
Clashscorea 2.39
a Clashscore is the number of serious steric overlaps (>0.4 Å) per 1000 atoms.
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4.2.3 Structural analysis
The solved crystal structure of the mDiaDID •Lip567–587 complex is depicted in
Figure 4.7 A. While the data resulted in well defined electron density for mDiaDID
only the N-terminal part of Lip567–587 was visible. An example of the electron density
for Liprin-α3 is shown in Figure 4.7 B, as difference omit map countered at 3 σ. No
electron density could be observed for the amino acids 583–587 of Liprin-α3.
Upon binding to mDiaDID, Liprin-α3 forms an α-helix spanning the amino acids
567–582. The binding occurs at the region of the armadillo repeat motifs (ARM)
ARM3–5. Liprin-α3 contacts the third α-helices (α3) of the three α-helices containing
ARMs, which form a concave surface for protein-protein interactions. Interestingly, the
third α-helix of ARM5 is part of the interdomain helix (ID, α17, α35), that connects the
mDiaDID with the dimerization domain (DD).
α33
ARM1
ARM2
ARM3
ARM4
ARM5
α31
α34
Diaphanous-inhibitory
domain (DID)
Liprin-α3
α35
(α17, ID)
N
C
α35
(α17, ID)N
NN
C
C
A
C
α31
α32
α33
α34
90°
T567 P568
R569
R572
B
α32
Figure 4.7 Crystal structure of the mDiaDID •Lip567–587 complex.
A: Ribbon representation of mDiaDID (aa 135–369, chain A) and Lip567–587 (visible aa 567–582,
chain B) on the left and a 90 ◦ clockwise rotated view on the right side. Lip561-582 binds to
the armadillo repeats (ARM) 3–5 and interacts with the interdomain helix (ID). B: F0 − FC
difference omit map of the N-terminal part of Lip567–587 covering residues threonine 567 to
arginine 572 (chain D) countered at 3 σ. The atomic coordinates and structure factors (code
4UWX) have been deposited in the Protein Data Bank (http://www.pdb.org/).
Since the C-terminal amino acids of the Lip567–587 fragment were not visible in the
crystal structure, additional peptides lacking these amino acids were purified and
analyzed by ITC, regarding their capability to interact with mDiaN (Figure 4.8).
66 4. Results
0.0 0.5 1.0 1.5 2.0 2.5
-3.00
-2.00
-1.00
0.00
-0.30
-0.20
-0.10
0.00
0 10 20 30 40
time / min
µc
al
/s
ec
0.0 0.5 1.0 1.5 2.0 2.5
-6.00
-4.00
-2.00
0.00
-0.40
-0.20
0.00
0 10 20 30 40
time / min
µc
al
/s
ec
kc
al
 m
ol
-1
 o
f i
nj
ec
ta
nt
[Lip561-582][mDiaN]-1
kc
al
 m
ol
-1
 o
f i
nj
ec
ta
nt
[Lip561-581][mDiaN]-1
A
Liprin-α3 (561-582)
 
N 1.0 0.03 Sites
KD 5.2
±
0.9 µM
-5.7
±
0.3 kcal mol-1
T∆S 1.4
∆H ±
kcal mol-1
27
270
µM
µMmDiaN (69-451)
Liprin-α3 (561-581)
 
N 1.2 0.03 Sites
KD 16
±
1.7 µM
-3.8
±
0.2 kcal mol-1
T∆S 2.7
∆H ±
kcal mol-1
27
270
µM
µMmDiaN (69-451)
B
Figure 4.8 ITC measurements with Liprin-α3 fragments visible in the protein structure.
ITC measurements of the purified Liprin-α3 fragments Lip561–581 and Lip561–582 together with
mDiaN at 20 ◦C in protein buffer. (KD: equilibrium dissociation constant; ∆H: change in reaction
enthalpy; ∆S: change in reaction entropy; N: stoichiometry of binding; T: temperature in Kelvin)
The fragment Lip561–582 is still able to bind to mDiaN with an affinity of 5.2 µM, which
is similar to the binding affinity of the fragment Lip567–587 (4.4 µM). However, deleting
the leucine at position 582 reduces the affinity to 16 µM, indicating that the peptide
Lip567–582 contains all the essential amino acids needed for the binding of Liprin-α3 to
mDia1 in vitro. A detailed overview of these interactions is shown in Figure 4.9.
Liprin-α3 binds to the armadillo repeat motifs (ARM) ARM3–5 of mDiaDID and aligns
in an antiparallel orientation to the interdomain helix (ID, α17, α35) (Figure 4.9 A,B).
Thereby, it makes extensive contacts towards the ID, predominantly forming electro-
static interactions. A salt bridge is formed between the R575 of Liprin-α3 (R575L) and
E358 of mDia1 (E358D), that are within a distance of 2.5 Å. Furthermore, R575L forms a
hydrogen bond with C354D also located on the ID. Additional salt bridges are formed
between R572L and the E358D and 362D (2.69 Å, 2.8 Å), thus tightly linking Liprin-α3
to the ID of mDiaDID. Besides the electrostatic interactions several hydrophobic inter-
actions are involved, including L573L, M576L and L580L. An overview of all residues
participating in the binding is shown in Figure 4.9 B. Based on these data mutational
studies were performed.
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Figure 4.9 Binding interface of mDiaDID and Lip567–587.
A: Close-up of the mDia1-Liprin-α3 binding site. Shown are the electrostatic interactions
between the arginines (R572, R575) of Liprin-α3 and the glutamic acids (E358, E362) of mDia1,
as well as hydrophobic interactions (L573, M576 and L580). B: Schematic presentation of the
interaction site of the mDiaDID •Lip567–587 complex, generated with LigPlot+ (version 1.4.5),
showing the hydrophobic and electrostatic contacts.
4.2.4 Mutational analysis
Several residues of mDia1 and Liprin-α3 were mutated and measured by ITC in order
to characterize the binding and to confirm the structural data. The mutations A256DD
and I259DD, that have been described in earlier studies to abolish binding of mDiaDID
to mDiaDAD, also interfere with Liprin-α3 binding. While mDiaN I259DD showed
no binding to Lip567–587 the mutant A256DD had a nearly tenfold decreased affinity
of 42 µM (Table 4.4). These data are in line with the structural data since I259DD is
located directly within the hydrophobic interface with Liprin-α3, whereas A256DD is
located at the edge of the binding interface (Figure 4.9 A,B). Furthermore, the mutant
N165DD, which has been shown to have an impact on mDia1-RhoA •GTP-binding,
and no impact on mDiaDAD-binding, does also not interfere with Liprin-α3 binding
(Table 4.4).
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Table 4.4 ITC data of the mutational characterization of the mDia1-Liprin-α3 binding inter-
face. The fragments with the indicated mutations were purified and measured via ITC in
protein buffer at 20 ◦C. Superscript S,C indicate whether the protein fragment was loaded
into the cell or syringe of the ITC200. (KD: equilibrium dissociation constant; ∆H: change in
reaction enthalpy; ∆S: change in reaction entropy; N: stoichiometry of binding; T: temperature
in Kelvin)
interaction KD ∆H T∆S N
µM kcal mol-1 kcal mol-1
Liprin 567–587 CLip567–587-SmDiaN I259D no binding
CLip567–587-SmDiaN N165D 5.0 ±0.3 −6.7 ±0.1 0.4 0.9
CLip567-587-SmDiaN A256D 42.0 ±6.0 −11.7 ±1.4 −5.8 0.8
SLip567–587-CmDiaDID E358R no binding
SLip567–587-CmDiaDID E362R no binding
SLip567–587-CmDiaDID E317R 14.6 ±1.1 −10.1 ±0.4 −3.6 0.8
Liprin 561–587 SLip561–587 R569E-CmDiaN no binding
SLip561-587 R572E-CmDiaN no binding
SLip561-587 L573E-CmDiaN no binding
SLip561-587 R575E-CmDiaN no binding
SLip561-587 M576E-CmDiaN no binding
SLip561-587 L580E-CmDiaN no binding
Based on the structural data different residues on the Lip561–587 fragment within the
hydrophobic core were mutated, including L573EL, M576EL and L580EL. None of
these mutated fragments showed any binding to mDiaN. In addition mutations of the
salt bridge forming residues R572EL and R575EL, as well as, R569EL did completely
abolish the binding. Likewise, opposite charge mutations of the counterparts on
mDia1 E358RD and E362RD did prevent any binding. Mutation of the residue E317RD,
which is not involved in any salt bridge formation reduced the affinity approximately
threefold to 14.6 µM (Table 4.4). The integrity of the mutated fragments was tested and
confirmed via size exclusion chromatography. They showed the same elution profiles
and peak symmetries as the wildtype samples (Figure A.6).
4.2.5 Binding specificity of mDia
In order to test the binding specificity of mDia1 to Liprin-α3, an mDia2 fragment,
similar to the mDiaN fragment in mDia1 was cloned and purified. This fragment
spanned the residues 87–467. Using this fragment, no binding to Lip457–587 could be
observed in ITC measurements under the same conditions used for the determination
of the mDia1-Liprin-α3 binding (Figure 4.10 C).
The alignment of mDiaDID of mDia1, mDia2 and mDia3 reveals the high conservation
of this region. However, especially in the case of charged residues some differences can
4.2. Crystal structure of the mDia1 •Liprin-α3 complex 69
Figure 4.10 Binding specificity of mDia to Liprin-α3.
A: Alignment of the Diaphanous inhibitory domain (DID) of mDia1, mDia2 and mDia. B:
Structural differences between mDia1 and mDia2. Shown is the superposition of the solved
mDia1 •Liprin-α3 structure (PDB: 4UWX) in gray and green and the modeled mDia2 structure
(SWISS-Model CITE). C: ITCs of mDia287–467 with Lip457–587. The measurements performed
with mDia2 WT and mDia2 K369C are shown in black and orange, respectively.
be spotted. While the majority of negatively charged amino acids is conserved, there
are same additional positively charged amino acids present in mDia2 and mDia3, in
comparison to mDia1 (Figure 4.10 A). Superposition of the solved mDia1 •Liprin-α3
structure with an mDia2 model indicates that especially K369 of mDia2 (C354 in mDia1)
seems to be of importance, since it is facing towards the binding interface. Thereby, it
would be in close contact to R575 of Liprin-α3, leading to an electrostatic repulsion
(Figure 4.10 B). A K369C mutation was introduced into the mDia2 fragment and the
binding towards Lip561–587 was measured again by ITC. Introducing this mutation did
not result in detectable binding, indicating that additional specificity determinants
must exit. (Figure 4.10 C).
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4.2.6 Liprin-α3 specificity and regulation by posttranslational phos-
phorylation
The Liprin-α3 region that has been shown to be essential for mDia1 binding is highly
conserved throughout different species. Especially, the arginines 569 and 572 in
Liprin-α3, that are responsible for the formation of salt bridges, seem to be present in
most organisms. The same holds true for the hydrophobic residues L573, M576 and
L580 (Figure 4.11 A). Alignments of human and mouse Liprin-α1 to Liprin-α4 reveal
that the different Liprins are highly conserved in the N-terminal half (aa 563–576) of
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Figure 4.11 Regulation of Liprin-α3 •mDia1 binding by posttranslational phosphorylation.
A: Alignment of the mDia1 binding region of Liprin-α3 in different species. B: Alignment of the
binding region of different Liprins in Homo sapiens and Mus musculus. A,B: The red bar spans
the residues which were visible within the crystal structure. The asterisks indicate the possible
phosphorylation sites found in Homo sapiens Liprin-α3 (T563/567 in mouse Liprin-α3). C: ITC
measurements of mDiaDID with a double phosphomimetic mutant (T563/567E) in Lip561–587
and a single phosphomimetic mutant (T567E) in Lip567–587 in orange with the corresponding
wildtype measurements in black.
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the mDia1 binding region. Although R569 and R575 are present in all Liprins several
hydrophobic residues, known to be important for the mDia1-Liprin-α3 interaction, are
not completely conserved. This makes it unlikely that other Liprins next to Liprin-α3
can bind with this region to mDia1 (Figure 4.11 B). Interestingly, it has been shown that
human Liprin-α3 can be phosphorylated at the threonines 563 and 567 (Mayya et al.,
2009). These positions seem to be of functional importance, since all Liprin isoforms
of each species carry a serine/threonine at those positions (Figure 4.11 A,B). Based
on this the phosphomimetic mutants T563/567E were introduced into the Lip561–587
fragment to test the effect on mDia1 binding. Indeed, the binding towards mDiaDID
was reduced to 33 µM as determined by ITC (Figure 4.11 C, Table 4.5). Additionally,
the binding enthalpy increased to -3.2 kcal mol-1, which was partially compensated
by an increase in favorable entropy (2.8 kcal mol-1). This indicates an altered binding
mechanism due to electrostatic interactions. Since of both threonines only T567 showed
a defined electron density in the crystal structure the fragment Lip567–587 with the
single mutant T567E was measured as well (Figure 4.11 D). Again the binding affinity
was reduced to 32 µM, associated with an increase in binding enthalpy and entropy.
These data show that the single T567 mutant is sufficient to mediate the loss of affinity
and support that T563 is not directly involved in the interaction with mDia1.
Table 4.5 Phosphomimetic Liprin-α3 ITC measurements. Data of the measurements shown
in Figure 4.11 C,D. (KD: equilibrium dissociation constant; ∆H: change in reaction enthalpy;
∆S: change in reaction entropy; N: stoichiometry of binding; T: temperature in Kelvin)
interaction KD ∆H T∆S N
µM kcal mol-1 kcal mol-1
Liprin 561-587 mDiaDID-Lip561-587 WT 9.3 ± 1.3 −8.2 ± 0.5 −1.4 0.9
mDiaDID-Lip561-587 T563/567E 33.0 ± 14 −3.2 ± 0.9 2.8 1.3
Liprin 567-587 mDiaDID-Lip567-587 WT 7.9 ± 0.9 −9.9 ± 0.5 −3.1 0.8
mDiaDID-Lip567-587 T567E 32.0 ± 19 −6.1 ± 3.6 −0.02 0.9
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4.3. Binding Mechanism
Once the the binding of Liprin-α3 to mDia1 and particularly the binding region had
been characterized functionally and structurally, the next aim was to elucidate how
Liprin-α3 interferes with RhoA and mDiaDAD binding towards mDiaN
Figure 4.12 Superposition of putative Liprin-α3 •mDiaDAD/RhoA complex.
A: Left Superposition of the mDiaDID •Lip567–587 structure (PDB: 4UWX, grey: mDiaDID, green:
Lip567–587 and a selected section of the mDiaN∆G •mDiaDAD structure (PDB: 3OBV, yellow:
mDiaN∆G, orange: mDiaDAD). Right detailed view of the overlapping binding regions of
Liprin-α3 and mDiaDAD. B: Same superposition as shown in A with the additional complex
mDiaN •RhoC •GppNHp (PDB: 1Z2C, darkgrey: mDiaN, blue: RhoC).
Interplay of Liprin-α3 and mDiaDAD
Sakamoto et al. showed that mDiaDAD (aa 1145–1196) can be displaced from mDia1 by
Lip457–737. Indeed, the binding sites of Liprin-α3 and mDiaDAD for mDia1 are highly
overlapping as shown by the superposition of the mDiaN∆G •mDiaDAD complex (PDB:
3OBV) and the solved structure of the mDiaDID •Lip567–687 structure (PDB: 4UWX)
(Figure 4.12 A). Particularly, the C-terminal region of the Liprin-α3 fragment covers
the same area as the DAD-core-region (DCR, aa 1175–1195). The adjacent DAD-basic-
region (DBR, aa 1196–1209), which is not visible in the structure has been shown to
align with the ID α-helix and thereby taking a similar path as the N-terminal part
of Lip567–587 (Figure 4.12 A right). The presence of these additional amino acids of
the DBR increase the affinity of mDiaDAD towards mDiaDID 70 fold (Lammers et al.,
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2005). This makes it unlikely that Liprin-α3 can displace mDiaDAD including the
DAD-basic-region from mDiaDID. In contrast to Liprin-α3 the binding of mDiaDAD to
mDiaDID mainly induced by hydrophobic interactions and is not creating salt bridges.
Interplay of Liprin-α3 and RhoA
The autoinhibitory state of mDia1, in which mDiaDAD binds to mDiaDID, is released
upon binding of RhoA to mDiaN. Sakamoto et al. could show that RhoA also displaces
Liprin-α3 from mDia1. Since the binding sites of mDiaDAD and Liprin-α3 closely
match, a similar RhoA induced displacement mechanism can be assumed. However, in
consideration of the structure presented here RhoC and Lip567–587 occupy completely
distinct and non-overlapping binding sites on mDia1 (Figure 4.12 B).
To gain further insights into the interactions of mDia1, Liprin-α3, RhoA and mDiaDAD
and into possible displacement mechanisms, the impact of Liprin-α3 for RhoA (4.3.1)
and mDiaDAD binding (4.3.2) to mDiaN was analyzed by ITC and stopped-flow experi-
ments.
4.3.1 Effect of Liprin-α3 on the RhoA •mDia1 interaction
ITC competition analysis of the RhoA-mDia1 interaction
As shown qualitatively by Sakamoto et al. RhoA was used successfully to displace
Lip457–737 from mDia1. In this study ITC measurements were used to quantitatively
analyze the interplay and the interference of shorter Liprin-α3 fragments on RhoA
binding to mDiaN. For this purpose complexes of Liprin-α3 fragments, containing
only the essential amino acids (aa 561–576, 561–582, 567–587) needed for mDia1
binding, and mDiaN were preformed before the addition of constitutively active RhoA
(RhoA Q63L).
RhoA Q63L binds to mDiaN with an affinity (KD) of 4 nM as determined by ITC (Fig-
ure 4.13 A). The stoichiometry for this interaction is 1:1, with a change in enthalpy of
-4.0 kcal mol-1. Additionally, the reaction was entropically driven (T∆S = 7.3 kcal mol-1),
resulting in a Gibbs free energy change of ∆G = -11.3 kcal mol-1 (Table 4.6). In presence
of Lip561–587 the binding affinity was reduced to 58 nM and the favorable enthalpy
change increased to -0.7 kcal mol-1, which can be explained by the release of the
Liprin-α3 fragment from mDiaN (Figure 4.13 B, Table 4.6). In addition the entropy
change increased to T∆S = 9.0 kcal mol-1, resulting in a Gibbs free energy change of
∆G = -9.9 kcal mol-1.
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Figure 4.13 ITC analysis of the influence of Liprin-α3 on the mDiaN-RhoA binding thermo-
dynamics.
All ITCs were performed at 20 ◦C in protein buffer. Active RhoA (RhoA Q63L) was titrated
to saturated complexes of mDiaN and Lip567–587 (B), Lip561–587 (C), Lip561–582 (D) or in the
absence of Liprin-α3 (A). The tested Liprin-α3-fragments reduced the binding affinity of RhoA
to mDiaN up to 10–15 fold.
As a control and to exclude an effect of the C- and N-terminal regions of the Liprin-α3
fragment the experiment was repeated with Lip567–587 and the structurally visible
fragment Lip561–582. Again the presence of Liprin-α3 reduced the binding affinity of
RhoA to mDiaN to 45 nM and 41 nM for Lip567–587 and Lip561–582, respectively. More-
over, ∆H increased, albeit to a lesser extend compared to Lip561–587 (Lip567–587: ∆H =
-2.0 kcal mol-1; Lip561–582: ∆H = -2.2 kcal mol-1) (Figure 4.13 C,D, Table 4.6). The positive
entropic contribution of the RhoA binding towards mDiaN, however, was not influ-
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enced by Lip567–587 (T∆S = 7.9 kcal mol-1) and Lip561–582 (T∆S = 7.7 kcal mol-1). Resulting
from that the Gibbs free energy change was similar for all tested Liprin-α3-fragments
(∆G = -9.7 to -9.9 kcal mol-1). Taken together, the presence of Liprin-α3 decreased the
binding affinity of RhoA to mDiaN by 10-15 fold with an increase of the negative ∆G
of approximately 1.5 kcal mol-1.
Table 4.6 Rho-Liprin-α3 ITC competition measurements. Data of the measurements shown
in Figure 4.13. KD: equilibrium dissociation constant; ∆H: change in reaction enthalpy; ∆S:
change in reaction entropy; N: stoichiometry of binding; T: temperature in Kelvin)
interaction KD ∆H T∆S N
nM kcal mol-1 kcal mol-1
without Liprin-α3 RhoA Q63L-mDiaN 4 ± 4 −4.0 ± 0.04 7.3 1.3
Liprin 567–587 RhoA Q63L-mDiaN •Liprin 45 ±21 −2.0 ± 0.04 7.9 1.0
Liprin 561–582 RhoA Q63L-mDiaN •Liprin 41 ±11 −2.2 ± 0.03 7.7 1.1
Liprin 561–587 RhoA Q63L-mDiaN •Liprin 58 ±37 −0.7 ± 0.02 9.0 1.0
Although RhoA and Liprin-α3 use distinct binding sites on mDia1, these data show
that the presence of Liprin-α3 alters and weakens the interaction of RhoA and mDia1.
However, these ITC experiments do not exclude the possibility of a ternary complex
formed by mDia1, RhoA and Liprin-α3. Therefore additional fluorescence polarization
assays were performed.
Fluorescence polarization assays of the putative ternary mDia1 • RhoA •Liprin-α3
complex
Fluorescence polarization assays were performed to exclude a possible ternary com-
plex formation of mDiaN •RhoA •Liprin-α3. Therefore, the fragments Lip567–587 and
Lip567–582 were synthesized with an N-terminal fluorescein label and titrated together
with mDiaN and RhoA (Figure 4.14). Upon addition of mDiaN to the labeled Lip567–587
fragment the polarization signal increased, indicating a complex formation of mDiaN
and Liprin-α3. Addition of active RhoA Q63L to the complex led to a decrease of
the fluorescence polarization signal. This drop of signal, to a level comparable to the
baseline, reflects the dissociation of the mDia1 •Liprin-α3 complex. The residues 583–
587 of Liprin-α3, that were not visible in the crystal structure, seem to be orientated
towards RhoA in a putative ternary mDia1 •Liprin-α3 •RhoA complex (Figure 4.12).
In order to exclude that these residues might contribute to the RhoA induced dissoci-
ation of Lip567–587 from mDiaN, the experiment was repeated using the C-terminally
truncated Lip567–582 fragment. As indicated by the changes in the polarization signal,
Lip567–582 still bound to mDiaN and was also dissociated from it by RhoA.
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Figure 4.14 Polarization assays of pu-
tative ternary mDia1 •RhoA •Liprin-α3
complexes.
The polarization signals of Lip567–587 and
Lip567–582 peptides were measured alone,
in complex with mDiaN and after titration
of RhoA Q63L to the complex. Addition
of RhoA reduced the polarization signal,
thus indicating the dissociation of both
Liprin-α3 fragments from mDiaN. The as-
say was performed in protein buffer at
20 ◦C. Data are presented as mean ± S.D.
of triplicate measurements.
These data confirm that active RhoA can displace Liprin-α3 from mDiaN, despite the
distinct binding region of Liprin-α3 on mDia1. In combination with the ITC competi-
tion experiments (Figure 4.13) and the protein structure these data rather support an
allosteric displacement mechanism of Liprin-α3 by RhoA, than a competition for an
overlapping binding-site.
Stopped-flow kinetics of the RhoA-mDia1 interaction
Besides thermodynamic data obtained from ITC measurements, stopped-flow analyses
can be performed to investigate the binding kinetics. Using this method the interaction
dynamics of mDia1 and RhoA were analyzed in presence and absence of Liprin-α3
fragments.
Influence of Liprin-α3 on the association rates of RhoA and mDiaN
Prior to the pre-equilibrium stopped-flow experiment RhoA was loaded with mant-
GppNHp (non-hydrolyzable GTP analogue). The fluorescently labeled RhoA was then
titrated with increasing concentration of mDiaN, under pseudo-first order conditions.
In order to analyze the effect of Liprin-α3 on RhoA binding a twofold molar excess of
different Liprin-α3 fragments was added to the titrated mDiaN. For this purpose the
N-terminally most extended fragment Lip217–587, as well as the fragments Lip561–587
Lip567–587 and Lip561–582, that were also measured in the ITC competition assays, were
used in this study. Single exponential fits of the primary data yielded the observed
association rate constants (kobs) (Figure A.9). These rates were plotted against the
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Figure 4.15 Stopped-flow analysis of the influence of Liprin-α3 on the mDia1 •RhoA inter-
action dynamics.
A: association rate constant. Mant-GppNHp loaded RhoA was titrated with increasing mDiaN
concentrations in presence/absence of different Liprin-α3-fragments. The slope of the linear
fit represents the association rate constant (kass). Data are shown as mean ± S.D. of three
independent experiments. B: dissociation rate constant. Complexes of mDia1 •RhoA •mant-
GppNHp were titrated with a 100-fold excess of active RhoA Q63L in the presence/absence of
Liprin-α3-fragments, as indicated. Data were fitted to a single exponential curve.
mDiaN concentration and finally a linear fit was applied resulting in the second order
association rate constant (kass) (Figure 4.15 A, Table 4.7). In the case of RhoA binding to
mDiaN in absence of Liprin-α3 the calculated association rate was kass = 1.00 µM-1 s-1
(Table 4.7). A distinguishable reduction in association can be detected, due to the
presence of Liprin-α3. All tested Liprin-α3-fragments nearly had the same reducing
effect, albeit the longest fragment Lip217–587 displayed the smallest effect with an
association rate constant of kass = 0.51 µM-1 s-1. The shorter fragments induced slightly
more severe effects (Lip561–587: kass = 0.27 µM-1 s-1; Lip567–587: kass = 0.37 µM-1 s-1;
Lip561–582: kass = 0.46 µM-1 s-1) (Figure 4.15 A, Table 4.7). To exclude the possibility
that the reduced association rates of RhoA to mDiaN, are based on some artificial
effect induced by the addition of a third protein to the solution, the Liprin-α3 mutant
L580E was used as a control. Previous ITC data showed that the fragment Lip561–587
containing the L580E mutant is not able to bind mDia1. Indeed, using this mutant in
the stopped-flow experiment nearly restored the association rate of RhoA to mDiaN
(kass = 0.83 M-1 s-1). In accordance with the ITC competition data these data elucidate
the importance of the Liprin-α3 residues 567–582, that were visible in the crystal
structure. Although, Liprin-α3 and RhoA exhibit no overlapping binding region on
mDia1, the association rate of RhoA to mDia1 is clearly affected by Liprin-α3.
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Influence of Liprin-α3 on the dissociation rates of RhoA and mDiaN
Comparable to the association rates the influence of different Liprin-α3 fragments
on the dissociation rate constant (kdiss) of RhoA and mDiaN were tested. Therefore,
a complex of mDiaN •RhoA •mant-GppNHp was preformed and mixed with a 100
fold molar excess of unlabeled and active RhoA Q63L. This approach makes it pos-
sible to analyze the release of fluorescently loaded RhoA from the complex over a
period of time. Equimolar ratios of the same Liprin-α3 fragments used for the asso-
ciation rate determination were mixed with RhoA Q63L in order to determine their
impact on the dissociation rate (Figure 4.15 B). As reported earlier the dissociation
kinetics showed a single exponential behavior. The obtained dissociation rate for the
RhoA-mDiaN interaction in absence of Liprin-α3 (kdiss = 2.35 m s-1) is in agreement
with the published data (Lammers et al., 2008). Addition of the fragments Lip217–587
(kdiss = 2.82 m s-1), Lip561–587 (kdiss = 2.84 m s-1), Lip567–587 (kdiss = 3.22 m s-1) and
Lip561–582 (kdiss = 3.22 m s-1) did only slightly increase the dissociation rate (Table 4.7).
Table 4.7 Effect of different Liprin-α3-fragments on the RhoA-mDia1 interaction dynamics
as determined by stopped-flow measurements. kass is the association rate constant, and kdiss
is the dissociation rate constant
Liprin-α3-fragment kass kdiss KD
µM-1s-1 ms-1 nM
Without fragment 1.00 ± 0.01 2.35 ± 0.09 2.4
217–587 0.51 ± 0.01 2.82 ± 0.07 5.5
567–587 0.37 ± 0.01 3.22 ± 0.04 8.7
561–582 0.46 ± 0.01 3.22 ± 0.07 7.0
561–587 0.27 ± 0.01 2.84 ± 0.11 10.5
561–587 L580E 0.83 ± 0.01 3.04 ± 0.05 3.7
Taken together, Liprin-α3 influences the binding dynamics of the RhoA •mDia1 in-
teraction. The association rate of RhoA is reduced, while the dissociation rate is only
marginally affected. Interestingly, all tested fragments showed a comparable impact on
the RhoA •mDia1 interaction emphasizing again the importance of Liprin-α3 residues
567–582.
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4.3.2 Effect of Liprin-α3 on the mDiaDAD •mDiaN interaction
Similar to the isothermal titration calorimetry (ITC) competition assays regarding the
influence of Liprin-α3 on the RhoA-mDiaN interaction, the effect for the mDiaDAD-
mDiaDID interaction was analyzed. In their study Sakamoto et al. used fluorescence
polarization assays to show that Lip457–737 is able to displace mDiaDAD from mDiaN.
However, in their experiments they used the DAD-core-region (DCR, aa 1075–1195),
which binds to mDiaDID with approximately 15 µM (Lammers et al., 2005). In com-
parison, the elongated fragment DAD1145–1200 displays a three orders of magnitude
enhanced binding affinity of 29 nM. Including the complete DAD-basic region (DBR,
1196–1209) even further increases the binding affinity of mDiaDAD to mDiaDID to 14 nM
(Table 4.8). This makes it actually unlikely, that Liprin-α3 is able to displace mDiaDAD
from mDia1.
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Figure 4.16 ITC analysis of the in-
fluence of mDiaDAD on the mDiaN -
Liprin-α3 binding thermodynam-
ics.
Liprin-α3 was titrated to preformed
complexes of mDiaN •DAD1145–1200
and mDiaN •DAD1145–1209 at 25 ◦C in
protein buffer. No heat signals could
be detected, indicating that Liprin-α3
was not able to displace mDiaDAD
from the complex or bind to mDiaN.
Indeed, titrating Liprin-α3 to the mDiaN •DAD1145–1200 and mDiaN •DAD1145–1209
complexes did not result in detectable changes in the heat signals (Figure 4.16). This
indicates that Liprin-α3 is not capable to displace mDiaDAD from mDiaN or to bind
mDiaN in presence of mDiaDAD.
Notably, when DAD1145–1200 was titrated to an mDiaDID •Liprin-α3 complex, the
complex dissociated and Liprin-α3 was released from mDiaDID, as shown by ITC
(Figure 4.17) and analytical size exclusion chromatography (Figure 4.18). In the initial
ITC experiment a saturated mDiaDID •Lip561–587 complex was preformed, with a
twofold molar excess of Liprin-α3. Subsequently, DAD1145–1200 was titrated to this
complex and the occurring heat signals deriving from the DAD1145–1200-mDiaDID
binding and simultaneously release of Lip561–587 were recorded (Figure 4.17 B). Since
the structural data showed a highly overlapping binding region for mDiaDAD and
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Figure 4.17 ITC experiments to analyze the influence of Liprin-α3 on the
mDiaDID •mDiaDAD binding thermodynamics.
A: ITC measurement of the DAD1145–1200-mDiaN interaction. B: DAD1145–1200 was titrated to a
preformed complex of mDiaDID •Lip561–587. The obtained binding curve was fitted with the
one-site and the competitive model. A,B: The experiment was performed at 25 ◦C in protein
buffer. (KD: equilibrium dissociation constant; ∆H: change in reaction enthalpy; ∆S: change in
reaction entropy; N: stoichiometry of binding; T: temperature in Kelvin)
Lip567–582 the formation of a ternary complex seems to be unlikely. Even though, the
binding sites are only highly overlapping and not identical, a competitive fit model was
applied to approximately determine the initial binding of Lip561–587 to mDiaDID. The
resulting binding affinity (KD = 37 nM) is in agreement with the direct measurement
(KD = 29 nM, Table 4.8, Figure 4.17 A). In comparison, the one-site model fit showed
a reduced affinity of 155 nM in the presence of Liprin-α3. The binding displayed an
unfavorable enthalpic contribution (11.3 kcal mol-1), as opposed to Lip561–587 alone
(-10.4 kcal mol-1, Table 4.2) and is mainly entropically driven (T∆S = 20.2 kcal mol-1).
The same experiment was repeated with the N-terminally elongated fragment Lip457–587
and the C-terminally elongated DAD1145–1209 (appendix Figure A.8). Similar to the
previous results Lip457–587 reduced the binding affinity of DAD1145–1209 to mDiaN∆GCC
from 14 nM (direct measurement), respectively 3 nM (competitive model) to 23 nM
(Table 4.8).
Although, the binding regions of mDiaDAD and Liprin-α3 on mDiaDID are highly over-
lapping and the ITC data confirm the influence of Liprin-α3 for the mDiaDAD binding,
the formation of a putative ternary complex needs to be investigated. Therefore, the
content of the ITC sample cell was used for an analytical size exclusion chromatogra-
phy (SEC) run and further SDS-PAGE analysis (Figure 4.18).
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Table 4.8 mDiaDAD-Liprin-α3 competition ITC measurements. Summary of the ITC compe-
tition experiment. (KD: equilibrium dissociation constant; ∆H: change in reaction enthalpy; ∆S:
change in reaction entropy; N: stoichiometry of binding; T: temperature in Kelvin)
interaction KD ∆H T∆S N
nM kcal mol-1 kcal mol-1
without Liprin-α3 DAD1145–1200-mDiaDID 29 ±38 1.8 ± 0.01 11.8 0.8
Liprin 561–587
(one-site model)
DAD1145–1200-
mDiaDID •Liprin561–587 155 ±16 11.3 ± 0.1 20.2 0.8
Liprin 561–587
(competitive model)
DAD1145–1200-
mDiaDID •Liprin561–587 37 ± 5 6.3 ± 0.1 11.8 0.9
without Liprin-α3 DAD1145–1209-mDiaN 14 ± 7 5.1 ± 0.1 15.5 0.8
Liprin 457–587
(one-site model)
DAD1145–1209-
mDiaN∆GCC •Liprin457–587 23 ±13 5.6 ± 0.1 15.9 1.0
Liprin 457–587
(competitive model)
DAD1145–1209-
mDiaN∆GCC •Liprin457–587 3 ± 1.6 3.9 ± 0.1 no data 1.0
The loaded sample showed three distinct elution peaks, as visualized by the absorption
at 220 and 280 nm. While mDiaDAD co-eluted with mDiaDID in the first peak, Lip561–587
eluted in the second peak. An excess of titrated mDiaDAD was visible within the third
peak. The same result was observed with the sample of the second ITC competition
assay using the fragments Lip457–587, DAD1145–1209 and mDiaN∆GCC (Figure A.8).
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Figure 4.18 Size exclusion chromatography and SDS-PAGE analysis of the putative ternary
mDiaDID •Lip561–587 •mDiaDAD complex.
A: The cell content of the ITC measurement from Figure 4.17 B was used for an analytical size
exclusion chromatography (SEC) run (S75 10/300). B: The resulting peaks from the SEC were
analyzed by SDS-PAGE.
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Taken all together, the ITC and SEC data clearly show that mDiaDAD can displace
Liprin-α3 from mDia1 and not vice versa. Liprin-α3 is only able to bind to the open
form of mDia1 and is not capable to effectively compete with mDiaDAD using these
conditions
4.4. Effect of Liprin-α3 on F-actin formation in different
cell types
Besides the extensive biochemical and structural characterization of the interactions
between Liprin-α3, RhoA and the autoinhibitory regulation of mDia1, the influence
of Liprin-α3 on cellular level was of great interest. The functionality of the minimal
Liprin-α3 fragments was analyzed by their effect on F-actin formation in mammalian
cells. Presence of Lip1–817 reduces the cellular Rho-induced F-actin content, as it has
been shown by Sakamoto et al..
4.4.1 Transiently transfected HeLa cells
The cellular effect of the different Liprin-α3 fragments was determined by co-expression
with active RhoA (RhoA G14V) in HeLa cells (Figure 4.19 A). For the quantification
the phalloidin stained filamentous actin (F-actin) of transfected cells was compared to
non-transfected cells of the same sample (Figure 4.19 B). As expected the transfection
of empty vectors (mock) had no effect on the F-actin content, while overexpressed
active RhoA significantly enhanced stress-fiber formation. Additional transfection of
full-length Liprin-α3 (Lipfl) had no effect on the increased amount of F-actin. However,
co-expression of the fragments Lip1-817, Lip561–587 and Lip561–582 lead to a significant
decrease in the cellular F-actin content compared to the level in RhoA G14V expressing
cells. This effect was not observed for Lip567–587. To exclude the possibility that the
N-terminally truncated Lip567–587 fragment is not able to bind mDia1 due to steric
interference with the N-terminal mCherry-tag, a polypetide linker (GSGSGS) was
added (Lip(3GS)567–587). Indeed, the fragment Lip(3GS)567–587 exhibited the same actin
reducing effect as Lip561-582, elucidating the importance of the Liprin-α3 N-terminus
for mDia1 binding. In addition to Lip561–587 the same construct containing a L580E
mutation (Lip561–587 L580E) was co-expressed with active RhoA. In accordance with the
ITC analysis (Table 4.4) the fragment had no effect on the F-actin content presumably
due to its abolished binding to mDia1.
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Figure 4.19 The effect of different Liprin-α3 fragments on the amount of F-actin in RhoA
overexpressing HeLa cells.
A: HeLa cells were transiently transfected with pEGFP-N3-RhoA (G14V mutant) and mCherry-
C1-Liprin-α3 fragments. CF647-phalloidin was used for the staining of filamentous actin and its
quantification. The images are shown as single 0.2 µm thick optical sections at the cell bottom.
In addition a close up of a single cell transfected with RhoA and full-length Liprin-α3 (Lipfl)
is shown as merge image of the DAPI, pEGFP-N3-RhoA and mCherry-C1-Lipfl fluorescence.
Scale bars: 50 µm. B: Quantification of the filamentous actin in Hela cells presented as the ratio
of transfected to non-transfected cells. Data are shown as mean ± S.D. with the number of
counted cells depicted in brackets. The experiment was repeated independently three times.
Depicted here is one representative experiment. ∗∗p <0.01 for indicated comparison. ###p <0.001
compared to mock transfection (one-way ANOVA).
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In this experiment overexpressed full-length Liprin-α3 had no visible effect on the
F-actin content in HeLa cells. However, Sakamoto et al. observed an increase of F-actin,
by siRNA induced knock-down of Liprin-α3 in HeLa cells. Therefore, the experiment
was repeated with murine neuroblastoma N2a cells, to investigate possible cell-type
dependent effects (4.4.2).
4.4.2 Transiently transfected N2a cells
Figure 4.20 The effect of different Liprin-α3 fragments on the amount of F-actin in RhoA
overexpressing N2a cells.
A: N2a cells were transiently transfected with pEGFP-N3-RhoA (G14V mutant) and mCherry-
C1-Liprin-α3 fragments. CF647-phalloidin was used for the staining of filamentous actin and
quantification. The images are shown as a single 0.2 µm thick optical section of the cell bottom.
In addition a close up of a cell transfected with RhoA and full-length Liprin-α3 (Lipfl) is
shown as merge image of the DAPI, pEGFP-N3-RhoA and mCherry-C1-Lipfl fluorescence.
Scale bars: 50 µm. B: Quantification of the filamentous actin in N2a cells presented as the
ratio of transfected to non-transfected cells. Data are shown as mean ± S.D. with the number
of counted cells depicted in brackets. The experiment was repeated independently three
times. Depicted here is one representative experiment. ∗ ∗ ∗p <0.001 for indicated comparison.
###p <0.001 compared to mock transfection (one-way ANOVA).
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Since Liprin-α3 is known to be expressed mainly in neuronal tissues, the effect of
different Liprin-α3 fragments on the amount of F-actin in RhoA overexpressing cells
was also tested in murine neuroblastoma N2a cells (Figure 4.20). For this reason the
Liprin-α3 fragments Lip561–582 and Lip(3GS)567–587 that showed a reducing effect on
F-actin in Hela cells were again co-transfected with active RhoA G14V. Additionally,
full-length Liprin-α3 was used, since it displayed no effect on the F-actin content in
HeLa cells. Overexpression of active RhoA (RhoA G14V) led to a significant increase
of filamentous actin (F-actin) in N2a cells, similar to what have been observed in
HeLa cells. Furthermore, co-expression of Lip561–582 and Lip(3GS)567–587 resulted in a
significant reduction of this effect. However, in contrast to the HeLa cells full-length
Liprin-α3 had the same reducing effect on the amount of F-actin in N2a cells, as the
smaller fragments. This indicates that indeed some cell type depended mechanisms
must exist, that bring full-length Liprin-α3 in a state capable of leading to this reduction
in the cellular F-actin content. (Figure 4.20).
As a control, the transfection efficiencies and protein expressions for both cell types
were analyzed to exclude that the observed effects are induced by differences in
protein abundance (Figure 4.21). Both cell types showed a nearly identical transfection
efficiency. More than 65 % of the HeLa and N2a cells were transfected with pEGFP-
N3-RhoA, while slightly less than 60 % of the cells were additionally transfected with
mCherry-C1-Liprin-α3 (Figure 4.21 A). The protein expression levels were controlled by
immunoblotting. Transfected cells were blotted and stained against pEGFP or mCherry.
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Figure 4.21 Comparison of the transfection efficiency and protein expression levels in HeLa
and N2a cells.
A: Transfection efficiency of pEGFP-N3-RhoA and mCherry-C1-Liprin-α3 of three indepen-
dent experiments. Depicted as mean ± S.D. B: Protein expression levels were analyzed by
immunoblotting. Liprin-α3 expression was detected with an anti mCherry antibody, RhoA
expression with an anti pEGFP antibody and an antibody against α-tubulin served as loading
control.
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Equal loading was controlled by SDS-PAGE (data not shown) and by staining against
α-tubulin, which has a similar expression in these two cell types (Figure 4.21 B). In both
cell types RhoA G14V, as well as Liprin-α3 were expressed substantially and showed
only slight differences in their expression level. While RhoA G14V was expressed
to a comparable extent, the amount of Liprin-α3 seemed to be marginally higher in
N2a cells. Overall, both cell types were equally transfected and displayed a similar
amount of expressed Liprin-α3 and RhoA, excluding a systematic influence on the
actin cytoskeleton regulation.
4.4.3 Localization of Liprin-α3 fragments in different cell types
Besides the differences in the regulation of the RhoA induced F-actin formation, some
variations in the cellular localization of the overexpressed Liprin-α3 fragments could be
observed. The N-terminally truncated fragments Lip(3GS)567–587 and Lip561–582 showed
a comparable diffuse cytosolic distribution in N2a and HeLa cells. However, Lip1–817
and full-length Liprin-α3 (Lipfl) were evenly clustered throughout the HeLa cells
(Figure 4.19 A inset). In contrast, Lipfl displayed an accumulation at the cell periphery
in N2a cells (Figure 4.20 inset).
5. Discussion
5.1. Summary of Results
Definition of the binding site
In the first part of this work the binding of mDia1 and Liprin-α3 was characterized
using recombinantly expressed proteins and isothermal titration calorimetry (ITC)
analyses. Different constructs of mDia1 and Liprin-α3 were cloned, purified and
their binding affinities were determined by ITC. Finally, mDiaDID and Lip567–587 were
identified to contain the essential residues needed for the binding. Using these
fragments the protein structure of the mDiaDID •Lip567–587 complex was solved up to a
final resolution of 1.65 Å. Based on the structural data the Liprin-α3-core region (LCR),
encompassing the amino acids 567–582 was defined. A closer look at the Liprin-α3
fragments used in the ITC studies, revealed that the N-terminally longest fragment
Lip217–587, forms higher oligomers in solution and binds mDia1 with a stoichiometry
of 0.5.
Crystal structure of the mDiaDID •Lip567–587 complex
The solved crystal structure showed, that Liprin-α3 binds to mDia1 via an α-helix
spanning the amino acids 567–582. The binding of the α-helix occurs at the armadillo
repeat motifs 3–5. It mainly contacts the third α-helix of ARM5, which is part of the
interdomain helix (ID, α17, α35), that connects the mDiaDID with the dimerization
domain (DD). Additionally, superpositions with published mDia1 structures showed,
that the binding sites on mDiaN for Liprin-α3 and mDiaDAD are highly overlapping,
whereas the binding of RhoA to mDia1 occurs at a distinct non-overlapping region.
Interplay of Liprin-α3, RhoA and mDiaDAD
ITC competition assays were used to study, whether the presence of Liprin-α3 interferes
with the binding of mDiaDAD and RhoA to mDiaN. Liprin-α3 decreased the binding
of RhoA to mDiaN by 10–15 fold, whereas the binding of mDiaDAD was only reduced
by 3–4 fold. The reduced binding affinity of RhoA in presence of Liprin-α3 is mainly
mediated by the slower RhoA-mDiaN association rate, as determined by stopped-flow
88 5. Discussion
measurements. Formation of possible ternary complexes were analyzed by analytical
size exclusion chromatography for mDiaDAD and by fluorescence polarization assays
for RhoA. The data clearly showed, that RhoA and mDiaDAD are able to dissociate
Liprin-α3 from mDiaN.
Effect of the different Liprin-α3 fragments on F-actin formation in cells.
Different fragments of Liprin-α3, including Lipfl and Lip567–587 were co-transfected
with active RhoA in HeLa cells and the mouse neuroblastoma cell line N2a. Except
for full-length Liprin-α3, all tested fragments showed a significant reduction of the
F-actin content in HeLa and N2a cells. Lipfl had no effect on the amount of F-actin in
HeLa cells, but reduced the amount of F-actin in N2a cells. In N2a cells overexpressed
full-length Liprin-α3 accumulated near the plasma membrane, whereas in HeLa cells
it was clustered throughout the cells.
5.2. Binding specificity of the mDia1-Liprin-α3
interaction
Sakamoto et al. used pull-down assays to identify all three isoforms of mDia as potential
binding partners of Liprin-α1 and Liprin-α3. Using ITC analysis the binding of mDia1
to Liprin-α3 could be confirmed in this study, whereas no binding was detected for
mDia2. The crystal structure of the mDiaDID •Lip567–587 complex presented here,
allows a detailed comparison of the interaction regions, resulting in the identification
of possible binding determinants within the mDia and Liprin isoforms. The mDiaDID
of the isoforms is highly conserved, though some differences of mDia1 towards mDia2
and mDia3 can be detected (Figure 4.10). Several positively charged amino acids
of mDia2 and mDia3 are substituted by neutral amino acids in mDia1. The single
mutation of K369 in mDia2 to the corresponding cysteine in mDia1 did not to lead
to an alteration of the Liprin-α3 binding specificity and as a consequence to binding
of Liprin-α3 to mDia2. This lysine is facing towards the binding interface, but it
does not seem to be the only specificity determinant. Distinct differences in the
electrostatic surface potential at the Liprin-α3 interacting site of mDia1 might be the
reason why Liprin-α3 binding is specific for mDia1, whereas it is not binding to mDia2
or presumably mDia3.
The sequences of the different Liprin-α isoforms are highly conserved in the N-terminal
half of the Liprin-α3-mDia1 interacting region (aa 567–576). This also includes some
of the amino acids involved in the binding of Liprin-α3 to mDia1, e.g. R572. Overall,
the Liprin-α1 fragment displays the most conserved N-terminal consensus sequence
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Figure 5.1 Secondary structure predictions of the mDia1-binding region of Liprin-α iso-
forms.
Fragments of the mouse Liprin-α isoforms (aa 567–582 in Liprin-α3) were analyzed concerning
their potential to form secondary structures. Predictions were performed using the PSIPRED
server (Buchan et al., 2013).
with Liprin-α3. However, the C-terminal residues of the mDia1 interaction region
are quite diverse in the different Liprin-α isoforms. Especially, L580 which has been
shown to mediate important hydrophobic interactions with A256 and Q307 of mDia1
is exclusively present in Liprin-α3. Additionally, secondary structure predictions using
the PSIPRED server (Buchan et al., 2013) of the corresponding Lip567–582 regions of all
Liprin-α isoforms, display striking differences in the formation of secondary structures
(Figure 5.1). The fragments of Liprin-α2 and -α4 are predicted to form short β-helices,
while Liprin-α1 and -α3 fragments most likely form α-helical structures. Interestingly,
the predicted α-helix of Liprin-α1 spans only four amino acids, while the predicted
and structurally confirmed α-helix of Liprin-α3 consists of more than 12 amino acids.
Based on the differences of the Liprin-α isoforms, regarding their sequence and
predicted secondary structures, binding of Liprin-α2 and -α4 to mDia1 can be excluded.
In the case of Liprin-α1 the binding to mDia1 seems to be unlikely. Either way, it can
be assumed that the interaction of Liprin-α1 with mDia1 is at least distinctly weaker
compared to the Liprin-α3, making a physiological relevance less likely. Since Liprins
can form hetero- and homooligomers the detected binding of Liprin-α1 to mDia1 in
pull-down experiments (Sakamoto et al., 2012a) could also reflect indirect interactions.
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Moreover, these data provide no information about possible mDia1 binding sites on
Liprin-α1, or -α2 and α4, that are distinct from the region identified for Liprin-α3.
Therefore, the binding of Liprin-α1 and mDia1 needs to be confirmed by more direct
in vitro assays, such as ITC.
5.3. Liprin-α3 interferes with mDiaDAD and RhoA
binding
5.3.1 Interplay of mDiaDAD and Liprin-α3
The crystal structure of mDiaDID •Lip567–587 presented here, reveals that the binding
site of Lip567–587 on mDia1 is highly overlapping with the binding region of the DAD-
core-region (DCR, aa 1175–1195). Both peptides bind to mDia1 along the negatively
charged ID, which has also been confirmed by mutational ITC studies. The opposite
charge mutations of E358R and E362R at the ID, that abolished the binding towards
Liprin-α3, have also been shown to decrease the binding to mDiaDAD (Lammers et al.,
2008).
In their study Sakamoto et al. postulated that Lip457–747 can displace the DAD-core
region (DCR, aa 1175–1195) from mDiaN. As judged by ITC studies, the DCR binds to
mDiaN with an affinity of 15 µM (Lammers et al., 2005). However, the importance of the
adjacent DAD-basic-region (DBR, aa 1196–1209) has been shown by previous ITC and
cell culture experiments. ITCs with mDiaDAD including the complete DBR resulted in
three orders of magnitude increased binding affinities towards mDiaDID. Additionally,
deletion and mutation studies of the DBR emphasized its importance for actin filament
formation and indicated the requirement of the DBR for the autoinhibitory regulation
of mDia1 (Wallar et al., 2006). In this study the physiological more relevant mDiaDAD
constructs DAD1145–1200 and DAD1145–1209 were used to analyze their impact on the
autoregulatory interactions of mDia1. The performed ITC competition assays show,
that Liprin-α3 is not able to dissociate DAD1145–1200 or DAD1145–1209 from mDiaDID. In
contrast, DAD1145–1200 and DAD1145–1209 were successfully used to displace Liprin-α3
from mDiaDID. Furthermore, the binding affinity of mDiaDAD to mDiaDID was only
slightly decreased in presence of Liprin-α3. In this work the interactions between
mDiaDID and mDiaDAD were investigated in vitro with intermolecular fragments.
Considering the intramolecular interactions occurring in vivo, the actual autoinhibitory
potential of mDia1 might be even more efficient. This further emphasizes a rather low
capacity of Liprin-α3 to compete with mDiaDAD for mDiaDID binding and indicates,
that Liprin-α3 preferentially binds to the open conformation of mDia1.
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Interestingly, the residues 583–587 of Lip567–587, that were not visible in the crys-
tal structure, N-567-TPRSARLERMAQALALQAGSP-587-C, are a perfect match for
the C-terminus of the consensus sequence defined for the DCR (aa: 1175–1196)
N-(G/A)(V/A)MDXLLEXL(K/R/Q)X(G/A)(S/G/A)(A/P)-C. However, these fragments
of Liprin-α3 and mDiaDAD align to mDiaN in the opposite direction (Figure 4.12 A).
As shown by ITC analysis the residues 583–587 of Liprin-α3 do not contribute to
the binding of mDia1 and might therefore fulfill a different function, e.g. acting as
a recognition site for other proteins. Whether this is of any physiological relevance,
needs further investigations.
5.3.2 Possible mechanisms leading to the displacement of Liprin-α3
from mDia1 by RhoA
The data presented in this work show that the binding affinity of RhoA to mDiaN is
decreased by 10–15 fold in the presence of Liprin-α3, and that RhoA is able to displace
Liprin-α3 from mDiaN, i.e. no ternary mDiaN-RhoA-Liprin-α3 complex can be formed.
Based on the structure of the mDiaDID •Lip567–587 complex presented here, it is not
obvious how Lip567–582 interferes with RhoA binding and how it is displaced from
mDiaDID, since both use completely distinct binding sites. Additionally, it remains
unclear how Liprin-α3 is able to weaken the binding affinity of RhoA by 10–15 fold,
despite the three orders of magnitude higher binding affinity of RhoA to mDia1. These
data suggest an allosteric displacement mechanism of Liprin-α3 from mDia1 by RhoA.
Two different mechanisms, that are not mutually exclusive, how RhoA displaces
Liprin-α3 from mDia1 seem to be possible.
The first mechanism involves the conformational flexibility within the C-terminal half
of the mDia1 interdomain helix (ID) and the dimerization domain (DD). Superpositions
of mDiaDID derived from several mDiaN crystal structures, either in the uncomplexed
form (PDB: 2BNX), or in complex with RhoC (PDB: 1Z2C), mDiaDAD (PDB: 2BAP) or
Lip567–587 (PDB: 4UWX), display conformational differences (Figure 5.2). The different
structures are highly similar regarding mDiaDID. However, structural differences upon
binding of mDiaDAD and RhoA to mDia1 are visible in the ID and the following
DD. Although, the C-terminal half of the ID and the DD are not existent in the
mDiaDID •Lip567–587 structure presented here, the data show that Liprin-α3 aligns
along the ID forming salt bridges to acidic residues in the ID. Binding of RhoA to
mDia1 might lead to alterations in the conformation of the ID/DD, which subsequently
could interfere with Liprin-α3 binding and thereby support the allosteric dissociation
of Liprin-α3 from mDia1.
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Figure 5.2 Structural comparison of the mDiaN in complex with different interaction part-
ners.
The depicted mDia domains of mDiaN •RhoC (PDB: 1Z2C), mDiaN∆G •mDiaDAD (PDB: 2BAP),
mDiaN (PDB: 2BNX) and mDiaDID •Lip567–587 (PDB: 4UWX) were superposed on mDiaDID
(aa 135–369). The root mean square deviations were within a range of 0.401–0.583 Å for the
peptide backbone and 0.367–0.541 Å for the Cα-atoms, displaying the high similarities in the
mDiaDID. Structural differences can be observed in the interdomain helix (ID) and the following
dimerization domain (DD, aa 370–451).
The second possible mechanism that could explain the displacement of Liprin-α3 from
mDia1 by RhoA is based on the electrostatic interactions between RhoA and mDiaN. In
presence of Liprin-α3 the association rates of RhoA and mDia1 were reduced, whereas
the dissociation rates were nearly unaffected, under the conditions tested. Earlier
studies implicated the importance of electrostatics for the association rates in protein
complex formation, e.g. for the interaction of Raf-RBD and Ras (Sydor et al., 1998;
Vijayakumar et al., 1998). A similar effect was also observed with the opposite charge
mutation K133E in the Rho-insert helix, which reduced the association rate of RhoA
to mDiaN (Lammers et al., 2008). Liprin-α3 binds to mDiaDID at a highly negatively
charged patch along the ID. In complex with mDiaN the positively charged insert helix
of RhoA is in close proximity to this patch (Figure 5.3). Taken together, presence of
Liprin-α3 could lead to a reduced electrostatic attraction of RhoA by mDia1, resulting
in a slower association.
5.3. Liprin-α3 interferes with mDiaDAD and RhoA binding 93
+ 10 kTe-1
- 10kTe-1
Liprin-α3
Diaphanous-inhibitory
domain (DID)
RhoC•GppNHp
C
N
Rho-insert helix
switch 
I/II
 region
interdomain helix 
(ID)
Figure 5.3 Electrostatic surface potential of mDiaDID in a putative ternary complex with
RhoC and Liprin-α3.
The mDiaDID •Lip567–587 structure (PDB: 4UWX) is shown together with RhoC from the
mDiaN •RhoC complex (PDB: 1Z2C). In addition the electrostatic surface potential of mDiaDID
is plotted onto the surface. Liprin-α3 interacts with the negatively charged groove on the
mDiaN surface, which is also in interaction distance of the Rho-insert helix. The shown elec-
trostatic surface potential of mDiaDID was generated using the Adaptive Poisson-Boltzmann
Solver (APBS). Blue represents a positive and red a negative charge. Scaled from -8 to +8 kTe-1.
RhoA has a bipartite binding site on mDia1 and the measured association rates were
2–3 orders of magnitude lower than expected for a diffusion controlled reaction.
Based on this at least a two-step binding mechanism can be assumed (5.1). Similar
mechanisms have also been postulated for the dissociation of mDiaDAD from mDiaDID
by RhoA (Rose et al., 2005) and the nucleotide exchange of Ras-like proteins by guanine-
nucleotide exchange factors (Vetter & Wittinghofer, 2001).
mDiaN • LiprinT + RhoA
k+1−⇀↽−
k−1
mDiaN • LiprinT • RhoAL
k+2−⇀↽−
k−2
mDiaN • RhoAT + Liprin
(5.1)
with T = tight and L = loose
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In accordance to a two-step binding mechanism, Liprin-α3 forms tight complex with
mDiaN. During the initial binding step active RhoA forms a loose contact with the
GTPase-binding domain of mDiaN (GBDN), which is not influenced by the presence
of Liprin-α3. Subsequently, RhoA binds to the armadillo repeat region of mDiaN
(mDiaDID) with residues from switch I/II and the Rho-insert helix. This would result
in a tight association of RhoA to mDiaN and finally to the dissociation of Liprin-α3
from mDiaDID.
5.4. Regulation of the inhibitory potency of Liprin-α3
While the overexpression of the smallest Liprin-α3 fragments reduced the amount of
F-actin in HeLa and N2a cells, full-length Liprin-α3 exclusively displayed this actin
reducing effect in neuroblastoma cells (N2a). This indicates that cell-type dependent
mechanisms must exist to bring full-length Liprin-α3 into a state capable of mDia1
binding and inactivation. Furthermore, overexpressed full-length Liprin-α3 was local-
ized at the plasma membrane of N2a cells, whereas it was clustered in the cytosol of
HeLa cells. A similar distribution was also detectable for the C-terminally truncated
fragment Lip1–817 in HeLa cells. In contrast, all N-terminally truncated Liprin-α3 frag-
ments tested, showed a diffuse cytosolic distribution. Taken together these data point
out the importance of the Liprin-α3 N-terminus for its regulation and that additional
events must occur in vivo, localizing Liprin-α3 at the cell periphery. This assumption is
further supported by the in vitro characterization of the different Liprin-α3 fragments.
In comparison to the shorter fragments, the N-terminally longest fragment, Lip217–587,
bound mDia1 with a 2–3 fold reduced affinity, as determined by ITC. Additionally,
the stoichiometry for this reaction was 0.5 (N = 1.0 for N-terminally truncated frag-
ments), indicating that one mDia1 molecule bound two Liprin-α3 fragments. The
effect was independent of the oligomeric state of the mDia1 fragments, since it was
observed using the mDiaDID monomer ,as well as the dimeric mDiaNCC fragment.
In accordance to this, the size exclusion chromatography analysis indicate a higher
oligomeric state of Lip217–587 compared to the shorter fragment analyzed. Furthermore,
Lip217–587 induced the lowest reduction of the RhoA-mDiaN association rate in the
stopped-flow experiments. Hence, it can be assumed that the N-terminus of Liprin-α3
mediates the homooligomerization, which leads to the masking of one mDia1 binding
site. The functional importance of the N-terminus for Liprin-α3 oligomerization and
the corresponding physiological influence has also been investigated for the role of
Liprin-α3 during the presynaptic assembly in C. elegans (Taru & Jin, 2011).
Besides the oligomeric state of Liprin-α3, additional events that regulate the localiza-
tion seem to be important for its functionality. The recruitment of Liprin-α3 to the
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plasma membrane in N2a cells is most likely induced by proteins of the leukocyte com-
mon antigen-related (LAR) family of transmembrane protein tyrosine phosphatases.
These proteins, which also led to the discovery of Liprins, are an integral component
of the plasma membrane and are mainly expressed in neuronal tissues. The binding
of Liprins to the cytoplasmic phosphatase domain of the transmembrane tyrosine
phosphatase occurs via the C-terminus of Liprins (Pulido et al., 1995), which was
missing in the shorter Liprin-α3 fragments tested. One possible result of the receptor
binding could be the dissociation of Liprin-α3 oligomers, which might unmask binding
sites for mDia1. Another consequence of the recruitment of Liprin-α3 to the plasma
membrane is the increase in its local subcellular concentration. Thereby, Liprin-α3
would be able to compete more efficiently with other proteins for mDia1 binding.
Another regulatory mechanism of Liprin-α3 that has been investigated for the first
time in this work is its phosphorylation at the conserved T567. This site has been
identified by mass spectrometry to be phosphorylated in human Liprin-α3. ITC studies
with the phosphomimetic mutant Lip567–587 T567E showed an approximately sixfold
reduced affinity to mDiaDID. This effect might be even stronger in vivo using the
phosphorylated tyrosine, instead of the mimetic mutant. Since, this site is conserved
throughout many organisms it is most likely that phosphorylation events at this site
play an important role in the regulation of Liprin-α3. Further studies are needed to
show how this phosphorylation is spatially and temporally regulated in vivo and to
find out which kinases and phosphatases are involved.
5.5. Mechanisms explaining the inhibition of F-actin
formation by Liprin-α3
The recruitment of further regulatory proteins by Liprin-α3, such as RhoGAPs has been
postulated as a possible mechanism, that explains the inhibitory effect of Liprin-α3 on
the F-actin formation (Sakamoto et al., 2012b). It has been reported, that the Xenopus
Liprin xKazrinA binds to RhoGAP p190B (Cho et al., 2010). A similar interaction
has also been identified between the C. elegans Liprin Syd-2 and Syd-1, a protein
containing a Rho-GTPase-like activating domain (Hallam et al., 2002). Admittedly,
interactions between Liprins and RhoGAPs have not been shown in mammals so far.
The recruitment of RhoGAPs by Liprin-α3 could lead to an enhanced hydrolysis of
the bound nucleotide and thereby inactivation of the Rho protein and its subsequent
displacement from mDia1. In the experiments conducted in this work even the
shortest Liprin-α3 fragments, containing only the essential amino acids needed for
the binding of mDia1, had the same effect on the amount of cellular F-actin as longer
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fragments. Based on their small size it is unlikely that these fragments are able to
recruit further regulatory proteins to mDia1. Therefore, the observed reduction in the
amount of cellular F-actin induced by short Liprin-α3 fragments must be regulated by
other mechanisms. However, it is still likely and not excluded from these data, that
full-length Liprin-α3 recruits other proteins to mDia1 in vivo.
The shortest Liprin-α3 fragment, that displayed an F-actin reducing effect in cells
was Lip576–582 (LCR). This fragment is not capable to sterically interfere with the
catalytic FH1 and FH2 domains of mDia1, when it is bound to mDiaDID. Therefore, the
F-actin reducing effect of the short Liprin-α3 fragments in HeLa and N2a cells must
be directly connected to the mDiaDID binding. Different mechanisms how the presence
of Liprin-α3 downregulates the function of mDia1 and constrains the activation by
RhoA are highlighted hereafter and are also summarized in Figure 5.4.
Firstly, the presence of Liprin-α3 alters the autoinhibitory regulation of mDia1 by
shifting the equilibrium of RhoA and mDiaDAD for mDiaN binding into the direction of
mDiaDAD. RhoA binds to mDiaN with a slightly higher affinity (KD = 4 nM), compared
to DAD1145–1209 (KD = 3–14 nM). In presence of Liprin-α3 the binding affinity of RhoA
to mDiaN is more strongly reduced (10–15 fold to 40–60 nM), compared to DAD1145–1209
(3–4 fold to 23 nM). As a result, mDiaDAD has a higher potential than RhoA to bind to
mDiaN, supporting the re-establishment of the autoinhibited state.
Secondly, it has been shown, that RhoGAPs bind to GTP loaded RhoA with an affinity
in the low nanomolar range (Graham et al., 1999). The 10–15 fold reduced binding
affinity of RhoA to mDia1, in presence of Liprin-α3 might lead to a more sufficient
competition of regulatory proteins such as RhoGAPs. Presence of Liprin-α3 could
support the inactivation of RhoA and subsequently lead to the inactivation of mDia1.
A similar effect might occur for mDiaDAD. The interaction of the C-terminal region
of mDia1 with PIP2 at the plasma membrane has been shown to inhibit the mDia1
mediated F-actin formation (Ramalingam et al., 2010). It has been postulated that
the inhibition of mDia1 is mediated by blocking the interaction of the FH2 domain
with actin subunits, leading to decreased actin nucleation and polymerization. In
the Liprin-α3 bound state the competitive binding potency of mDiaDID for mDiaDAD
decreases, which could support the interaction of mDiaDAD with PIP2. This would
lead to an altered inhibition mechanism of mDia1 due to an enhanced insertion of its
C-terminus into the plasma membrane.
Thirdly, Liprin-α3 can interfere with other proteins that have been reported to bind to
the mDiaDID. Sakamoto et al. showed, that the binding of Liprin-α3 to mDiaN leads
to the translocation of mDia1 from the plasma membrane. For example, IQGAP1
has been reported to recruit mDia1 to the plasma membrane in phagocytic cups, by
binding to mDiaDID (Brandt et al., 2007). Additional proteins that are identified to
bind to mDiaDID-DD and are reported to be involved in the localization of mDia1 are
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Neurochondrin, Abi, Anillin and the recently identified F-Bar protein CIP4/Toca-1
(Ryu et al., 2009; Schwaibold & Brandt, 2008; Watanabe et al., 2010; Yan et al., 2013).
These proteins might also recruit further regulatory proteins to mDia1. In the case of
Anillin it has been shown, that it interacts with RhoA (Piekny & Glotzer, 2008). Thus,
binding of Liprin-α3 to mDiaDID might interfere with a range of mDia1 regulating
events, possibly enhancing the inhibitory potential of Liprin-α3.
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Figure 5.4 Model for the inhibition
of mDia1 function by Liprin-α3.
The Liprin-core-region (LCR, aa 567–
582) binds to mDiaDID only in the
open state of the formin. In pres-
ence of Liprin-α3 the binding affin-
ity of mDiaDAD to mDiaN is more
efficiently reduced than RhoA bind-
ing. Thereby, the re-establishment of
the autoinhibited conformation is sup-
ported. Furthermore, blocking of the
mDiaDID binding interface for other
proteins, such as IQGAPs could inter-
fere with the membrane localization
of mDia1. Additionally, other Rho reg-
ulatory proteins, such as RhoGAPS
could be recruited by Liprin-α3, lead-
ing to RhoA inactivation and dissoci-
ation from mDiaN (not shown in the
model). The simplified model does
not include the dimeric state of mDia1
and oligomeric states (homo- and het-
erooligomers) of Liprin-α3.
5.6. Physiological relevance of the mDia1-Liprin-α3
interaction
The regulation of synapse morphogenesis by Liprins (Dliprin-α) and the receptor
protein tyrosine phosphatase (Dlar) has been firstly described in Drosophila (Kaufmann
et al., 2002). Further studies showed that the Dlar induced modulation of synaptic
actin is linked to Diaphanous-related formins (DRFs) (Pawson et al., 2008). As shown
in this study and by Sakamoto et al., Liprin-α3 is able to directly regulate the activity
of mDia1 and thereby the formation of cellular F-actin. Hitherto, the interactions of
Liprins and DRFs have been exclusively described in neuronal cells. Primarily mDia1
has been described for the formin induced regulation of actin in a neuronal context
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(Arakawa et al., 2003). Taken together, the inhibition of formins by Liprin-α3 seems to
display an exclusive mechanism for mDia1 regulation, that is specific for neuronal cells
and tissues. This is further supported by the already highlighted binding specificity of
mDia1 and Liprin-α3, which is mainly expressed in neuronal cells.
Although the postulated models (5.5) explain how Liprin-α3 might exert the inhibitory
effect on F-actin formation, some general questions remain unanswered. Taken
the much higher affinities of mDiaDAD and RhoA for mDiaN it is not obvious how
Liprin-α3 can bind to mDia1 in the first place. The ITC competition analyses performed
in this study support the postulated idea, that Liprin-α3 preferentially binds to mDia1
in the open conformation (Sakamoto et al., 2012a). This indicates, that additional
cellular mechanisms must exist holding the formin in an open conformation even if
RhoA is released. In line with this, in vitro actin polymerization assays showed, that
mDia1 is only partially activated by RhoA (Maiti et al., 2012). Current models postulate
an interaction of the mDia1 N-terminus with the negatively charged PIP2, following the
RhoA mediated recruitment of mDia1 to the plasma membrane. Subsequently, binding
of scaffold proteins, such as IQGAP, to mDiaDID further strengthen the interaction of
the N-terminus with the plasma membrane. Finally, the C-terminus of mDia1 also
clusters PIP2, resulting in its insertion into the lipid bilayer and the inhibition of formin
induced actin polymerization (Ramalingam et al., 2010). Hitherto, no mechanisms
are known, that keep cytosolic mDia1 in an open conformation. Taken together with
the periphery localization of full-length Liprin-α3 in N2a cells, this indicates that the
binding of Liprin-α3 to mDia1 is spatially restricted to the plasma membrane.
Binding of Liprin-α3 to mDia1 could aid in the establishment of an inactive pool of
mDia1, that might either still be bound to the plasma membrane or gets translocated
to the cytoplasm. Sakamoto et al. showed that Liprin-α3 induces the translocation of
mDiaN∆GCC (aa 135–570) from the plasma membrane. However, in their experiment
Sakamoto et al. did not take into account the far N- and C-terminus of mDia1, which
also strongly contribute to the localization of mDia1. In further studies it should be
investigated whether Liprin-α3 can also interfere with RhoA independent mechanisms
that localize full-length mDia1 at the plasma membrane, e.g. the interactions of IQGAP,
Anillin, Toca-1 or Neurochondrin with mDia1 or the insertion of the N-terminal
domain into the lipid bilayer.
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5.7. Conclusion and Outlook
In a comprehensive, functional and structural study the interaction of Liprin-α3 with
mDia1 and the interplay with RhoA and mDiaDAD were analyzed. It was shown
that Liprin-α3 is able to reduce the binding of both, mDiaDAD and RhoA, to mDiaDID.
Moreover, cell culture experiments showed, that the minimal mDia1-binding Liprin-α3
peptide (Liprin-core region, LCR) is able to reduce the amount of cellular F-actin.
Additionally, the presented data highlight the importance of the oligomeric state of
Liprin-α3 and indicate a possible regulation by phosphorylation.
Although, the results from this study can explain the fundamental mechanisms of how
mDia1 function is inhibited by Liprin-α3, succeeding studies are needed to investigate
the regulation under physiological conditions. The local concentration, the regulation
via post-translational modifications and the localization of the interaction partners
can influence the interplay mechanistically. Further experiments might answer how
Liprin-α3 is able to bind to mDia1 in the first place and in which sequential order the
activation by RhoA, inhibition by mDiaDAD and binding of Liprin-α3 to mDia1 occur.
Super-resolution microscopy and FRET assays might aid in answering these questions
and could give further insights into the impact of Liprin-α3 on the localization and
autoinhibition of mDia1 in cells.
This study elucidates, that besides functioning as a scaffold protein Liprin-α3 is also
involved in the regulation of the actin cytoskeleton. The results of this study could be
of therapeutic interest, since they might display new possibilities to regulate F-actin
formation during processes such as metastasis or tumor invasions, by specific inhibition
of formins.
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Figure A.1 Mutational analysis of the mDia1-Liprin-α3 interaction I.
ITC measurements of Lip561–587 containing the indicated mutations with mDia1 fragments.
Experiments were performed at 20 ◦C in protein buffer. No binding could be detected for any
of the tested mutations in Liprin-α3.
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Figure A.2 Mutational analysis of the mDia1-Liprin-α3 interaction II.
ITC measurements of Lip567–587 with mDia1 fragments containing the indicated mutations.
Experiments were performed at 20 ◦C in protein buffer. (KD: equilibrium constant; ∆H: changes
in reaction enthalpy; ∆S: change in reaction entropy; N: stoichiometry of binding; T: temperature
in Kelvin)
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Figure A.3 Interaction of mDia1 and Liprin-α3 as determined by ITC I.
Shown are the ITC measurements of the depicted mDia1 and Liprin-α3 fragments at 20 ◦C in
protein buffer. The determined equilibrium constant (KD) is shown for every interaction. All
thermodynamic data are summarized in Table 4.2.
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Figure A.4 Interaction of mDia1 and Liprin-α3 as determined by ITC II.
Shown are the ITC measurements of the depicted mDia1 and Liprin-α3 fragments at 20 ◦C in
protein buffer. The determined equilibrium constant (KD) is shown for every interaction. All
thermodynamic data are summarized in Table 4.2.
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Figure A.5 Interaction of mDia1 and Liprin-α3 as determined by ITC III.
Shown are the ITC measurements of the depicted mDia1 and Liprin-α3 fragments at 20 ◦C in
protein buffer. No binding could be detected using these fragments. The thermodynamic data
are summarized in Table 4.2.
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Figure A.6 Analytical size exclusion chromatography of Liprin-α3 and mDia1 mutants.
The purified Liprin561–587 and mDia135–369 fragments containing the depicted mutations
were analyzed by size exclusion chromatography using S75 10/300 and S200 10/300 columns.
Elution was monitored at 280 nm. All fragments showed a similar running behavior.
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Figure A.7 Ramachandran plots by residue type.
Ramachandran analysis was performed with MolProbity version 4.2 (Chen et al., 2009). 99.4 %
(480/483) of all residues were in favored (98 %) regions. 100.0 % (483/483) of all residues were
in allowed (>99.8 %) regions. There were no outliers.
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Table A.1 Validation of the Lip567–587 •mDiaN structure. Validation by MolProbity 4.0 version
4.02 Clashscore is the number of serious steric overlaps (> 0.4 ,Å) per 1000 atoms
No. of residues (total: 483) No. of residues in % Goal in %
Poor rotamers 0 0 <1
Ramachandran outliers 0 0 <0.05
Ramachandran favored 480 99.38 >98
Ramachandran allowed 483 100 >99.8
Cb-deviations >0.25 Å 0 0 0
Clashscore 2.39
0.0 0.5 1.0 1.5 2.0
0.00
2.00
4.00
6.00
-0.10
-0.05
0.00
0.05
0.10
0.15
0.20
0.25
0 10 20 30 40
time / min
µc
al
/s
ec
kc
al
 m
ol
-1
 o
f i
nj
ec
ta
nt
Liprin-α3 (457-587)
 
• mDia1 (135-570)
N 1.0 0.02 Sites
K 23
±
13 nM
5.6
±
0.1 kcal mol-1
T∆S 15.9
∆H ±
kcal mol-1
27
270
µM
µMmDiaDAD (1145-1209)
one-site model:
N 1.0 0.03 Sites
K 3
±
1.6 nM
3.9
±
0.1 kcal mol-1
T∆S  no data
∆H ±
competitive-model
[DAD1145-1209]
[Lip457-587•mDiaN∆GCC]-1
14.77
elution / mL
8 10 12 14 16 18ab
so
rp
tio
n 
at
 2
80
/2
20
 n
m
 / 
m
AU
0
100
200
300
Peak 1 Peak 2
11.42
mDia1
Liprin
DAD
      
M   1     2   
Peak 
250
kDa
130
100
70
55
35
15
25
10
A
B
Figure A.8 ITC experiments to analyze the influence of Lip457–587 on the
mDiaN∆GCC •mDiaDAD binding thermodynamics.
B: DAD1145–1209 was titrated to a preformed complex of mDiaN∆GCC •Lip457–587. The obtained
binding curve was fitted with the one-site and the competitive model (KD: equilibrium
constant; ∆H: changes in reaction enthalpy; ∆S: change in reaction entropy; N: stoichiometry of
binding; T: temperature in Kelvin). B: Size exclusion chromatography and SDS-PAGE analysis
of the putative ternary mDiaN∆GCC •Lip457–587 •mDiaDAD complex. The cell content of the
ITC measurement from (A) was used for an analytical size exclusion chromatography run (S75
10/300) and the resulting peaks from the SEC were analyzed by SDS-PAGE. Lip457–587 was
dissociated from mDiaN∆GCC by mDiaDAD.
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Figure A.9 Primary data of the association-rates determined by stopped-flow kinetics.
The fluorescence signal is shown over time for mDiaN without (A) or in presence of Liprin-α3
fragments (B-F). 250 nM (final concentration) of RhoA •mant-GppNHp was titrated with
increasing mDia1 concentration (final: 0.6 µM–40.7 µM) establishing pseudo-first order condi-
tions. Single exponential fits to the primary data result in the observed rate-constants, kobs for
association of RhoA and mDiaN with and without Liprin-α3.
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Abbreviations
% percentage
% (v/v) volume per volume (volume fraction)
% (w/v) weight per volume (mass fraction)
◦C degree Celsius
µ micro
b-ME b-mercaptoethanol
∆G Gibbs free energy change
∆H reaction enthalpy change
∆S reaction entropy change
aa amino acids
A ampere
ARM armadillo repeat
ARR armadillo repeat region
BSA bovine serum albumin
CC coiled-coil
CF carboxyuorescein
Da dalton
DAD Diaphanous-autoregulatory domain
DAPI 4’,6-Diamidin-2-phenylindol
DBR DAD-basic region
DCR DAD-core region
DD dimerization domain
DID Diaphanous-inhibitory domain
DMEM Dulbecco’s Modied Eagle’s Medium
DNA deoxyribonucleic acid
dNTP deoxyribonucleotide
DP differential power
DRF Diaphanous-related formin
e extinction coefcient
e.g. exempli gratia (for example)
et al. et alteri/-a/-um (and others)
FH formin holomogy domain
g gravitational acceleration
g gram
GAP GTPase-activating protein
GBD GTPase binding domain
128 A. Abbreviations
GDP guanosine diphosphate
GEF guanine nucleotide exchange factor
GSH glutathion
GTP guanosine triphosphate
h hour
HRP horseradish peroxidase
IPTG isopropyl-ß-D-thiogalactopyranosid
ITC isothermal titration calorimetry
KA equilibrium association constant
Kass association rate constant
KD equilibrium dissociation constant
Kdiss dissociation rate constant
Kobs observed association rate constants
L liter
LB lysogeny broth
ln natural logarithm
mant methylanthraniloyl
m milli
M molar
mDia mouse Diaphanous-related protein
min minute
n nano
NPF nucleation promoting factor
O/N over night
OD optical density
PBS phosphate buffered saline
PBST phosphate buffered saline containing Tween-20
PCR polymerase chain reaction
pH pondus hydrogenii
PTM posttranslational modification
PVDF polyvinylidene fluoride
R gas constant
rpm rounds per minute
RT room temperature
SDS-PAGE sodium dodecyl sulfate polyacrylamide gel electrophoresis
sec, s second
SEC size exclusion chromatography
Tris tris(hydroxymethyl)aminomethane ((HOCH2)3CNH2)
U unit
V voltage
v volume
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